
<html lang="en"     class="pb-page"  data-request-id="8a4fd6dd-ea72-4b2e-8a09-b5e9bfee58d0"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.1c00166;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2021.64.issue-14"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of 8,9-seco-ent-Kaurane Diterpenoids as Potential Leads for the Treatment of Triple-Negative Breast Cancer" /></meta><meta name="dc.Creator" content="Run-Zhu  Fan" /></meta><meta name="dc.Creator" content="Lin  Chen" /></meta><meta name="dc.Creator" content="Tong  Su" /></meta><meta name="dc.Creator" content="Wei  Li" /></meta><meta name="dc.Creator" content="Jia-Luo  Huang" /></meta><meta name="dc.Creator" content="Jun  Sang" /></meta><meta name="dc.Creator" content="Gui-Hua  Tang" /></meta><meta name="dc.Creator" content="Sheng  Yin" /></meta><meta name="dc.Description" content="Triple-negative breast cancer (TNBC) is a lethal malignancy without safe and effective therapeutic drugs. In this study, the anti-TNBC bioassay-guided isolation of the medicinal plant Croton kongen..." /></meta><meta name="Description" content="Triple-negative breast cancer (TNBC) is a lethal malignancy without safe and effective therapeutic drugs. In this study, the anti-TNBC bioassay-guided isolation of the medicinal plant Croton kongen..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 8, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.1c00166" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00166" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.1c00166" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00166" /></link>
        
    
    

<title>Discovery of 8,9-seco-ent-Kaurane Diterpenoids as Potential Leads for the Treatment of Triple-Negative Breast Cancer | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00166" /></meta><meta property="og:title" content="Discovery of 8,9-seco-ent-Kaurane Diterpenoids as Potential Leads for the Treatment of Triple-Negative Breast Cancer" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0013.jpeg" /></meta><meta property="og:description" content="Triple-negative breast cancer (TNBC) is a lethal malignancy without safe and effective therapeutic drugs. In this study, the anti-TNBC bioassay-guided isolation of the medicinal plant Croton kongensis followed by the structural modification led to the construction of a small ent-kaurane diterpenoid library (1–25). With subsequent biological screening, 20 highly potent compounds (IC50s &lt; 3 μM) were identified. Among them, 8,9-seco-ent-kaurane 6 displayed comparable activity (IC50s ∼ 80 nM) to doxorubicin but with better selectivity. The analysis of structure–activity relationships suggested that the cleavage of the C8–C9 bond and the presence of α,β-unsaturated ketone moiety were essential for the activity. The mechanistic study revealed that 6 induced apoptosis, autophagy, and metastasis suppression in TNBC cells via inhibition of Akt. In vivo, 6 significantly suppressed the TNBC tumor growth without causing side effects. All these results suggested that 6 may serve as a promising lead for the development of novel anti-TNBC agents in the future." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.1c00166"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00166">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.1c00166&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.1c00166&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.1c00166&amp;href=/doi/10.1021/acs.jmedchem.1c00166" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 9926-9942</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.1c00133" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.1c00175" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of 8,9-seco-<i>ent</i>-Kaurane Diterpenoids as Potential Leads for the Treatment of Triple-Negative Breast Cancer</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Run-Zhu Fan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Run-Zhu Fan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Run-Zhu++Fan">Run-Zhu Fan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lin Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lin Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lin++Chen">Lin Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tong Su</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tong Su</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tong++Su">Tong Su</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wei Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wei Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Li">Wei Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jia-Luo Huang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jia-Luo Huang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jia-Luo++Huang">Jia-Luo Huang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jun Sang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jun Sang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jun++Sang">Jun Sang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0003-1446-7501" title="Orcid link">https://orcid.org/0000-0003-1446-7501</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gui-Hua Tang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gui-Hua Tang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gui-Hua++Tang">Gui-Hua Tang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-8831-7154" title="Orcid link">https://orcid.org/0000-0002-8831-7154</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Sheng Yin</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sheng Yin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#fe8797908d96ccbe939f9792d08d878d8bd09b9a8bd09d90"><span class="__cf_email__" data-cfemail="5a2333342932681a373b3336742923292f743f3e2f743934">[email protected]</span></a>. Tel and Fax: +86-20-39943090.</span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sheng++Yin">Sheng Yin</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-5678-6634" title="Orcid link">https://orcid.org/0000-0002-5678-6634</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00166&amp;href=/doi/10.1021%2Facs.jmedchem.1c00166" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 9926–9942</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 8, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>28 January 2021</li><li><span class="item_label"><b>Published</b> online</span>8 July 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 July 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.1c00166" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00166</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9926%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRun-Zhu%2BFan%252C%2BLin%2BChen%252C%2BTong%2BSu%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D14%26contentID%3Dacs.jmedchem.1c00166%26title%3DDiscovery%2Bof%2B8%252C9-seco-ent-Kaurane%2BDiterpenoids%2Bas%2BPotential%2BLeads%2Bfor%2Bthe%2BTreatment%2Bof%2BTriple-Negative%2BBreast%2BCancer%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9942%26publicationDate%3DJuly%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.1c00166"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">665</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.1c00166" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of 8,9-seco-ent-Kaurane Diterpenoids as Potential Leads for the Treatment of Triple-Negative Breast Cancer&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Run-Zhu&quot;,&quot;last_name&quot;:&quot;Fan&quot;},{&quot;first_name&quot;:&quot;Lin&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Tong&quot;,&quot;last_name&quot;:&quot;Su&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Jia-Luo&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Jun&quot;,&quot;last_name&quot;:&quot;Sang&quot;},{&quot;first_name&quot;:&quot;Gui-Hua&quot;,&quot;last_name&quot;:&quot;Tang&quot;},{&quot;first_name&quot;:&quot;Sheng&quot;,&quot;last_name&quot;:&quot;Yin&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;9926-9942&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.1c00166&quot;},&quot;abstract&quot;:&quot;Triple-negative breast cancer (TNBC) is a lethal malignancy without safe and effective therapeutic drugs. In this study, the anti-TNBC bioassay-guided isolation of the medicinal plant Croton kongensis followed by the structural modification led to the construction of a small ent-kaurane diterpenoid library (1–25). With subsequent biological screening, 20 highly potent compounds (IC50s &lt; 3 μM) were identified. Among them, 8,9-seco-ent-kaurane 6 displayed comparable activity (IC50s ∼ 80 nM) to doxorubicin but with better selectivity. The analysis of structure–activity relationships suggested that the cleavage of the C8–C9 bond and the presence of α,β-unsaturated ketone moiety were essential for the activity. The mechanistic study revealed that 6 induced apoptosis, autophagy, and metastasis suppression in TNBC cells via inhibition of Akt. In vivo, 6 significantly suppressed the TNBC tumor growth without causing side effects. All these results suggested that 6 may serve as a promising lead for the development of &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00166&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00166" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00166&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00166" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00166&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00166" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00166&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00166&amp;href=/doi/10.1021/acs.jmedchem.1c00166" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.1c00166" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.1c00166" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.1c00166%26sid%3Dliteratum%253Aachs%26pmid%3D34236840%26genre%3Darticle%26aulast%3DFan%26date%3D2021%26atitle%3DDiscovery%2Bof%2B8%252C9-seco-ent-Kaurane%2BDiterpenoids%2Bas%2BPotential%2BLeads%2Bfor%2Bthe%2BTreatment%2Bof%2BTriple-Negative%2BBreast%2BCancer%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D14%26spage%3D9926%26epage%3D9942%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291651" title="Anions">Anions</a>,</li><li><a href="/action/doSearch?ConceptID=291149" title="Apoptosis">Apoptosis</a>,</li><li><a href="/action/doSearch?ConceptID=292527" title="Autophagy">Autophagy</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00166&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Triple-negative breast cancer (TNBC) is a lethal malignancy without safe and effective therapeutic drugs. In this study, the anti-TNBC bioassay-guided isolation of the medicinal plant <i>Croton kongensis</i> followed by the structural modification led to the construction of a small <i>ent</i>-kaurane diterpenoid library (<b>1</b>–<b>25</b>). With subsequent biological screening, 20 highly potent compounds (IC<sub>50</sub>s < 3 μM) were identified. Among them, 8,9-seco-<i>ent</i>-kaurane <b>6</b> displayed comparable activity (IC<sub>50</sub>s ∼ 80 nM) to doxorubicin but with better selectivity. The analysis of structure–activity relationships suggested that the cleavage of the C8–C9 bond and the presence of α,β-unsaturated ketone moiety were essential for the activity. The mechanistic study revealed that <b>6</b> induced apoptosis, autophagy, and metastasis suppression in TNBC cells via inhibition of Akt. <i>In vivo</i>, <b>6</b> significantly suppressed the TNBC tumor growth without causing side effects. All these results suggested that <b>6</b> may serve as a promising lead for the development of novel anti-TNBC agents in the future.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41257" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41257" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Breast cancer (BC) is the most common female malignancy and represents the second leading cause of cancer death worldwide.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Although most BCs are curable in an early stage with the progress of diagnostic techniques and targeted treatments, a specific subtype of BC, triple-negative breast cancer (TNBC), still remains high mortality due to its high metastatic and recurrent rates.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> TNBC, accounting for 15–20% in diagnosed BCs, is characterized by being devoid of the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Because it lacks the targetable receptors that are expressed in other types of BC and possesses complex pathological processes, treating this notoriously aggressive disease is challenging. Conventional chemotherapeutics, such as anthracyclines and taxanes, are still the primary option for TNBC in clinics.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Although these cytotoxic regimens may initially bring certain benefits to TNBC patients, their inevitable toxicity and easily decreased sensitivity (drug resistance) often result in poor clinical outcomes at later stages, with low survival rates and high recurrence rates.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Recent progress in TNBC drug discovery shows several promising targeted agents with clear mechanisms and fewer side effects, such as Akt inhibitor Capivasertib, PARP inhibitor Olaparib, and PD-L1 inhibitor Atezolizumab. However, these drugs are still under clinical trials.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> Thus, the discovery of safe and effective therapeutic agents for TNBC is still compelling.</div><div class="NLM_p last">Natural products have historically been of crucial importance in the identification and development of anticancer agents.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8−10)</a> In the past few years, our group has endeavored to discover anticancer agents from medicinal plants and has proved that Euphorbiaceae plants are valuable sources of structurally intriguing and biologically significant diterpenoids.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> In the current study, the anti-TNBC bioassay-guided isolation of a medicinal Euphorbiaceae plant, <i>Croton kongensis</i>, led to the isolation of a series of <i>ent</i>-kaurane diterpenoids. Subsequent structural modification and biological evaluation allowed the identification of 8,9-seco-<i>ent</i>-kaurane <b>6</b> as a promising anti-TNBC candidate. Herein, we report the details of the bioassay-guided isolation, structure elucidation, modification, and SARs of these diterpenoids, as well as the potential action mechanism of <b>6</b>.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84772" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84772" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Anti-TNBC Bioassay-Guided Isolation and Structure Elucidation</h3><div class="NLM_p">The air-dried powder of the stems of <i>C. kongensis</i> was extracted with 95% EtOH at room temperature. The resulting crude extract was then suspended in H<sub>2</sub>O and successively partitioned with petroleum ether, EtOAc, and <i>n</i>-butyl alcohol. The EtOAc fraction that displayed promising cytotoxicity against human TNBC cell line MDA-MB-231 (IC<sub>50</sub> = 6.8 μg/mL) was further subjected to a series of separations to afford compounds <b>1</b>–<b>9</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Among them, <b>1</b> and <b>2</b> are new compounds.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of compounds <b>1</b>–<b>25</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00166&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>1</b> was obtained as a colorless crystal. The molecular formula C<sub>20</sub>H<sub>30</sub>O<sub>5</sub> was established by its high-resolution electrospray ionization mass spectrometry (HRESIMS) data at <i>m</i>/<i>z</i> 373.1971 [M + Na]<sup>+</sup> (calcd: 373.1985). The <sup>1</sup>H and <sup>13</sup>C NMR spectra of <b>1</b> showed a high resemblance to those of shikoccidin, a known penta-oxygenated <i>ent</i>-kaurane diterpenoid, except for the absence of an acetyl group in shikoccidin.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Detailed two-dimensional (2D) NMR analyses (<sup>1</sup>H–<sup>1</sup>H COSY, HSQC, and HMBC) revealed that <b>1</b> bore a hydroxyl group at C-1 instead of an acetoxy at C-3 in shikoccidin (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00166/suppl_file/jm1c00166_si_001.pdf" class="ext-link">Figure S1</a>). The relative configuration of <b>1</b> was established by the NOESY experiment as well as comparison of its one-dimensional (1D) NMR data with those of shikoccidin. Particularly, the β-orientation of 1-OH was assigned by the NOE correlations of H<sub>3</sub>-20/H-1, H<sub>α</sub>-6, and H-14 (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00166/suppl_file/jm1c00166_si_001.pdf" class="ext-link">Figure S2</a>). Finally, the structure including the absolute configuration of <b>1</b> was confirmed by a single-crystal X-ray crystallographic analysis [flack parameter, 0.05 (7)] (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Compound <b>1</b> was given a trivial name crokongendin A.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. ORTEP diagram of compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00166&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>2</b> had the molecular formula C<sub>22</sub>H<sub>28</sub>O<sub>5</sub>, as established by HRESIMS (<i>m</i>/<i>z</i> 373.2001 [M + H]<sup>+</sup>, calcd 373.2010). The <sup>1</sup>H and <sup>13</sup>C NMR data (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00166/suppl_file/jm1c00166_si_001.pdf" class="ext-link">Table S1</a>) of <b>2</b> were similar to those of taibaihenryiin C, a known <i>ent</i>-abietane diterpenoid, with the notable differences being the presence of an α,β-unsaturated ketone moiety and the shifted location of the acetoxy group in <b>2</b>. A detailed 2D NMR analysis (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00166/suppl_file/jm1c00166_si_001.pdf" class="ext-link">Figure S1</a>) further assigned the α,β-unsaturated ketone and acetoxy groups at rings B and C-1, respectively. The stereochemistry of <b>2</b> was found to be the same as that of taibaihenryiin C<sup>14</sup> by the NOE experiment and comparison of their 1D NMR data. Therefore, compound <b>2</b> was assigned as depicted and was named crokongendin B.</div><div class="NLM_p last">The known compounds, euphoranginone D (<b>3</b>),<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a><i>ent</i>-kaurane-3-oxo-16β,17-diol (<b>4</b>),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a><i>ent</i>-16β-H-3-oxokauran-17-ol (<b>5</b>),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> kongensin D (<b>6</b>),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> kongeniod B (<b>7</b>),<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> kongensin A (<b>8</b>),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and kongensin F (<b>9</b>),<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> were identified by comparison of their spectroscopic data with those in the literature studies.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Structural Modification</h3><div class="NLM_p">As compounds <b>6–9</b> represent a rare 8,9-seco-<i>ent</i>-kaurane skeleton and <b>6</b> could be sustainably transformed from <i>ent</i>-kaurane <b>1</b> via the retro-aldol reaction, the structural modification was started from <b>6</b> and <b>8</b> with available amounts. Briefly, the α,β-unsaturated ketone moiety, the substituents on C-7 and C-1, and the formation of the C8–C9 bond were investigated to explore the influences of these kaurane-characterized functional groups on the activity. As shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, the acylation of 7-OH in <b>6</b> with ethanoyl chloride, benzoyl chloride, chloroacetyl chloride, propionyl chloride, acrylyl chloride, and 3-butenoyl chloride in triethyl amine and freshly distilled CH<sub>2</sub>Cl<sub>2</sub> afforded <b>10</b>, <b>11</b>, <b>12</b>, <b>13</b>, <b>14</b>, <b>15</b>, and <b>18</b>, respectively. The acylation of <b>8</b> with acryl chloride and chloroacetyl chloride under the same conditions yielded <b>16</b> and <b>17</b>, respectively. The oxidation of 1-OH in <b>6</b> with the Dess–Martin reagent in CH<sub>2</sub>Cl<sub>2</sub> gave ketone <b>19</b>, which underwent acetylation, benzoylation, and chloroacetylation to afford <b>20</b>, <b>21</b>, and <b>22</b>, respectively. The oxidation of the double bond in <b>6</b> with <i>m</i>-CPBA in CH<sub>2</sub>Cl<sub>2</sub> afforded 8,14-epoxide <b>23</b>. In addition, Pd/C-catalyzed hydrogenation of <b>6</b> in EtOAc and CH<sub>3</sub>OH resulted in the generation of <b>24</b> and <b>25</b>, respectively.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0012.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 8,9-seco-<i>ent</i>-Kaurane Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00166&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) CH<sub>3</sub>OH, rt, overnight; (b) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, rt, overnight; (c) Dess–Martin periodinane, CH<sub>2</sub>Cl<sub>2</sub>, rt, 4 h; (d) benzoyl/ethanoyl/chloroacetyl chlorides, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 4 h; (e) benzoyl/ethanoyl/propionyl/acryloyl/chloroacetyl/3-butenoyl chlorides, CH<sub>2</sub>Cl<sub>2</sub>, rt, 5 h; (f) ethanoyl/chloroacetyl chlorides, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 5 h; (g) 10% Pd/C, H<sub>2</sub>, EtOAc, rt, 2 h; and (h) 10% Pd/C, H<sub>2</sub>, CH<sub>3</sub>OH, rt, 2 h.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Effects of Diterpenoids on Breast Cancer Cell Lines</h3><div class="NLM_p">The cytotoxicity of the obtained diterpenoids was measured on human TNBC cell lines MDA-MB-231 (mesenchymal-like subtype) and MDA-MB-468 (basal-like I subtype) and the estrogen receptor positive BC cell line MCF-7 by the MTT method. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, most of the compounds (<b>1</b>, <b>2</b>, and <b>6–23</b>) exhibited potent cytotoxicity (IC<sub>50</sub>s < 3 μM) against all cell lines and were generally more effective on TNBC cells than on MCF-7. Among these diterpenoids, 8,9-seco-<i>ent</i>-kaurane <b>6</b> displayed the most pronounced activity on both TNBC cells (IC<sub>50</sub>s ∼ 80 nM), being comparable to the first-line drug doxorubicin (Dox).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Cytotoxicity of Diterpenoids toward BC Cell Lines<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">MDA-MB-231</th><th class="colsep0 rowsep0" align="center">MDA-MB-468</th><th class="colsep0 rowsep0" align="center">MCF-7</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">0.153 ± 0.0120</td><td class="colsep0 rowsep0" align="left">0.116 ± 0.00635</td><td class="colsep0 rowsep0" align="left">0.248 ± 0.0148</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">1.77 ± 0.185</td><td class="colsep0 rowsep0" align="left">0.842 ± 0.0953</td><td class="colsep0 rowsep0" align="left">1.24 ± 0.0601</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">>5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">>5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">>5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">0.0783 ± 0.00610</td><td class="colsep0 rowsep0" align="left">0.0716 ± 0.00228</td><td class="colsep0 rowsep0" align="left">0.113 ± 0.0103</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">0.185 ± 0.0220</td><td class="colsep0 rowsep0" align="left">0.121 ± 0.0131</td><td class="colsep0 rowsep0" align="left">0.215 ± 0.0213</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">0.177 ± 0.0135</td><td class="colsep0 rowsep0" align="left">0.228 ± 0.0180</td><td class="colsep0 rowsep0" align="left">0.120 ± 0.0120</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">0.677 ± 0.0602</td><td class="colsep0 rowsep0" align="left">0.236 ± 0.0110</td><td class="colsep0 rowsep0" align="left">0.266 ± 0.00317</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">0.561 ± 0.0748</td><td class="colsep0 rowsep0" align="left">0.257 ± 0.0279</td><td class="colsep0 rowsep0" align="left">0.587 ± 0.0462</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">0.466 ± 0.0690</td><td class="colsep0 rowsep0" align="left">0.301 ± 0.0319</td><td class="colsep0 rowsep0" align="left">0.999 ± 0.105</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">0.551 ± 0.0519</td><td class="colsep0 rowsep0" align="left">0.909 ± 0.166</td><td class="colsep0 rowsep0" align="left">1.09 ± 0.0682</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">0.983 ± 0.0502</td><td class="colsep0 rowsep0" align="left">0.893 ± 0.172</td><td class="colsep0 rowsep0" align="left">0.999 ± 0.0894</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">0.166 ± 0.0368</td><td class="colsep0 rowsep0" align="left">0.382 ± 0.0298</td><td class="colsep0 rowsep0" align="left">1.22 ± 0.0817</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">0.564 ± 0.0607</td><td class="colsep0 rowsep0" align="left">0.890 ± 0.0722</td><td class="colsep0 rowsep0" align="left">1.19 ± 0.149</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">0.978 ± 0.110</td><td class="colsep0 rowsep0" align="left">0.762 ± 0.0340</td><td class="colsep0 rowsep0" align="left">0.226 ± 0.0180</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">1.08 ± 0.095</td><td class="colsep0 rowsep0" align="left">0.643 ± 0.0326</td><td class="colsep0 rowsep0" align="left">0.235 ± 0.0497</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">0.237 ± 0.0293</td><td class="colsep0 rowsep0" align="left">0.395 ± 0.0450</td><td class="colsep0 rowsep0" align="left">1.12 ± 0.0359</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">0.1240 ± 0.0235</td><td class="colsep0 rowsep0" align="left">0.194 ± 0.0293</td><td class="colsep0 rowsep0" align="left">0.379 ± 0.0186</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">0.287 ± 0.0390</td><td class="colsep0 rowsep0" align="left">0.215 ± 0.0486</td><td class="colsep0 rowsep0" align="left">0.538 ± 0.0458</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">2.00 ± 0.284</td><td class="colsep0 rowsep0" align="left">2.07 ± 0.250</td><td class="colsep0 rowsep0" align="left">0.882 ± 0.128</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">1.61 ± 0.134</td><td class="colsep0 rowsep0" align="left">0.345 ± 0.0464</td><td class="colsep0 rowsep0" align="left">0.505 ± 0.0600</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">0.473 ± 0.0675</td><td class="colsep0 rowsep0" align="left">0.319 ± 0.0500</td><td class="colsep0 rowsep0" align="left">1.60 ± 0.0649</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">>5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">>5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Dox</td><td class="colsep0 rowsep0" align="left">0.0805 ± 0.0156</td><td class="colsep0 rowsep0" align="left">0.0521 ± 0.00713</td><td class="colsep0 rowsep0" align="left">0.0795 ± 0.00615</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Cells were treated with compounds for 96 h, and cell viability was determined by the MTT method. Data represented the mean ± standard deviation (SD) of at least three independent experiments, and each experiment was performed in triplicate. Cell viability was calculated according to the following formula: <span class="NLM_inline-formula"><img class="imgWithoutFigViewer inline-formula-styles" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_m001.gif" alt="" id="_i9" /></img></span> Doxorubicin was used as a positive control.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Structure–Activity Relationships</h3><div class="NLM_p last">In general, 8,9-seco-<i>ent</i>-kaurane diterpenoids showed better activity than the <i>ent</i>-kaurane ones, suggesting that the cleavage of the C8–C9 bond was beneficial to the activity. <i>ent</i>-Kaureane <b>1</b> was an exception, probably due to its easy transformation to 8,9-seco-<i>ent</i>-kaurane <b>6</b> in the solution state (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Previous studies showed that <i>ent</i>-kauranes with good anti-TNBC activities normally featured an oxygen bridge between C-20 and C-6 or C-7.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a> For 8,9-seco-<i>ent</i>-kaurane type, the structural optimization was deployed on four regions, 1-OH, 7-OH, Δ<sup>8,14</sup>, and Δ<sup>16</sup>. The epoxidation of Δ<sup>8,14</sup> or hydrogenation of Δ<sup>16</sup> led to a dramatic decrease of the activity, as shown by <b>6</b> vs <b>23</b> and <b>25</b>, suggesting that the conjugated system in the <i>exo</i>-methylene cyclopentanone moiety was essential for the activity. The presence of 7-OH was favorable for the activity, as the acylation or etherification of this hydroxyl led to a decrease of the activity, as shown by <b>6</b> vs <b>7</b> and <b>10</b>–<b>15</b>, <b>8</b> vs <b>9</b>, <b>16</b> and <b>17</b>, and <b>19</b> vs <b>20</b>–<b>22</b>. Within the 7-OH modification group, the presence of an ether group showed a better activity than the ester ones, as shown by <b>7</b> vs <b>10</b>–<b>15</b>, and <b>9</b> vs <b>16</b> and <b>17</b>. Similarly, the presence of 1-OH was beneficial to the activity, as the oxidation or acylation of 1-OH led to ca. 3-fold decrease in activity, as shown by <b>6</b> vs <b>8</b> and <b>19</b>. Overall, the free hydroxyls at C-1 and C-7 were considered to be positive factors for the activity, and the α,β-unsaturated ketone moiety was the key for cytotoxicity.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Evaluation of Cytotoxicity of <b>6</b> on Normal Cell Lines</h3><div class="NLM_p">As a promising anti-TNBC agent, the selectivity of <b>6</b> between the cancer cells and normal cells was evaluated. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, the cytotoxicity of <b>6</b> on human normal breast epithelial cell line MCF-10A, human embryonic kidney cell line HEK-293, and human normal liver cell line LO2 indicated its good selectivity over the TNBC cell lines, with the selectivity index (SI) values being at 14, 26 or greater than 66, respectively. Comparison with that of Dox, the superior SI of <b>6</b> suggested its safer and more-tolerated potential.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Cytotoxicity of 6 toward Normal Cell Lines<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">MCF-10A</th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">HEK-293</th><th class="rowsep1 colsep0" colspan="2" align="center">LO2</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cell types</th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">SI</th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">SI</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">SI</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char="±">1.05 ± 0.0602</td><td class="colsep0 rowsep0" align="char" char=".">14.0</td><td class="colsep0 rowsep0" align="char" char="±">1.96 ± 0.140</td><td class="colsep0 rowsep0" align="char" char=".">26.2</td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">>66.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Dox</td><td class="colsep0 rowsep0" align="char" char="±">0.0330 ± 0.00684</td><td class="colsep0 rowsep0" align="char" char=".">0.498</td><td class="colsep0 rowsep0" align="char" char="±">0.106 ± 0.0186</td><td class="colsep0 rowsep0" align="char" char=".">1.60</td><td class="colsep0 rowsep0" align="left">0.256 ± 0.0240</td><td class="colsep0 rowsep0" align="left">3.86</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Cells were treated with compounds for 96 h, and cell viability was determined by the MTT method. Data represented the mean ± SD of at least three independent experiments, and each experiment was performed in triplicate. Selectivity index (SI) was calculated according to the following formula: <span class="NLM_inline-formula"><img class="imgWithoutFigViewer inline-formula-styles" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_m002.gif" alt="" id="_i13" /></img></span>. Doxorubicin was used as a positive control.</p></div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Compound <b>6</b> Suppressed Proliferation of TNBC Cells</h3><div class="NLM_p">To evaluate the antiproliferative potential of <b>6</b> on TNBC cells, the colony formation assay was carried out. As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, the colony numbers of TNBC cells were dose-dependently decreased with the treatment of <b>6</b> in 2 weeks, suggesting that <b>6</b> could suppress the long-term proliferative capacity of TNBC cells.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Colony formation assay of MDA-MB-231 and MDA-MB-468 cells treated with or without different concentrations of <b>6</b> (0.05, 0.1, and 0.2 μM) for 2 weeks. The corresponding quantitative analysis is included. Data represented the mean ± SD of at least three independent experiments. *<i>P</i> < 0.05, <sup>**</sup><i>P</i> < 0.01, and <sup>***</sup><i>P</i> < 0.001 vs the solvent control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00166&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Compound <b>6</b> Induced TNBC G2/M Cell Cycle Arrest and Regulated the Expression of G2/M-Related Proteins</h3><div class="NLM_p">To explore the underlying mechanism of <b>6</b>, the regulation of <b>6</b> on the cell cycle was first evaluated. The TNBC cells were treated with various concentrations of <b>6</b>, and the cell cycle distribution was tested by flow cytometry. As illustrated in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A, <b>6</b> effectively arrested cells in the G2/M phase in a dose-dependent manner. Since cyclin B1/CDK1 complex plays a key role in promoting the progression of G2/M transition,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and it is mainly inhibited by the CDK inhibitor p21,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> the effects of <b>6</b> on the expression of cyclin B1, CDK1, and p21 were further evaluated by western blot. As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B, in <b>6</b>-treated TNBC cells, the expression of p21 was significantly upregulated while the expression of cyclin B1 and CDK1 were downregulated, suggesting that <b>6</b> induced TNBC cell G2/M arrest via regulation of these cell-cycle-related proteins.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>6</b> induced G2/M cell cycle arrest in TNBC cells. MDA-MB-231 and MDA-MB-468 cells were treated with or without <b>6</b> at different concentrations (1, 2, and 5 μM) for 24 h. (A) Flow cytometry analysis of cell cycle assay. (B) Western blot analysis of protein expression related to the cell cycle. The corresponding quantitative analysis is included. Data represented the mean ± SD of at least three independent experiments. *<i>P</i> < 0.05, <sup>**</sup><i>P</i> < 0.01, and <sup>***</sup><i>P</i> < 0.001 vs the solvent control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00166&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Compound <b>6</b> Induced Apoptosis via Mitochondrial Depolarization and Regulation of Apoptosis-Related Proteins</h3><div class="NLM_p">According to the above-mentioned cell cycle analysis, we supposed that <b>6</b> might induce the apoptosis of TNBC cells. To confirm this, TNBC cells were treated with various concentrations of <b>6</b> for 24 h, and then, the cells were stained with annexin V–FITC/ propidium iodide (PI) and analyzed by flow cytometry. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A, the percentages of early and late apoptotic cells were dose-dependently increased with the treatment of <b>6</b> in 24 h, suggesting that <b>6</b> induced the apoptosis of TNBC cells. As irreversible mitochondrial depolarization is the main pathway in apoptosis, which could be reflected by the decrease of the mitochondrial membrane potential (MMP, ΔΨ<i>m</i>),<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> the changes of MMP were detected by JC-10 staining of mitochondria in TNBC cells.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B, the cells in control groups had well-defined integral mitochondrial membranes, with aggregates (cells with high MMP) accounting for the predominant proportion (>90%) in JC-10 stained cells. When treated with various concentrations of <b>6</b>, the mitochondrial membranes of TNBC cells were permeabilized and the proportion of monomers (cells with low MMP) were dose-dependently increased. These results suggested that <b>6</b> could induce a dramatic depletion of MMP, leading to apoptosis. Mitochondrial membrane permeabilization is a switchlike event regulated by the balance of anti-apoptotic protein bcl2 and pro-apoptotic protein bax, and the dynamic change of bcl2 and bax can lead to mitochondrial depolarization. When mitochondrial depolarization occurs, caspase 3 is cleaved into the activated form c-caspase 3, which further cleaves PARP to form c-PARP with the loss of DNA repairing function.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Thus, the influence of <b>6</b> on the upstream or downstream regulators of MMP was further investigated. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C, <b>6</b> decreased the ratios of bcl2/bax and significantly increased c-caspase 3 and c-PARP, suggesting that <b>6</b> could induce apoptosis via regulation of these cell death-related proteins.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>6</b> induced apoptosis in TNBC cells. MDA-MB-231 and MDA-MB-468 cells were treated with or without <b>6</b> at different concentrations (1, 2, and 5 μM) for 24 h. Flow cytometry analysis of (A) apoptotic cells and (B) ΔΨ<i>m</i> with JC-10. (C) Western blot analysis of protein expression related to apoptosis. The quantitative analysis is included. Data represented the mean ± SD of at least three independent experiments. *<i>P</i> < 0.05, <sup>**</sup><i>P</i> < 0.01, and <sup>***</sup><i>P</i> < 0.001 vs the solvent control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00166&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Compound <b>6</b> Induced Autophagy to Promote Apoptosis</h3><div class="NLM_p">Accumulating evidence suggests that apoptosis is deeply involved with autophagy and their comprehensive crosstalk can lead to synergism or antagonism on cell death.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Therefore, the influence of <b>6</b> on autophagy was further investigated. In the autophagy process, ATG5, ATG7, and the cleaved form of LC3 (LC3-II) play important roles in the elongation and closure of the autophagosome membrane, and SQSTM1 (p62) is an adapter protein that recognizes ubiquitinated autophagic cargos and links them to the autophagic vesicles.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> When autophagosomes are transported to lysosomes, the p62 and cargos are degraded and the autophagic flux is completed. Thus, the regulation of these autophagy-related proteins together could be used to estimate the process of autophagy. As shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A, <b>6</b> dose-independently increased ATG5, ATG7, and LC3-II expression and almost eliminated p62 in high dose group, suggesting that <b>6</b> induced autophagy in TNBC cells. To understand the interplay between apoptosis and autophagy, the apoptosis process was investigated under the blockage of autophagy by using chloroquine, a lysosomal inhibitor.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B, when cells were treated with chloroquine alone, both LC3-II and p62 were increased because of the incomplete autophagic flux. When the cells were treated with the combination of <b>6</b> and chloroquine, the apoptotic related protein c-PARP was substantially decreased as compared to the <b>6</b>-only group, indicating that the blockage of autophagy could attenuate the <b>6</b>-induced apoptosis in TNBC cells. Taken together, <b>6</b> induced autophagy to promote apoptosis in TNBC cells.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>6</b> induced autophagy to promote apoptosis in TNBC cells. (A) Western blot analysis of protein expression related to autophagy in MDA-MB-231 and MDA-MB-468 cells induced by <b>6</b> at different concentrations (1, 2, and 5 μM) for 24 h. (B) Western blot analysis of protein expression in MDA-MB-231 cells induced by 5 μM <b>6</b> with or without co-treatment of chloroquine (20 μM) for 24 h. The corresponding quantitative analysis is included. Data represented the mean ± SD of at least three independent experiments. *<i>P</i> < 0.05, <sup>**</sup><i>P</i> < 0.01, and <sup>***</sup><i>P</i> < 0.001 vs the solvent control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00166&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Compound <b>6</b> Inhibited the Migration and Invasion of MDA-MB-231 Cells</h3><div class="NLM_p">One reason for the poor prognosis of TNBC is the high incidence of metastasis. To investigate whether <b>6</b> could inhibit the TNBC metastasis, the antimigration and anti-invasion potentials of <b>6</b> were evaluated by scratch assay and transwell invasion assay on the highly metastatic MDA-MB-231 cells. As shown in the scratch assay (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A), the wound width of the control group was gradually diminishing along with time, while the treatment of <b>6</b> significantly restrained the migration in a dose-dependent manner. Similarly, in the transwell invasion assay (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B), the number of invaded cells was dose-dependently decreased by the treatment of <b>6</b>, with ca. 80% reduction in the high dose group (0.2 μM) as compared to the control group. As the matrix metalloproteinase family is considered as the main promoter in cancer cell metastasis, and it is mainly activated by β-catenin,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> the regulation of <b>6</b> on the expression of β-catenin and the key matrix metalloproteinase members MMP2 and MMP9 were further evaluated by western blot. As shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C, the treatment of <b>6</b> dose-dependently reduced the expression of β-catenin, MMP2, and MMP9 in MDA-MB-231 cells, confirming the antimetastatic potential of <b>6</b> in TNBC cells.</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>6</b> inhibited the migration and invasion of MDA-MB-231 cells. (A) Scratch assay for migration capability on MDA-MB-231 cells induced by <b>6</b> at different concentrations (0.1 and 0.2 μM) for 24, 48, and 72 h. (B) Transwell invasion assay on MDA-MB-231 cells induced by <b>6</b> at different concentrations (0.1 and 0.2 μM) for 48 h. (C) Western blot analysis of protein expression related to migration and invasion in MDA-MB-231 cells induced by <b>6</b> at different concentrations (0.1 and 0.2 μM) for 24 h. The corresponding quantitative analysis is included. Data represented the mean ± SD of at least three independent experiments. The migration rate was calculated by % migration rate<sub>24h/48h/72h</sub> = (width<sub>0h</sub> – width<sub>24h/48h/72h</sub>)/width<sub>0h</sub> × 100%. *<i>P</i> < 0.05, <sup>**</sup><i>P</i> < 0.01, and <sup>***</sup><i>P</i> < 0.001 vs the solvent control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00166&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Compound <b>6</b> Inhibited Akt Signaling in TNBC Cells</h3><div class="NLM_p">Accumulating evidence suggests that apoptosis, autophagy, and metastasis in TNBC are closely related to the aberrant activation of the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)/mechanistic target of rapamycin (mTOR) signaling.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Akt is the key regulator in this pathway with over a hundred substrates. Activated Akt can phosphorylate p21, leading to negative regulation of the cell-growth-inhibiting activity of p21. Activated Akt also phosphorylates the pro-apoptotic proteins in the bcl-2 family to inhibit their function. Meanwhile, the activation of Akt can suppress the autophagic flux and maintain the accumulation of β-catenin for cell migration and invasion.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Since <b>6</b> could affect the above-mentioned regulators involving cell cycle arrest, apoptosis, autophagy, and metastasis in TNBC, its possible influence on PI3K/Akt/mTOR signaling was further explored.</div><div class="NLM_p">First, the expression levels of PI3K, phosphorylated PI3K (p-PI3K), Akt, phosphorylated Akt (p-Akt), mTOR, and phosphorylated mTOR (p-mTOR) in TNBC cells were evaluated by western blot analysis. As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A, the levels of p-Akt and its downstream p-mTOR were significantly decreased with the treatment of <b>6</b> in a dose-dependent manner, while the level of its upstream p-PI3K was not changed. Meanwhile, <b>6</b> had no influence on the expression of PI3K, Akt, and mTOR. These results suggested that <b>6</b> might affect the p-PI3K downstream phosphorylation cascades.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Then, the kinase assay of PI3K was performed by ADP-Glo assay. The results showed that <b>6</b> did not affect the PI3K activities by competitively binding to the sites where p-PI3K interacts with its substrates (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00166/suppl_file/jm1c00166_si_001.pdf" class="ext-link">Figure S4</a>). Therefore, we supposed that <b>6</b> might bind to the allosteric region of Akt to prevent the membrane interaction or inter-domain conformational changes necessary for Akt activation.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a> Akt is composed of three isoforms, named Akt1, Akt2, and Akt3, in which Akt1 is the main isoform responsible for cancer cell proliferation and survival.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Then the ligand–protein interaction between <b>6</b> and Akt1 was assessed in the native cellular environment using the cellular thermal shift assay (CETSA).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B, <b>6</b> significantly shifted the melting curves of Akt1 in TNBC cells and led to thermal stabilization of Akt1, suggesting that <b>6</b> could directly bind to Akt1.</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Compound <b>6</b> inhibited Akt signaling in TNBC cells. (A) Western blot analysis of protein expression related to Akt signaling in MDA-MB-231 and MDA-MB-468 cells induced by <b>6</b> at different concentrations (1, 2, and 5 μM) for 24 h. (B) CETSA of Akt1 in MDA-MB-231 and MDA-MB-468 cells incubated with <b>6</b> (2 μM) for 2 h. (C) Western blot analysis of protein expression of Akt1 in MDA-MB-231 and MDA-MB-468 cells with transfection of negative control or Akt1 siRNA. (D) Proliferation inhibition induced by different concentrations of  <b>6</b> on MDA-MB-231 and MDA-MB-468 cells for 24 h with transfection of negative control (CsiRNA) or Akt1 siRNA (Akt1siRNA). The corresponding quantitative analysis is included. Data represented the mean ± SD of at least three independent experiments. *<i>P</i> < 0.05, <sup>**</sup><i>P</i> < 0.01, and <sup>***</sup><i>P</i> < 0.001 vs solvent control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00166&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To investigate whether <b>6</b> exerted its anti-TNBC effect mainly through Akt inhibition, Akt1 knockdown experiments were performed by siRNA in TNBC cells (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>C). As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>D, the cytotoxicity of <b>6</b> was remarkably decreased in Akt1-silenced TNBC cells, with the cell viability being 30–40% greater than that of the CsiRNA group (negative control). These results suggested that <b>6</b> exerted the anti-TNBC effect via the inhibition of Akt.</div><div class="NLM_p last">In addition, there is a crosstalk between PI3K/Akt signaling and the extracellular-regulated kinase (ERK) signaling. When Akt phosphorylation is suppressed, ERK phosphorylation might be provoked, resulting in the attenuation of therapeutic efficacy.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38,39)</a> To investigate whether <b>6</b> could regulate the ERK signaling, the expression of ERK and p-ERK was evaluated by western blot. As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A, <b>6</b> had little influence on both ERK and p-ERK, suggesting that <b>6</b> might bring a promising therapeutic benefit.</div></div><div id="sec2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Compound <b>6</b> Suppressed TNBC Xenograft Tumor Growth in NOD/SCID Mice</h3><div class="NLM_p">To determine the <i>in vivo</i> antitumor efficacy of <b>6</b>, TNBC xenograft mouse models were developed by subcutaneously injecting MDA-MB-468 cells into the female NOD/SCID mice. After the tumors were grown to 50 mm<sup>3</sup> in 7 days, 32 mice were equally randomly divided into four groups: vehicle group, low-dose group (5 mg/kg <b>6</b> per day), high-dose group (10 mg/kg <b>6</b> per day), and positive control group (5 mg/kg doxorubicin per week). The tumor volume was monitored during the intraperitoneally injected treatments until 33 days, and the tumors and organ tissues were harvested for further analysis. As shown in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A,C,D, <b>6</b> dose-dependently suppressed the growth of TNBC xenograft tumors, with obvious reduction in the tumor weight (reduced by 58%) and volume (reduced by 44.8%) in the high-dose group as compared to the vehicle group. Meanwhile, there was no significant difference in the body weight between the vehicle group and the <b>6</b>-treated groups (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>B). The result of the positive control group was not obtained because the mice successively died from the 9th day to the 16th day with visible weight loss and sluggish behavior (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00166/suppl_file/jm1c00166_si_001.pdf" class="ext-link">Figure S5</a>), probably being due to the intrinsic cytotoxicity of Dox. In addition, the potential cytotoxicity of <b>6</b> was evaluated by histological analysis of the heart, liver, spleen, lung, and kidney tissues of the high-dose group. As shown in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>E, no abnormality was observed in these tissues, implying that <b>6</b> was more safe and tolerable than Dox with the same dosage.</div><figure id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Compound <b>6</b> suppressed the TNBC xenograft tumor growth in female NOD/SCID mice. Vehicle (normal saline per day), <b>6</b> (5 mg/kg per day), <b>6</b> (10 mg/kg per day), and doxorubicin (Dox, 5 mg/kg per week) were administrated intraperitoneally for 33 days. Then, the mice were sacrificed, and the tumors were photographed and weighed. (A) The image of isolated tumors derived from mice. (B) The body weight changes of each group during the treatment period measured every 2 days. (C) The weight of isolated tumors derived from mice. (D) The tumor volume changes of each group during the treatment period measured every 2 days. The tumor volume was calculated according to the formula <i>V</i> = (π/6) × <i>L</i> × <i>W</i><sup>2</sup>, where <i>L</i> is the length (mm) and <i>W</i> is the width (mm). (E) Representative images of hematoxylin and eosin (H&E) staining in hearts, livers, spleens, lungs, and kidneys chosen from slices of 3 randomly chosen mice. Data represented the mean ± SD of 8 mice. *<i>P</i> < 0.05 and <sup>**</sup><i>P</i> < 0.01, and <sup>***</sup><i>P</i> < 0.001 vs vehicle group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00166&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The inhibition of <b>6</b> on TNBC progression was further confirmed by immunohistochemical analysis of several biomarkers in tumor tissues. Ki67, a cell cycle nuclear nonhistone protein that regulates the cell circle, is a proliferative and prognostic marker in breast cancer.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> CD31, the platelet-endothelial cell adhesion molecule involved in blood vessel formation, is used as a biomarker detecting the tumor microvessel density.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> TdT-mediated dUTP nick end labeling (TUNEL) is used to mark DNA strand breaks generated during apoptosis, and LC3B acts as an autophagic indicator. As shown in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>, compared with the control group, the treatment of <b>6</b> led to a large area of necrosis in tumor tissues, and the stains of Ki67 and CD31 were dose-dependently decreased, while the stains of TUNEL and LC3B were accordingly increased. Collectively, these findings demonstrated that <b>6</b> induced apoptosis and autophagy in TNBC tumor cells and inhibited tumor angiogenesis, eventually leading to tumor necrosis.</div><figure id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Immunohistochemical staining of TNBC xenograft tumors. Representative images of H&E, Ki67, TUNEL, CD31, and LC3B staining in tumors. Images were captured and chosen from slices of 3 randomly chosen mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00166&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12228" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12228" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">TNBC is a highly malignant subtype of breast cancer without safe and effective therapeutic drugs. In the current study, a small diterpenoid library was constructed by bioassay-guided chemical investigation of the medicinal plant <i>C. kongensis</i>. A group of rare 8,9-seco-<i>ent</i>-kaurane diterpenoids were identified as potential anti-TNBC agents by subsequent biological screening. Among them, <b>6</b> showed promising anti-TNBC efficacy <i>in vitro</i> and <i>in vivo</i>, being comparable to Dox but with better tolerance. The mechanistic study revealed that <b>6</b> was an Akt inhibitor, which could induce apoptosis, autophagy, cell G2/M circle arrest, and inhibit cell migration and invasion. The SARs analysis suggested that the cleavage of the C8–C9 bond and the presence of α,β-unsaturated ketone moiety were essential for the activity, which made <b>6</b> a promising template for developing novel anti-TNBC agents in the future.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17721" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17721" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General</h3><div class="NLM_p last">The X-ray data were collected using an Agilent Xcalibur Nove X-ray diffractometer. Melting points were measured on an X-4 melting instrument and were uncorrected. Optical rotations were measured on a Rudolph Autopol I automatic polarimeter, UV spectra on a Shimadzu UV-2450 spectrophotometer, and IR spectra on Bruker Tensor 37 infrared spectrophotometers. 1D and 2D NMR spectra were recorded on Bruker AM-400 and AM-500 spectrometers at 25 °C. ESIMS was measured on a Finnigan LCQ Decainstrument, and HRESIMS was performed on a Waters Micromass Q-TOF spectrometer. Column chromatography (CC) was performed on silica gel (300–400 mesh, Qingdao Haiyang Chemical Co., Ltd.), reversed-phase C<sub>18</sub> (RP-C<sub>18</sub>) (12 nm, S-50 μm, YMC Co., Ltd.), Sephadex LH-20 gel (Amersham Biosciences), and MCI gel (CHP20P, 75–150 μm, Mitsubishi Chemical Industries Ltd.). A Shimadzu LC-20 AT equipped with a SPD-M20A PDA detector was used for high-performance liquid chromatography (HPLC). A YMC-pack ODS-A column (250 mm × 10 mm, S-5 μm, 12 nm) and a Phenomenex Lux cellulose-2 chiral column (10 mm × 250 mm, 5 μm) were used for semipreparative HPLC separation. All solvents used were of analytical grade (Guangzhou Chemical Reagents Company, Ltd.).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Plant Material</h3><div class="NLM_p last">The stems of <i>C. kongensis</i> Gagnep (Euphorbiaceae) were collected in the Xishuangbanna City, Yunnan Province, P. R. China, in May 2018, and were authenticated by Associate Professor You-Kai Xu of Xishuangbanna Tropical Botanical Garden. A voucher specimen (accession number: YNBD-201808) has been deposited at the School of Pharmaceutical Sciences, Sun Yat-sen University.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Extraction and Isolation</h3><div class="NLM_p">The air-dried powder of the stems of <i>C. kongensis</i> (10 kg) was extracted with 95% EtOH (3 × 10 L) at room temperature (rt) to give a crude extract (400 g). The extract was suspended in H<sub>2</sub>O (2 L) and successively partitioned with petroleum ether (PE, 3 × 2 L) and EtOAc (3 × 2 L) to yield two corresponding portions. The EtOAc extract (110 g) was subjected to an MCI gel column eluted with MeOH/H<sub>2</sub>O (5:5 → 10:0) to afford Fr. I–V. Fr. II (20 g) was subjected to a silica gel column (PE/EtOAc, 10:1 → 1:5) to afford Fr. IIA–IIC. Fr. IIA (3 g) was further separated by CC on reversed-phase silica gel C<sub>18</sub> eluted with a MeOH/H<sub>2</sub>O gradient (3:7 → 8:2) to give Fr. IIA1–IIA3; then, Fr. IIA2 (600 mg) was loaded onto a Sephadex LH-20 column and eluted with MeOH to give <b>6</b> (425 mg), and Fr. IIA3 (540 mg) was purified by CC on a silica gel eluted with (PE/EtOAc, 8:1 → 1:1) to obtain <b>2</b> (100 mg) and <b>8</b> (145 mg). Fr. IIB (700 mg) was subjected to silica gel CC (PE/CH<sub>2</sub>Cl<sub>2</sub>, 5:1 → 1:1) to afford <b>1</b> (20 mg). Fr. III (4 g) was subjected to silica gel CC (CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH, 100:1 → 20:1) to afford Fr. IIIA–IIIE. Fr. IIIB (280 mg) was subjected to silica gel CC (CH<sub>2</sub>Cl<sub>2</sub>) and purified on a Sephadex LH-20 column and eluted with MeOH to obtain <b>3</b> (15 mg) and <b>4</b> (5 mg). Fr. IIIC (190 mg) was subjected to silica gel CC (CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH, 100:1 → 40:1) and purified on HPLC (MeOH/H<sub>2</sub>O, 7.5:2.5, 3 mL/min) to obtain <b>5</b> (14 mg, <i>t</i><sub>R</sub> 11 min). Fr. V (7g) was subjected to silica gel CC (CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH, 100:1 → 20:1) to afford Fr. VA–VB. Fr. VA was subjected to silica gel CC (PE/EtOAc, 20:1 → 10:1) to obtain <b>7</b> (8 mg) and <b>9</b> (10 mg). The purity of compounds <b>1</b>–<b>9</b> was greater than 95% as determined by <sup>1</sup>H NMR spectrum.</div><div id="s0044" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Compound <b>1</b></h4><div class="NLM_p last">A colorless crystal obtained in PE/acetone (3:1); mp 173–175 °C; [α]<sub class="stack">D</sub><sup class="stack">25</sup> −28.0 (<i>c</i> 0.13, MeOH); UV (MeOH) λ<sub>max</sub> (log ε) 230 (3.86) nm; IR (KBr) <i>ν</i><sub>max</sub> 3194, 2939, 1720, 1668, 1449, 1255, 1082, 1042, 973, 951 cm<sup>–1</sup>; <sup>1</sup>H and <sup>13</sup>C NMR data, see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>; HRESIMS <i>m</i>/<i>z</i> 373.1971 [M + Na]<sup>+</sup> (calcd for C<sub>20</sub>H<sub>30</sub>O<sub>5</sub>Na<sup>+</sup>, 373.1985).</div></div><div id="s0045" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Compound <b>2</b></h4><div class="NLM_p last">White powder; [α]<sub class="stack">D</sub><sup class="stack">25</sup> −174.0 (<i>c</i> 0.20, MeOH); UV (MeOH) λ<sub>max</sub> (log ε) 214 (3.89) nm; IR (KBr) <i>ν</i><sub>max</sub> 2947, 1745, 1730, 1667, 1609, 1450, 1388, 1372, 1325, 1246 1219 cm<sup>–1</sup>; <sup>1</sup>H and <sup>13</sup>C NMR data, see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>; HRESIMS <i>m</i>/<i>z</i> 373.2001 [M + H]<sup>+</sup> (calcd for C<sub>22</sub>H<sub>28</sub>O<sub>5</sub><sup>+</sup>, 373.2010).</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Synthesis of <b>10</b>–<b>18</b> by Acylation of <b>6</b> and <b>8</b></h3><div class="NLM_p">A solution of acyl chloride (50 μL) was added to a stirred solution of <b>6</b> (10 mg, 0.03 mmol) or <b>8</b> (10 mg, 0.026 mmol) and a catalytic amount of triethylamine in freshly distilled CH<sub>2</sub>Cl<sub>2</sub> (2 mL). The reaction mixture was stirred at rt for 5 h and quenched by adding H<sub>2</sub>O (1 mL). After removal of the solvent under vacuum, the residue was purified on a flash silica gel column eluted with PE/EtOAc (10:1). The acyl chloride used in the experiment were benzoyl chloride, ethanoyl chloride, propionyl chloride, acryloyl chloride, chloroacetyl chloride, and 3-butenoyl chloride, with the acylation products being compounds <b>10</b> (7 mg, 62%), <b>11</b> (6 mg, 46%), <b>12</b> (4 mg, 33%), <b>13</b> (8 mg, 69%), <b>14</b> (7 mg, 60%), <b>15</b> (8 mg, 64%), <b>16</b> (9 mg, 72%), <b>17</b> (6 mg, 44%), and <b>18</b> (7 mg, 53%).</div><div id="s0046" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Compound <b>10</b></h4><div class="NLM_p last">Colorless oil; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ<sub>H</sub> 7.20 (1H, d, <i>J</i> = 2.7 Hz, H-14), 6.14 (1H, s, Ha-17), 5.50 (1H, dd, <i>J</i> = 12.1, 4.5 Hz, H-7), 5.43 (1H, s, Hb-17), 3.62 (1H, brs, H-1), 3.58 (1H, d, <i>J</i> = 3.3 Hz, H-13), 2.65 (1H, m, H<sub>β</sub>-11), 2.62 (1H, m, H<sub>α</sub>-12), 2.05 (1H, m, H<sub>α</sub>-11), 2.00 (3H, s, 7-OAc), 1.96 (1H, m, H<sub>α</sub>-2), 1.92 (1H, m, H<sub>β</sub>-6), 1.81 (1H, m, H<sub>β</sub>-3), 1.75 (1H, m, H<sub>β</sub>-12), 1.48 (1H, m, H<sub>β</sub>-2), 1.44 (1H, dd, <i>J</i> = 6.33, 1.70 Hz, H-5), 1.28 (1H, m, H<sub>α</sub>-6), 1.25 (1H, m, H<sub>α</sub>-3), 1.16 (3H, s, H<sub>3</sub>-18), 0.97 (3H, s, H<sub>3</sub>-19), 0.96 (3H, s, H<sub>3</sub>-20); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ<sub>C</sub> 214.6 (C, C-9), 194.3 (C, C-15), 169.9 (C, 7-OAc), 160.3 (CH, C-14), 145.9 (C, C-16), 144.9 (C, C-8), 116.9 (CH<sub>2</sub>, C-17), 71.1 (CH, C-1), 66.8 (CH, C-7), 57.2 (C, C-10), 42.6 (CH, C-13), 38.4 (CH, C-5), 36.2 (CH<sub>2</sub>, C-11), 34.5 (C, C-4), 33.7 (CH<sub>2</sub>, C-3), 33.5 (CH<sub>3</sub>, C-18), 33.3 (CH<sub>2</sub>, C-6), 27.9 (CH<sub>2</sub>, C-2), 26.0 (CH<sub>2</sub>, C-12), 23.3 (CH<sub>3</sub>, C-19), 21.1 (CH<sub>3</sub>, 7-OAc), 17.8 (CH<sub>3</sub>, C-20); HRESIMS <i>m</i>/<i>z</i> 397.1977 [M + Na]<sup>+</sup> (calcd for C<sub>22</sub>H<sub>30</sub>O<sub>5</sub>Na<sup>+</sup>, 397.1985).</div></div><div id="s0047" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Compound <b>11</b></h4><div class="NLM_p last">Colorless powder; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ<sub>H</sub> 8.00 (2H, dd, <i>J</i> = 8.4, 1.4 Hz, H-3′/7′), 7.55 (1H, m, H-5′), 7.42 (2H, dd, <i>J</i> = 7.8, 7.0 Hz, H-4′/6′), 7.31 (1H, d, <i>J</i> = 2. 8 Hz, H-14), 6.16 (1H, s, Ha-17), 5.75 (1H, dd, <i>J</i> = 12.1, 4.5 Hz, H-7), 5.45 (1H, s, Hb-17), 3.64 (1H, brs, H-1), 3.61 (1H, brs, H-13), 2.67 (1H, m, H<sub>β</sub>-11), 2.67 (1H, m, H<sub>α</sub>-12), 2.09 (1H, m, H<sub>α</sub>-11), 2.06 (1H, m, H<sub>β</sub>-6), 2.02 (1H, m, H<sub>α</sub>-2), 1.83 (1H, m, H<sub>β</sub>-3), 1.82 (1H, m, H<sub>β</sub>-12), 1.53 (1H, m, H-5), 1.49 (1H, m, H<sub>β</sub>-2), 1.45 (1H, m, H<sub>α</sub>-6), 1.31 (1H, m, H<sub>α</sub>-3), 1.24 (3H, s, H<sub>3</sub>-18), 1.00 (3H, s, H<sub>3</sub>-19), 0.99 (3H, s, H<sub>3</sub>-20); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ<sub>C</sub> 214.6 (C, C-9), 194.3 (C, C-15), 165.5 (C, C-1′), 160.2 (CH, C-14), 145.9 (C, C-16), 145.0 (C, C-8), 133.0 (C, C-5′), 130.1 (C, C-4′/6′), 129.6 (C, C-3′/7′), 116.9 (CH<sub>2</sub>, C-17), 71.1 (CH, C-1), 67.4 (CH, C-7), 57.3 (C, C-10), 42.7 (CH, C-13), 38.4 (CH, C-5), 36.2 (CH<sub>2</sub>, C-11), 34.6 (C, C-4), 33.7 (CH<sub>2</sub>, C-3), 33.6 (CH<sub>3</sub>, C-18), 33.4 (CH<sub>2</sub>, C-6), 27.9 (CH<sub>2</sub>, C-2), 26.0 (CH<sub>2</sub>, C-12), 23.4 (CH<sub>3</sub>, C-19), 17.9 (CH<sub>3</sub>, C-20); HRESIMS <i>m</i>/<i>z</i> 459.2149 [M + Na]<sup>+</sup> (calcd for C<sub>27</sub>H<sub>32</sub>O<sub>5</sub>Na<sup>+</sup>, 459.2142).</div></div><div id="s0048" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Compound <b>12</b></h4><div class="NLM_p last">Colorless oil; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ<sub>H</sub> 7.23 (1H, d, <i>J</i> = 2.8 Hz, H-14), 6.15 (1H, s, Ha-17), 5.59 (1H, dd, <i>J</i> = 12.2, 4.6 Hz, H-7), 5.45 (1H, s, Hb-17), 4.01 [2H, brs, 7-OC(O)CH<sub>2</sub>Cl], 3.63 (1H, brs, H-1), 3.62 (1H, brs, H-13), 2.68 (1H, m, H<sub>β</sub>-11), 2.62 (1H, m, H<sub>α</sub>-12), 2.07 (1H, m, H<sub>α</sub>-11), 2.01 (1H, m, H<sub>α</sub>-2), 1.96 (1H, m, H<sub>β</sub>-6), 1.79 (1H, m, H<sub>β</sub>-3), 1.79 (1H, m, H<sub>β</sub>-12), 1.48 (1H, m, H<sub>β</sub>-2), 1.44 (1H, d, <i>J</i> = 6.0 Hz, H-5), 1.33 (1H, m, H<sub>α</sub>-6), 1.26 (1H, m, H<sub>α</sub>-3), 1.17 (3H, s, H<sub>3</sub>-18), 0.98 (3H, s, H<sub>3</sub>-19), 0.95 (3H, s, H<sub>3</sub>-20); <sup>13</sup>C NMR (125M Hz, CDCl<sub>3</sub>) δ<sub>C</sub> 214.6 (C, C-9), 194.0 (C, C-15), 166.3 [C, 7-O<u class="uu">C</u>(O)CH<sub>2</sub>Cl], 160.8 (CH, C-14), 145.6 (C, C-16), 143.8 (C, C-8), 117.2 (CH<sub>2</sub>, C-17), 71.0 (CH, C-1), 68.8 (CH, C-7), 57.2 (C, C-10), 42.7 (CH, C-13), 40.9 [CH<sub>2</sub>, 7-OC(O)<u class="uu">C</u>H<sub>2</sub>Cl], 38.3 (CH, C-5), 36.2 (CH<sub>2</sub>, C-11), 34.6 (C, C-4), 33.6 (CH<sub>2</sub>, C-3), 33.5 (CH<sub>3</sub>, C-18), 33.1 (CH<sub>2</sub>, C-6), 27.9 (CH<sub>2</sub>, C-2), 25.9 (CH<sub>2</sub>, C-12), 23.3 (CH<sub>3</sub>, C-19), 17.8 (CH<sub>3</sub>, C-20); HRESIMS <i>m</i>/<i>z</i> 431.1600 [M + Na]<sup>+</sup> (calcd for C<sub>22</sub>H<sub>29</sub>O<sub>5</sub>ClNa<sup>+</sup>, 431.1596).</div></div><div id="s0049" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Compound <b>13</b></h4><div class="NLM_p last">Colorless oil; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ<sub>H</sub> 7.19 (1H, d, <i>J</i> = 2.8 Hz, H-14), 6.13 (1H, s, Ha-17), 5.50 (1H, dd, <i>J</i> = 12.1, 4.4 Hz, H-7), 5.43 (1H, s, Hb-17), 3.61 (1H, brs, H-1), 3.58 (1H, brs, H-13), 2.64 (1H, m, H<sub>β</sub>-11), 2.64 (1H, m, H<sub>α</sub>-12), 2.07 [2H, qd, <i>J</i> = 7.6, 4.0 Hz, 7-OC(O)C<u class="uu">H</u><sub>2</sub>CH<sub>3</sub>], 2.05 (1H, m, H<sub>α</sub>-11), 1.99 (1H, m, H<sub>α</sub>-2), 1.94 (1H, m, H<sub>β</sub>-6), 1.77 (1H, m, H<sub>β</sub>-3), 1.77 (1H, m, H<sub>β</sub>-12), 1.48 (1H, m, H<sub>β</sub>-2), 1.44 (1H, s, H-5), 1.26 (1H, m, H<sub>α</sub>-6), 1.26 (1H, m, H<sub>α</sub>-3), 1.17 (3H, s, H<sub>3</sub>-18), 1.09 [3H, t, <i>J</i> = 7.58 Hz, 7-OC(O)CH<sub>2</sub>C<u class="uu">H</u><sub>3</sub>], 0.97 (3H, s, H<sub>3</sub>-19), 0.95 (3H, s, H<sub>3</sub>-20); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ<sub>C</sub> 214.6 (C, C-9), 194.3 (C, C-15), 173.4 [C, 7-OC(O)CH<sub>2</sub>CH<sub>3</sub>], 160.2 (CH, C-14), 145.9 (C, C-16), 145.0 (C, C-8), 116.9 (CH<sub>2</sub>, C-17), 71.0 (CH, C-1), 66.7 (CH, C-7), 57.2 (C, C-10), 42.6 (CH, C-13), 38.4 (CH, C-5), 36.2 (CH<sub>2</sub>, C-11), 34.5 (C, C-4), 33.7 (CH<sub>2</sub>, C-3), 33.5 (CH<sub>3</sub>, C-18), 33.3 (CH<sub>2</sub>, C-6), 27.9 (CH<sub>2</sub>, C-2), 27.5 [CH<sub>2</sub>, 7-OC(O)<u class="uu">C</u>H<sub>2</sub>CH<sub>3</sub>], 26.0 (CH<sub>2</sub>, C-12), 23.4 (CH<sub>3</sub>, C-19), 17.8 (CH<sub>3</sub>, C-20), 8.9 [CH<sub>2</sub>, 7-OC(O)CH<sub>2</sub><u class="uu">C</u>H<sub>3</sub>]; HRESIMS <i>m</i>/<i>z</i> 427.1876 [M + K]<sup>+</sup> (calcd for C<sub>23</sub>H<sub>32</sub>O<sub>5</sub>K<sup>+</sup>, 427.1881).</div></div><div id="s0050" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Compound <b>14</b></h4><div class="NLM_p last">Colorless oil; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ<sub>H</sub> 7.22 (1H, d, <i>J</i> = 2.8 Hz, H-14), 6.37 [1H, dd, <i>J</i> = 17.3, 1.4 Hz, 7-OC(O)CHC<u class="uu">H</u><sub><u class="uu">2</u></sub>], 6.14 (1H, s, Ha-17), 6.06 [1H, dd, <i>J</i> = 17.3, 10.4 Hz, 7-OC(O)C<u class="uu">H</u>CH<sub>2</sub>], 5.80 [1H, dd, <i>J</i> = 10.4, 1.4 Hz, 7-OC(O)CHC<u class="uu">H</u><sub><u class="uu">2</u></sub>], 5.58 (1H, dd, <i>J</i> = 12.1, 4.5 Hz, H-7), 5.43 (1H, s, Hb-17), 3.62 (1H, brs, H-1), 3.59 (1H, d, <i>J</i> = 3.2 Hz, H-13), 2.67 (1H, m, H<sub>β</sub>-11), 2.63 (1H, m, H<sub>α</sub>-12), 2.06 (1H, m, H<sub>α</sub>-11), 1.99 (1H, m, H<sub>α</sub>-2), 1.95 (1H, m, H<sub>β</sub>-6), 1.78 (1H, m, H<sub>β</sub>-3), 1.78 (1H, m, H<sub>β</sub>-12), 1.50 (1H, m, H<sub>β</sub>-2), 1.46 (1H, dd, <i>J</i> = 6.3, 1.6 Hz, H-5), 1.34 (1H, m, H<sub>α</sub>-6), 1.28 (1H, m, H<sub>α</sub>-3), 1.18 (3H, s, H<sub>3</sub>-18), 0.98 (3H, s, H<sub>3</sub>-19), 0.96 (3H, s, H<sub>3</sub>-20); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ<sub>C</sub> 214.6 (C, C-9), 194.3 (C, C-15), 165.1 [C, 7- O<u class="uu">C</u>(O)CHCH<sub>2</sub>], 160.3 (CH, C-14), 145.8 (C, C-16), 144.8 (C, C-8), 131.0 [C, 7- OC(O)CH<u class="uu">C</u>H<sub>2</sub>], 128.3 [C, 7- OC(O)<u class="uu">C</u>HCH<sub>2</sub>], 116.9 (CH<sub>2</sub>, C-17), 71.1 (CH, C-1), 67.0 (CH, C-7), 57.2 (C, C-10), 42.6 (CH, C-13), 38.4 (CH, C-5), 36.2 (CH<sub>2</sub>, C-11), 34.6 (C, C-4), 33.7 (CH<sub>2</sub>, C-3), 33.5 (CH<sub>3</sub>, C-18), 33.3 (CH<sub>2</sub>, C-6), 27.9 (CH<sub>2</sub>, C-2), 26.0 (CH<sub>2</sub>, C-12), 23.3 (CH<sub>3</sub>, C-19), 17.8 (CH<sub>3</sub>, C-20); HRESIMS <i>m</i>/<i>z</i> 409.1989 [M + Na]<sup>+</sup> (calcd for C<sub>23</sub>H<sub>30</sub>O<sub>5</sub>Na<sup>+</sup>, 409.1985).</div></div><div id="s0051" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Compound <b>15</b></h4><div class="NLM_p last">Colorless oil; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ<sub>H</sub> 7.19 (1H, d, <i>J</i> = 2.7 Hz, H-14), 6.13 (1H, s, Ha-17), 5.51 (1H, dd, <i>J</i> = 12.1, 4.5 Hz, H-7), 5.43 (1H, s, Hb-17), 4.88 [1H, s, 7-OC(O)CH<sub>2</sub>C(C<u class="uu">H</u><sub>2</sub>)CH<sub>3</sub>], 4.81 [1H, s, 7-OC(O)CH<sub>2</sub>C(C<u class="uu">H</u><sub>2</sub>)CH<sub>3</sub>], 3.61 (1H, brs, H-1), 3.58 (1H, d, <i>J</i> = 3.3 Hz, H-13), 2.97 [2H, s, 7-OC(O)C<u class="uu">H</u><sub><u class="uu">2</u></sub>C(CH<sub>2</sub>)CH<sub>3</sub>], 2.67 (1H, m, H<sub>β</sub>-11), 2.62 (1H, m, H<sub>α</sub>-12), 2.05 (1H, m, H<sub>α</sub>-11), 1.98 (1H, m, H<sub>α</sub>-2), 1.92 (1H, ddd, <i>J</i> = 13.7, 6.3, 4.6 Hz, H<sub>β</sub>-6), 1.80 (1H, m, H<sub>β</sub>-3), 1.80 (1H, m, H<sub>β</sub>-12), 1.49 (1H, m, H<sub>β</sub>-2), 1.43 (1H, dd, <i>J</i> = 6.2, 1.8 Hz, H-5), 1.27 (1H, m, H<sub>α</sub>-6), 1.27 (1H, m, H<sub>α</sub>-3), 1.76 [3H, s, 7-OC(O)CH<sub>2</sub>C(CH<sub>2</sub>)C<u class="uu">H</u><sub><u class="uu">3</u></sub>], 1.16 (3H, s, H<sub>3</sub>-18), 0.97 (3H, s, H<sub>3</sub>-19), 0.95 (3H, s, H<sub>3</sub>-20); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ<sub>C</sub> 214.6 (C, C-9), 194.3 (C, C-15), 170.3 [C, 7-O<u class="uu">C</u>(O)CH<sub>2</sub>C(CH<sub>2</sub>)CH<sub>3</sub>], 160.3 (CH, C-14), 145.8 (C, C-16), 144.8 (C, C-8), 138.3 [C, 7-OC(O)CH<sub>2</sub><u class="uu">C</u>(CH<sub>2</sub>)CH<sub>3</sub>], 116.9 (CH<sub>2</sub>, C-17), 114.8 [CH<sub>2</sub>, 7-OC(O)CH<sub>2</sub>C(<u class="uu">C</u>H<sub>2</sub>)CH<sub>3</sub>], 71.0 (CH, C-1), 67.1 (CH, C-7), 57.2 (C, C-10), 43.3 [CH<sub>2</sub>, 7-OC(O)<u class="uu">C</u>H<sub>2</sub>C(CH<sub>2</sub>)CH<sub>3</sub>], 42.6 (CH, C-13), 38.4 (CH, C-5), 36.2 (CH<sub>2</sub>, C-11), 34.5 (C, C-4), 33.7 (CH<sub>2</sub>, C-3), 33.5 (CH<sub>3</sub>, C-18), 33.2 (CH<sub>2</sub>, C-6), 27.9 (CH<sub>2</sub>, C-2), 25.9 (CH<sub>2</sub>, C-12), 23.3 (CH<sub>3</sub>, C-19), 22.5 [CH<sub>2</sub>, 7-OC(O)CH<sub>2</sub>C(CH<sub>2</sub>)<u class="uu">C</u>H<sub>3</sub>], 17.8 (CH<sub>3</sub>, C-20); HRESIMS <i>m</i>/<i>z</i> 437.2294 [M + Na]<sup>+</sup> (calcd for C<sub>25</sub>H<sub>34</sub>O<sub>5</sub>Na<sup>+</sup>, 437.2298).</div></div><div id="s0052" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Compound <b>16</b></h4><div class="NLM_p last">Colorless oil; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ<sub>H</sub> 7.19 (1H, d, <i>J</i> = 2.8 Hz, H-14), 6.17 (1H, s, Ha-17), 5.51 (1H, dd, <i>J</i> = 12.0, 4.6 Hz, H-7), 5.44 (1H, s, Hb-17), 4.78 (1H, brs, H-1), 3.61 (1H, d, <i>J</i> = 3.5 Hz, H-13), 2.61 (1H, m, H<sub>α</sub>-12), 2.55 (1H, m, H<sub>β</sub>-11), 2.01 (3H, s, 7-OAc), 2.00 (3H, s, 1-OAc), 1.94 (1H, m, H<sub>β</sub>-6), 1.82 (1H, m, H<sub>α</sub>-2), 1.76 (1H, m, H<sub>β</sub>-12), 1.71 (1H, m, H<sub>β</sub>-3), 1.71 (1H, m, H<sub>β</sub>-2), 1.63 (1H, m, H<sub>α</sub>-11), 1.45 (1H, dd, <i>J</i> = 6.1, 1.8 Hz, H-5), 1.33 (1H, m, H<sub>α</sub>-6), 1.28 (1H, m, H<sub>α</sub>-3), 1.18 (3H, s, H<sub>3</sub>-18), 1.03 (3H, s, H<sub>3</sub>-19), 0.99 (3H, s, H<sub>3</sub>-20); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ<sub>C</sub> 211.9 (C, C-9), 193.9 (C, C-15), 169.9 (C, 7-OAc), 169.6 (C, 1-OAc), 160.1 (CH, C-14), 146.0 (C, C-16), 144.9 (C, C-8), 116.6 (CH<sub>2</sub>, C-17), 73.3 (CH, C-1), 66.8 (CH, C-7), 56.3 (C, C-10), 42.4 (CH, C-13), 39.0 (CH, C-5), 34.60 (CH<sub>2</sub>, C-11), 34.57 (C, C-4), 34.4 (CH<sub>2</sub>, C-3), 33.4 (CH<sub>3</sub>, C-18), 32.9 (CH<sub>2</sub>, C-6), 26.1 (CH<sub>2</sub>, C-12), 24.0 (CH<sub>2</sub>, C-2), 23.5 (CH<sub>3</sub>, C-19), 21.7 (CH<sub>3</sub>, 1-OAc), 21.0 (CH<sub>3</sub>, 7-OAc), 17.6 (CH<sub>3</sub>, C-20); HRESIMS <i>m</i>/<i>z</i> 439.2101 [M + Na]<sup>+</sup> (calcd for C<sub>24</sub>H<sub>32</sub>O<sub>6</sub>Na<sup>+</sup>, 439.2091).</div></div><div id="s0053" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Compound <b>17</b></h4><div class="NLM_p last">Colorless oil; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ<sub>H</sub> 7.22 (1H, d, <i>J</i> = 2.8 Hz, H-14), 6.19 (1H, s, Ha-17), 5.59 (1H, dd, <i>J</i> = 12.1, 4.6 Hz, H-7), 5.46 (1H, s, Hb-17), 4.79 (1H, brs, H-1), 4.02 [2H, d, <i>J</i> = 1.2 Hz, 7-OC(O)CH<sub>2</sub>Cl], 3.64 (1H, d, <i>J</i> = 3.4 Hz, H-13), 2.55 (1H, m, H<sub>β</sub>-11), 2.62 (1H, m, H<sub>α</sub>-12), 2.00 (3H, s, 1-OAc), 1.97 (1H, m, H<sub>β</sub>-6), 1.83 (1H, m, H<sub>α</sub>-2), 1.75 (1H, m, H<sub>β</sub>-12), 1.67 (1H, m, H<sub>β</sub>-3), 1.67 (1H, m, H<sub>β</sub>-2), 1.63 (1H, m, H<sub>α</sub>-11), 1.45 (1H, dd, <i>J</i> = 6.1, 2.0 Hz, H-5), 1.38 (1H, m, H<sub>α</sub>-6), 1.32 (1H, m, H<sub>α</sub>-3), 1.18 (3H, s, H<sub>3</sub>-18), 1.03 (3H, s, H<sub>3</sub>-19), 0.99 (3H, s, H<sub>3</sub>-20); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ<sub>C</sub> 211.9 (C, C-9), 193.7 (C, C-15), 169.6 (C, 1-OAc), 166.3 [C, 7-O<u class="uu">C</u>(O)CH<sub>2</sub>Cl], 160.7 (CH, C-14), 145.7 (C, C-16), 143.8 (C, C-8), 117.0 (CH<sub>2</sub>, C-17), 73.1 (CH, C-1), 68.6 (CH, C-7), 56.2 (C, C-10), 42.5 (CH, C-13), 40.8 [CH<sub>2</sub>, 7-OC(O)<u class="uu">C</u>H<sub>2</sub>Cl], 39.0 (CH, C-5), 34.6 (CH<sub>2</sub>, C-11), 34.6 (C, C-4), 34.3 (CH<sub>2</sub>, C-3), 33.3 (CH<sub>3</sub>, C-18), 32.6 (CH<sub>2</sub>, C-6), 26.0 (CH<sub>2</sub>, C-12), 23.9 (CH<sub>2</sub>, C-2), 23.4 (CH<sub>3</sub>, C-19), 17.6 (CH<sub>3</sub>, C-20); HRESIMS <i>m</i>/<i>z</i> 473.1693 [M + Na]<sup>+</sup> (calcd for C<sub>24</sub>H<sub>31</sub>O<sub>6</sub>ClNa<sup>+</sup>, 473.1701).</div></div><div id="s0054" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Compound <b>18</b></h4><div class="NLM_p last">Colorless oil; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ<sub>H</sub> 7.22 (1H, d, <i>J</i> = 2.3 Hz, H-14), 6.39 [1H, dd, <i>J</i> = 15.5, 1.4 Hz, 7-OC(O)CHC<u class="uu">H</u><sub>2</sub>], 6.34 [1H, dd, <i>J</i> = 15.3, 1.1 Hz, 1-OC(O)CHC<u class="uu">H</u><sub>2</sub>], 6.14 (1H, s, Ha-17), 6.08 [1H, t, <i>J</i> = 10.5 Hz, 7-OC(O)C<u class="uu">H</u>CH<sub>2</sub>], 6.04 [1H, t, <i>J</i> = 10.5 Hz, 1-OC(O)C<u class="uu">H</u>CH<sub>2</sub>], 5.88 [1H, dd, <i>J</i> = 10.5, 1.1 Hz, 1-OC(O)CHC<u class="uu">H</u><sub>2</sub>], 5.82 [1H, dd, <i>J</i> = 10.5, 1.4 Hz, 7-OC(O)CHC<u class="uu">H</u><sub>2</sub>], 5.60 (1H, dd, <i>J</i> = 12.0, 4.6 Hz, H-7), 5.40 (1H, s, Hb-17), 4.89 (1H, brs, H-1), 3.60 (1H, d, <i>J</i> = 3.3 Hz, H-13), 2.58 (1H, m, H<sub>α</sub>-12), 2.55 (1H, m, H<sub>β</sub>-11), 2.00 (1H, ddd, <i>J</i> = 13.6, 5.9, 4.6 Hz, H<sub>β</sub>-6), 1.88 (1H, m, H<sub>α</sub>-2), 1.72 (1H, m, H<sub>β</sub>-12), 1.69 (1H, m, H<sub>β</sub>-3), 1.66 (1H, m, H<sub>β</sub>-2), 1.58 (1H, m, H<sub>α</sub>-11), 1.55 (1H, dd, <i>J</i> = 6.1, 2.0 Hz, H-5), 1.40 (1H, m, H<sub>α</sub>-6), 1.30 (1H, m, H<sub>α</sub>-3), 1.22 (3H, s, H<sub>3</sub>-18), 1.05 (3H, s, H<sub>3</sub>-19), 1.01 (3H, s, H<sub>3</sub>-20); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ<sub>C</sub> 212.2 (C, C-9), 194.1 (C, C-15), 165.1 [C, 7-O<u class="uu">C</u>(O)CHCH<sub>2</sub>], 164.4 [C, 1-O<u class="uu">C</u>(O)CHCH<sub>2</sub>], 160.5 (CH, C-14), 145.9 (C, C-16), 144.6 (C, C-8), 131.7 [C, 1-OC(O)CH<u class="uu">C</u>H<sub>2</sub>], 131.1 [C, 7-OC(O)CH<u class="uu">C</u>H<sub>2</sub>], 128.6 [C, 7-OC(O)<u class="uu">C</u>HCH<sub>2</sub>], 128.2 [C, 1- OC(O)<u class="uu">C</u>HCH<sub>2</sub>], 116.6 (CH<sub>2</sub>, C-17), 73.1 (CH, C-1), 67.0 (CH, C-7), 56.3 (C, C-10), 42.5 (CH, C-13), 38.8 (CH, C-5), 34.9 (CH<sub>2</sub>, C-11), 34.7 (C, C-4), 34.5 (CH<sub>2</sub>, C-3), 33.5 (CH<sub>3</sub>, C-18), 32.6 (CH<sub>2</sub>, C-6), 25.9 (CH<sub>2</sub>, C-2), 24.0 (CH<sub>2</sub>, C-12), 23.3 (CH<sub>3</sub>, C-19), 17.6 (CH<sub>3</sub>, C-20); HRESIMS <i>m</i>/<i>z</i> 463.2093 [M + Na]<sup>+</sup> (calcd for C<sub>26</sub>H<sub>32</sub>O<sub>6</sub>Na<sup>+</sup>, 463.2091).</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Synthesis of <b>19</b> by Oxidation of <b>6</b></h3><div class="NLM_p">A solution of <b>6</b> (50 mg, 0.15 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) was treated with Dess–Martin reagent (127 mg, 0.3 mmol) at r. t. for 4 h. The mixture was filtered and evaporated to dryness. Then, the residue was purified by a flash silica gel CC eluted with PE/EtOAc (10:1) to afford <b>19</b> (48 mg, 97%).</div><div id="s0055" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Compound <b>19</b></h4><div class="NLM_p last">White powder; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ<sub>H</sub> 7.23 (1H, d, <i>J</i> = 2.7 Hz, H-14), 6.14 (1H, s, Ha-17), 5.46 (1H, s, Hb-17), 4.79 (1H, dd, <i>J</i> = 11.5, 5.2 Hz, H-7), 3.62 (1H, d, <i>J</i> = 3.7 Hz, H-13), 2.68 (1H, dd, <i>J</i> = 12.6, 4.2 Hz, H<sub>α</sub>-12), 2.59 (1H, m, H<sub>α</sub>-2), 2.32 (1H, m, H<sub>α</sub>-11), 2.29 (1H, m, H<sub>β</sub>-2), 1.99 (1H, m, H<sub>β</sub>-6), 1.88 (1H, dd, <i>J</i> = 18.6, 12.5 Hz, H<sub>β</sub>-11), 1.80 (1H, ddd, <i>J</i> = 14.0, 5.7, 3.5 Hz, H<sub>β</sub>-12), 1.71 (1H, m, H<sub>α</sub>-3), 1.67 (1H, m, H<sub>β</sub>-3), 1.39 (1H, dd, <i>J</i> = 6.7, 1.4 Hz, H-5), 1.24 (1H, m, H<sub>α</sub>-6), 1.16 (3H, s, H<sub>3</sub>-18), 1.15 (3H, s, H<sub>3</sub>-20), 1.13 (3H, s, H<sub>3</sub>-19); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ<sub>C</sub> 212.1 (C, C-1), 209.1 (C, C-9), 195.1 (C, C-15), 159.5 (CH, C-14), 148.4 (C, C-8), 145.4 (C, C-16), 117.5 (CH<sub>2</sub>, C-17), 66.3 (C, C-10), 63.9 (CH, C-7), 44.5 (CH, C-5), 42.3 (CH, C-13), 38.6 (CH<sub>2</sub>, C-3), 36.1 (CH<sub>2</sub>, C-6), 35.1 (CH<sub>2</sub>, C-2), 33.7 (C, C-4), 32.3 (CH<sub>2</sub>, C-11), 31.8 (CH<sub>3</sub>, C-18), 26.1 (CH<sub>2</sub>, C-12), 21.2 (CH<sub>3</sub>, C-19), 17.5 (CH<sub>3</sub>, C-20); HRESIMS <i>m</i>/<i>z</i> 353.1722 [M + Na]<sup>+</sup> (calcd for C<sub>20</sub>H<sub>26</sub>O<sub>4</sub>Na<sup>+</sup>, 353.1723).</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Synthesis of <b>20</b>–<b>22</b> by Acylation of <b>19</b></h3><div class="NLM_p">A solution of acyl chloride (50 μL) was added to a stirred solution of <b>19</b> (12 mg, 0.036 mmol) and a catalytic amount of triethylamine in freshly distilled CH<sub>2</sub>Cl<sub>2</sub> (2 mL). The reaction mixture was stirred at rt for 4 h and quenched by adding H<sub>2</sub>O (1 mL). After removal of the solvent under vacuum, the residue was purified on a flash silica gel column eluted with PE/EtOAc (10:1). The acyl chlorides used in the experiment were benzoyl chloride, ethanoyl chloride, and chloroacetyl chloride with the acylation products being compounds <b>20</b> (9 mg, 67%), <b>21</b> (7 mg, 45%), and <b>22</b> (8 mg, 55%).</div><div id="s0056" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Compound <b>20</b></h4><div class="NLM_p last">Colorless oil; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ<sub>H</sub> 7.17 (1H, d, <i>J</i> = 2.6 Hz, H-14), 6.16 (1H, s, Ha-17), 5.58 (1H, dd, <i>J</i> = 11.8, 5.2 Hz, H-7), 5.46 (1H, s, Hb-17), 3.61 (1H, d, <i>J</i> = 3.7 Hz, H-13), 2.68 (1H, dd, <i>J</i> = 13.6, 3.0 Hz, H<sub>α</sub>-12), 2.58 (1H, m, H<sub>α</sub>-2), 2.33(1H, m, H<sub>α</sub>-11), 2.29 (1H, m, H<sub>β</sub>-2), 2.05 (1H, m, H<sub>β</sub>-6), 2.00 (3H, s, 7-OAc), 1.89 (1H, dd, <i>J</i> = 18.6, 12.4 Hz, H<sub>β</sub>-11), 1.80 (1H, dt, <i>J</i> = 13.3, 4.7 Hz, H<sub>β</sub>-12), 1.72 (1H, m, H<sub>α</sub>-3), 1.68 (1H, m, H<sub>β</sub>-3), 1.43 (1H, d, <i>J</i> = 6.7 Hz, H-5), 1.21 (1H, m, H<sub>α</sub>-6), 1.24 (3H, s, H<sub>3</sub>-18), 1.14 (3H, s, H<sub>3</sub>-20), 1.12 (3H, s, H<sub>3</sub>-19); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ<sub>C</sub> 211.8 (C, C-1), 209.2 (C, C-9), 194.2 (C, C-15), 169.9 (C, 7-OAc) 159.7 (CH, C-14), 145.0 (C, C-16), 144.8 (C, C-8), 117.8 (CH<sub>2</sub>, C-17), 66.4 (CH, C-7), 66.2 (C, C-10), 44.1 (CH, C-5), 42.4 (CH, C-13), 38.5 (CH<sub>2</sub>, C-3), 32.7 (CH<sub>2</sub>, C-6), 35.0 (CH<sub>2</sub>, C-2), 33.7 (C, C-4), 32.4 (CH<sub>2</sub>, C-11), 31.6 (CH<sub>3</sub>, C-18), 26.1 (CH<sub>2</sub>, C-12), 21.1 (CH<sub>3</sub>, C-19), 21.0 (CH<sub>3</sub>, 7-OAc) 17.5 (CH<sub>3</sub>, C-20); HRESIMS <i>m</i>/<i>z</i> 395.1833 [M + Na]<sup>+</sup> (calcd for C<sub>22</sub>H<sub>28</sub>O<sub>5</sub>Na<sup>+</sup>, 395.1829).</div></div><div id="s0057" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Compound <b>21</b></h4><div class="NLM_p last">Colorless powder; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ<sub>H</sub> 8.00 (2H, d, <i>J</i> = 7.6 Hz, H-3′/7′), 7.56 (1H, t, <i>J</i> = 7.4 Hz H-5′), 7.43 (2H, t, <i>J</i> = 7.6 Hz, H-4′/6′), 7.28 (1H, d, <i>J</i> = 2. 8 Hz, H-14), 6.19 (1H, s, Ha-17), 5.84 (1H, dd, <i>J</i> = 11.8, 5.1 Hz, H-7), 5.48 (1H, s, Hb-17), 3.64 (1H, d, <i>J</i> = 3.9 Hz, H-13), 2.70 (1H, td, <i>J</i> = 14.0, 4.7 Hz, H<sub>α</sub>-12), 2.62 (1H, m, H<sub>α</sub>-2), 2.37 (1H, m, H<sub>α</sub>-11), 2.32 (1H, m, H<sub>β</sub>-2), 2.20 (1H, dt, <i>J</i> = 13.4, 6.0 Hz, H<sub>β</sub>-6), 1.94 (1H, dd, <i>J</i> = 18.6, 12.4 Hz, H<sub>β</sub>-11), 1.83 (1H, dt, <i>J</i> = 13.9, 4.8 Hz, H<sub>β</sub>-12), 1.76 (1H, m, H<sub>α</sub>-3), 1.73 (1H, m, H<sub>β</sub>-3), 1.54 (1H, d, <i>J</i> = 6.61 Hz, H-5), 1.39 (1H, t, <i>J</i> = 12.6 Hz, H<sub>α</sub>-6), 1.32 (3H, s, H<sub>3</sub>-18), 1.17 (3H, s, H<sub>3</sub>-20), 1.16 (3H, s, H<sub>3</sub>-19); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ<sub>C</sub> 211.8 (C, C-1), 209.4 (C, C-9), 194.2 (C, C-15), 165.5 (C, C-1′), 159.6 (CH, C-14), 145.0 (C, C-16), 144.9 (C, C-8), 133.2 (C, C-5′), 129.6 (C, C-3′/7′), 128.4 (C, C-4′/6′), 117.9 (CH<sub>2</sub>, C-17), 66.9 (CH, C-7), 66.2 (C, C-10), 42.4 (CH, C-13), 44.2 (CH, C-5), 35.1 (CH<sub>2</sub>, C-2), 32.4 (CH<sub>2</sub>, C-11), 33.8 (C, C-4), 38.6 (CH<sub>2</sub>, C-3), 31.6 (CH<sub>3</sub>, C-18), 32.7 (CH<sub>2</sub>, C-6), 26.2 (CH<sub>2</sub>, C-12), 21.2 (CH<sub>3</sub>, C-19), 17.5 (CH<sub>3</sub>, C-20); HRESIMS <i>m</i>/<i>z</i> 457.1979 [M + Na]<sup>+</sup> (calcd for C<sub>27</sub>H<sub>30</sub>O<sub>5</sub>Na<sup>+</sup>, 457.1985).</div></div><div id="s0058" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Compound <b>22</b></h4><div class="NLM_p last">Colorless oil; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ<sub>H</sub> 7.20 (1H, d, <i>J</i> = 2.8 Hz, H-14), 6.18 (1H, s, Ha-17), 5.67 (1H, dd, <i>J</i> = 11.8, 5.2 Hz, H-7), 5.48 (1H, s, Hb-17), 4.02 [2H, s, 7-OC(O)CH<sub>2</sub>Cl], 3.63 (1H, d, <i>J</i> = 3.6 Hz, H-13), 2.68 (1H, m, H<sub>α</sub>-12), 2.59 (1H, m, H<sub>α</sub>-2), 2.35 (1H, m, H<sub>α</sub>-11), 2.09 (1H, ddd, <i>J</i> = 13.5, 6.7, 5.2 Hz, H<sub>β</sub>-6), 1.81 (1H, m, H<sub>β</sub>-12), 1.68 (1H, m, H<sub>β</sub>-3), 2.30 (1H, m, H<sub>β</sub>-2), 1.89 (1H, dd, <i>J</i> = 18.9, 12.7 Hz, H<sub>β</sub>-11), 1.72 (1H, m, H<sub>α</sub>-3), 1.44 (1H, d, <i>J</i> = 5.3 Hz, H-5), 1.29 (1H, m, H<sub>α</sub>-6), 1.25 (3H, s, H<sub>3</sub>-18), 1.14 (3H, s, H<sub>3</sub>-20), 1.13 (3H, s, H<sub>3</sub>-19); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ<sub>C</sub> 211.6 (C, C-1), 209.2 (C, C-9), 193.7 (C, C-15), 166.3 [C, 7-O<u class="uu">C</u>(O)CH<sub>2</sub>Cl], 160.1 (CH, C-14), 144.8 (C, C-16), 143.8 (C, C-8), 118.1 (CH<sub>2</sub>, C-17), 68.3 (CH, C-7), 66.1 (C, C-10), 42.5 (CH, C-13), 40.8 [CH<sub>2</sub>, 7-OC(O)<u class="uu">C</u>H<sub>2</sub>Cl], 44.1 (CH, C-5), 38.5 (CH<sub>2</sub>, C-3), 33.7 (C, C-4), 32.4 (CH<sub>2</sub>, C-11), 32.4 (CH<sub>2</sub>, C-6), 31.5 (CH<sub>3</sub>, C-18), 26.1 (CH<sub>2</sub>, C-12), 35.0 (CH<sub>2</sub>, C-2), 21.1 (CH<sub>3</sub>, C-19), 17.5 (CH<sub>3</sub>, C-20); HRESIMS <i>m</i>/<i>z</i> 429.1437 [M + Na]<sup>+</sup> (calcd for C<sub>22</sub>H<sub>27</sub>O<sub>5</sub>ClNa<sup>+</sup>, 429.1439).</div></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Synthesis of <b>23</b> by Epoxidation of <b>6</b></h3><div class="NLM_p">A solution of <b>6</b> (10 mg, 0.03 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1.5 mL) was added to m-CPBA (8 mg, 0.045 mmol) at r. t. for one night. The mixture was filtered and evaporated to dryness. Then, the residue was purified by a flash silica gel CC eluted with PE/EtOAc (10:1) to afford <b>23</b> (5 mg, 48%).</div><div id="s0059" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Compound <b>23</b></h4><div class="NLM_p last">Colorless oil; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ<sub>H</sub> 6.28 (1H, s, Ha-17), 5.53 (1H, s, Hb-17), 4.66 (1H, dd, <i>J</i> = 11.6, 3.5 Hz, H-7), 3.68 (1H, brs, H-14), 3.68 (1H, brs, H-1), 3.21 (1H, brs, H-13), 2.95 (1H, dd, <i>J</i> = 19.8, 11.8, 2.5 Hz, Ha-11), 2.69 (1H, m, Ha-12), 2.20 (1H, dd, <i>J</i> = 19.7, 8.0, 2.6 Hz, Hb-11), 2.04 (1H, m, Ha-2), 1.92 (1H, m, Ha-6), 1.83 (1H, m, Ha-3), 1.70 (1H, m, Hb-12), 1.65 (1H, m, H-5), 1.51 (1H, m, Hb-2), 1.28 (1H, m, Hb-3), 1.18 (1H, m, Hb-6), 1.14 (3H, s, H<sub>3</sub>-18), 1.01 (3H, s, H<sub>3</sub>-19), 1.01 (3H, s, H<sub>3</sub>-20); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ<sub>C</sub> 213.8 (C, C-9), 197.1 (C, C-15), 145.2 (C, C-16), 122.6 (CH<sub>2</sub>, C-17), 71.0 (CH, C-1), 64.7 (C, C-8), 61.8 (CH, C-7), 60.7 (CH, C-14), 57.1 (C, C-10), 40.0 (CH, C-13), 37.4 (CH, C-5), 36.4 (CH<sub>2</sub>, C-11), 34.8 (C, C-4), 33.9 (CH<sub>2</sub>, C-3), 33.6 (CH<sub>3</sub>, C-18), 33.4 (CH<sub>2</sub>, C-6), 28.0 (CH<sub>2</sub>, C-2), 25.4 (CH<sub>2</sub>, C-12), 22.9 (CH<sub>3</sub>, C-19), 17.1 (CH<sub>3</sub>, C-20). The NMR data were same as those of kongensin C.</div></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Synthesis of <b>24</b> and <b>25</b> by Reduction of <b>6</b></h3><div class="NLM_p">A solution of <b>6</b> (15 mg, 0.045 mmol) in EtOAc (1.5 mL) was treated with 10% Pd/C under an atmosphere of hydrogen at rt for 2 h. The mixture was filtered and evaporated to dryness. Then, the residue was purified by a flash silica gel CC eluted with PE/EtOAc (10:1) to give <b>24</b> (12 mg, 80%). The above method was also used to prepare <b>25</b> (7 mg, 47%), except that the solvent EtOAc was replaced by CH<sub>3</sub>OH.</div><div id="s0060" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Compound <b>24</b></h4><div class="NLM_p last">Colorless crystal; obtained in PE/acetone (5:1); mp 220–225 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ<sub>H</sub> 7.35 (1H, d, <i>J</i> = 3.3 Hz, H-14), 4.58 (1H, d, <i>J</i> = 10.6 Hz, H-7), 3.57 (1H, brs, H-1), 3.15 (1H, dd, <i>J</i> = 6.2, 3.3 Hz, H-13), 2.29 (1H, dd, <i>J</i> = 19.0, 12.1 Hz, H<sub>β</sub>-11), 2.47 (1H, q, <i>J</i> = 6.8 Hz, H-16), 2.42 (1H, m, H<sub>α</sub>-12), 2.14 (1H, dd, <i>J</i> = 19.0, 6.5 Hz, H<sub>α</sub>-11), 1.99 (1H, tt, <i>J</i> = 14.1, 3.2 Hz, H<sub>α</sub>-2), 1.83 (1H, m, H<sub>β</sub>-6), 1.79 (1H, m, H<sub>β</sub>-3), 1.70 (1H, m, H<sub>β</sub>-12), 1.47 (1H, dq, <i>J</i> = 14.5, 3. 8 Hz, H<sub>β</sub>-2), 1.41 (1H, dd, J = 5. 9, 1.9 Hz, H-5), 1.25 (1H, m, H<sub>α</sub>-3), 1.19 (1H, d, <i>J</i> = 2.0 Hz, H<sub>α</sub>-6), 1.13 (3H, d, J = 7.3 Hz, H<sub>3</sub>-17), 1.06 (3H, s, H<sub>3</sub>-18), 0.96 (3H, s, H<sub>3</sub>-19), 0.94 (3H, s, H<sub>3</sub>-20); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ<sub>C</sub> 213.9 (C, C-9), 210.3 (C, C-15), 162.8 (CH, C-14), 145.6 (C, C-8), 71.0 (CH, C-1), 64.1 (CH, C-7), 57.2 (C, C-10), 44.9 (CH, C-16), 42.5 (CH, C-13), 37.8 (CH, C-5), 37.2 (CH<sub>2</sub>, C-11), 37.0 (CH<sub>2</sub>, C-6), 34.5 (C, C-4), 33.6 (CH<sub>2</sub>, C-3), 33.5 (CH<sub>3</sub>, C-18), 27.8 (CH<sub>2</sub>, C-2), 23.2 (CH<sub>3</sub>, C-19), 21.1 (CH<sub>2</sub>, C-12), 17.7 (CH<sub>3</sub>, C-20), 10.0 (CH<sub>3</sub>, C-17); HRESIMS <i>m</i>/<i>z</i> 357.2041 [M + Na]<sup>+</sup> (calcd for C<sub>20</sub>H<sub>30</sub>O<sub>4</sub>Na<sup>+</sup>, 357.2036).</div></div><div id="s0061" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Compound <b>25</b></h4><div class="NLM_p last">Colorless crystal; obtained in PE/acetone (3:1); mp 190–195 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ<sub>H</sub> 4.37 (1H, dd, <i>J</i> = 12.2, 4.4 Hz, H-7), 3.95 (1H, brs, H-1), 2.53 (1H, m, H-13), 2.37 (1H, m, H<sub>α</sub>-11), 2.33 (1H, m, H-16), 2.30 (1H, m, H<sub>α</sub>-14), 2.17 (1H, dd, <i>J</i> = 12.8, 2.5 Hz, H-5), 2.12 (1H, m, H<sub>α</sub>-14), 1.96 (1H, m, H<sub>α</sub>-2), 1.86 (1H, m, H<sub>α</sub>-12), 1.86 (1H, m, H<sub>β</sub>-6), 1.81 (1H, m, H<sub>β</sub>-3), 1.81 (1H, m, H<sub>β</sub>-12), 1.51 (1H, dq, <i>J</i> = 14.4, 3.4 Hz, H<sub>β</sub>-2), 1.43 (1H, d, <i>J</i> = 12.4 Hz, H<sub>α</sub>-6), 1.12 (1H, m, H<sub>α</sub>-3), 1.15 (3H, s, H<sub>3</sub>-20), 1.07 (1H, m, H<sub>β</sub>-11), 1.07 (3H, d, <i>J</i> = 8.2 Hz, H<sub>3</sub>-17), 0.96 (3H, s, H<sub>3</sub>-18), 0.85 (3H, s, H<sub>3</sub>-19); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ<sub>C</sub> 225.6 (C, C-15), 80.5 (C, C-9), 71.8 (CH, C-1), 67.7 (CH, C-7), 62.2 (C, C-8), 48.7 (CH, C-16), 46.2 (C, C-10), 40.1 (CH, C-5), 34.3 (CH<sub>2</sub>, C-3), 34.2 (CH, C-13), 33.4 (CH<sub>3</sub>, C-18), 33.2 (C, C-4), 31.6 (CH<sub>2</sub>, C-11), 28.8 (CH<sub>2</sub>, C-14), 28.6 (CH<sub>2</sub>, C-6), 26.7 (CH<sub>2</sub>, C-12), 26.4 (CH<sub>2</sub>, C-2), 21.8 (CH<sub>3</sub>, C-19), 20.2 (CH<sub>3</sub>, C-20), 10.0 (CH<sub>3</sub>, C-17); HRESIMS <i>m</i>/<i>z</i> 359.2192 [M + Na]<sup>+</sup> (calcd for C<sub>20</sub>H<sub>32</sub>O<sub>4</sub>Na<sup>+</sup>, 359.2193).</div></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> X-ray Crystallographic Analysis</h3><div id="s0064" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Crystal Data for Compound <b>1</b></h4><div class="NLM_p">C<sub>20</sub>H<sub>30</sub>O<sub>5</sub>, (<i>M</i> = 350.44 g/mol): orthorhombic, space group <i>P</i>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub> (no. 19), <i>a</i> = 6.27358(8) Å, <i>b</i> = 13.80118(19) Å, <i>c</i> = 25.2543(4) Å, <i>V</i> = 2186.59(5) Å<sup>3</sup>, <i>Z</i> = 4, <i>T</i> = 100 K, μ (Cu Kα) = 0.611 mm<sup>–1</sup>, <i>Dc</i> = 1.065 g/cm<sup>3</sup>, 21556 reflections were measured (7.3 ≤ 2θ ≤ 152.118), and 4507 unique (<i>R</i><sub>int</sub> = 0.0483, <i>R</i><sub>sigma</sub> = 0.0275), which were used in all calculations. The final <i>R</i><sub>1</sub> was 0.0380 (<i>I</i> > 2σ(<i>I</i>)) and <i>w<i>R</i></i><sub>2</sub> was 0.1099. Flack parameter = 0.05 (7). Crystallographic data for the structure of <b>1</b> have been deposited in the Cambridge Crystallographic Data Centre (deposition number: CDCC 1890525).</div><div id="s0062" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> Crystal Data for Compound <b>24</b></h5><div class="NLM_p last">4-(C<sub>20</sub>H<sub>30</sub>O<sub>4</sub>) (<i>M</i> = 1337.75 g/mol): triclinic, space group <i>P</i><sub>1</sub> (no. 1), <i>a</i> = 10.49160(10) Å, <i>b</i> = 14.10490 (10) Å, <i>c</i> = 14.36770 (10) Å, α = 99.4670 (10), β = 109.2780 (10), γ = 111.3840 (10), <i>V</i> = 1767.92(3) Å<sup>3</sup>, <i>Z</i> = 1, <i>T</i> = 100.00 (10) K, μ (Cu Kα) = 0.686 mm<sup>–1</sup>, <i>Dc</i> = 1.256 g/cm<sup>3</sup>, 62927 reflections were measured (6.89 ≤ 2θ ≤ 144.236), and 12953 unique (<i>R</i><sub>int</sub> = 0.0374, <i>R</i><sub>sigma</sub> = 0.0242), which were used in all calculations. The final <i>R</i><sub>1</sub> was 0.0428 (<i>I</i> > 2σ(<i>I</i>)) and <i>w<i>R</i></i><sub>2</sub> was 0.1232. Flack parameter = 0.03 (8). Crystallographic data for the structure of <b>24</b> have been deposited in the Cambridge Crystallographic Data Centre (deposition number: CDCC 1890558).</div></div><div id="s0063" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> Crystal Data for Compound <b>25</b></h5><div class="NLM_p last">C<sub>20</sub>H<sub>32</sub>O<sub>4</sub>, (<i>M</i> =336.45 g/mol): monoclinic, space group <i>P</i>2<sub>1</sub> (no. 4), <i>a</i> = 22.74361(16) Å, <i>b</i> = 7.64671(4) Å, <i>c</i> = 22.98947(16) Å, β = 116.8744(9), <i>V</i> = 3566.38(5) Å<sup>3</sup>, <i>Z</i> = 8, <i>T</i> = 99.97(17) K, μ (Cu Kα) = 0.681 mm<sup>–1</sup>, <i>Dc</i> = 1.253 g/cm<sup>3</sup>, 72871 reflections were measured (4.308 ≤ 2θ ≤ 144.226), 13738 unique (<i>R</i><sub>int</sub> = 0.0370, R<sub>sigma</sub> = 0.0275), which were used in all calculations. The final <i>R</i><sub>1</sub> was 0.0342 (<i>I</i> > 2σ(<i>I</i>)) and <i>w<i>R</i></i><sub>2</sub> was 0.1000. Flack parameter = −0.06 (4). Crystallographic data for the structure of <b>25</b> have been deposited in the Cambridge Crystallographic Data Centre (deposition number: CDCC 1890560).</div></div></div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Cell Culture</h3><div class="NLM_p last">Human triple-negative breast cancer cell lines MDA-MB-231 and MDA-MB-468 were obtained from American Type Culture Collection. Human estrogen receptor-positive breast cancer cell line MCF-7 and human embryonic kidney cell line HEK-293 were purchased from Cell Bank of Shanghai Institute of Biochemistry and Cell Biology (Chinese Academy of Sciences, Shanghai, China). Human normal liver cell line LO2 and human normal breast epithelial cell line MCF-10A were provided by Procell Life Science & Technology (Wuhan, China). MDA-MB-231, MCF-7, HEK-293, and LO2 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) (Gibco) supplemented with 10% fetal bovine serum (FBS, Gibco). MDA-MB-468 cells were grown in the RPMI medium 1640 (Gibco) supplemented with 10% FBS. MCF-10A were maintained in DMEM/F-12 medium supplemented with 5% horse serum, 20 ng/mL epidermal growth factor, 0.5 μg/ml hydrocortisone, 10 μg/mL insulin, 1% NEAA, and 1% penicillin/streptomycin (Procell, China). All cells were cultured under standard conditions (5% CO<sub>2</sub> at 37 °C in a humidified environment).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Cytotoxicity Assay</h3><div class="NLM_p last">Cell cytotoxicity was measured using the MTT method. Briefly, cells were plated in 96-well plates (1 × 10<sup>3</sup> cells/well) for 24 h. Later, the attached cells were treated with different concentrations of compounds for 96 h. After the cells were incubated with 5 mg/mL MTT (Millipore) for another 4 h, the suspension was discarded and, subsequently, the dark blue crystals (formazan) were dissolved in dimethyl sulfoxide (DMSO) (Millipore). Then, the absorbance at 570 nm was measured using a FlexStation 3 multifunction microplate reader (Molecular Devices). For the cells placed in 12-well plates and 24-well plates, cell viability was measured by survival cell counting. The cell viability was finally calculated as the percentage compared to the control group.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Cell Cycle Assay</h3><div class="NLM_p last">Cells were plated in 12-well plates (1 × 10<sup>5</sup> cells/well) for 24 h and incubated with or without different concentrations of <b>6</b> for another 24 h. The cell cycle assay was performed according to the instruction of the Cell Cycle Detection Kit (KeyGenBioTech, China) and analyzed by Cytomics TM FC 500 flow cytometry (Beckman Coulter).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Colony Formation Assay</h3><div class="NLM_p last">Cells were plated in 6-well plates (1000 cells/well) for 24 h and later treated with or without different concentrations of compound <b>6</b>. After 2 weeks, cells were fixed with 4% paraformaldehyde (Biosharp, China) for 10 min, and then stained with crystal violet solution (Beyotime, China). The number of colonies was counted.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Annexin-V-FITC/PI Dual Staining</h3><div class="NLM_p last">Cells were plated in 12-well plates (1 × 10<sup>5</sup> cells/well) for 24 h and incubated with or without different concentrations of <b>6</b> for another 24 h. Further detailed procedures were performed according to the instructions of the Annexin V-FITC/PI Apoptosis Detection Kit (YEASEN, China), and the percentage of apoptotic cells was measured by Epics XL flow cytometry (Beckman Coulter).</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Mitochondrial Membrane Potential Analysis</h3><div class="NLM_p last">The mitochondrial membrane potential (ΔΨ<i>m</i>) changes were determined using the mitochondrial membrane potential sensitive fluorescent dye, JC-10 (Enhanced JC-1, KeyGenBioTech, China). Cells were plated in 12-well plates (1 × 10<sup>5</sup> cells/well) for 24 h and incubated with or without different concentrations of <b>6</b> for another 24 h. The detailed procedures were implemented according to the corresponding manufacturer’s instructions. The completed samples were detected by Epics XL flow cytometry.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Scratch Assay</h3><div class="NLM_p last">Cells were plated in 12-well plates (1 × 10<sup>5</sup> cells/well) for 24 h. Scratches were made in confluent monolayers using 200 μL pipette tips and washed with phosphate-buffered saline (PBS) to remove nonadherent cells. Then, the low serum DMEM medium (5% FBS) was incubated with or without different concentrations of <b>6</b>, and images were taken under EVOS FL Auto Cell Imaging System (Thermo) after certain time periods.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Transwell Invasion Assay</h3><div class="NLM_p last">Cells were placed in cell culture inserts (1 × 10<sup>5</sup> cells/well, Corning) coated with Matrigel (Corning), and serum-free DMEM medium was incubated with or without different concentrations of <b>6</b> simultaneously. The inserts were put into 24-well plates that contained DMEM supplemented with 10% FBS. After 48 h, the cells on the top side of the filters were wiped by cotton swaps, while cells on the lower side were then fixed in 4% paraformaldehyde and stained with crystal solution violet. Images were taken under EVOS FL Auto Cell Imaging System, and the cells were counted.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Western Blot Analysis</h3><div class="NLM_p last">Cells were collected from 6-well plates (5 × 10<sup>5</sup> cells/well), which were treated with or without different concentrations of compounds for 24 h. Then, cells were lysed with RIPA buffer (Beyotime, China) containing 150 mM NaCl, 50 mM Tris (pH 7.4), 0.1% (w/v) sodium dodecyl sulfate (SDS), 1 mM ethylenediamine tetraacetic acid (EDTA), 10 μM phenylmethylsulfonyl fluoride (PMSF), and phosphatase inhibitor (Roche, Switzerland). The total protein concentrations were determined by the bicinchoninic acid (BCA) protein assay kit (Beyotime, China). Then, equal amounts of proteins were loaded per well and separated by 10% sodium dodecyl sulfate-polyacrylamide gel (SDS-PAGE) and later transferred onto polyvinylidene difluoride membranes (Millipore). The membranes were washed in Tris-buffered saline with Tween 20 (TBS-T) and incubated in 5% skim milk (Sigma) at rt for 2 h on a rotary shaker. After washing with TBS-T, the primary antibodies were incubated performed overnight at 4 °C. Then, the washed membranes were incubated with specific secondary antibodies at rt for 1 h and washed again with TBS-T. Immunoreactive bands were visualized with Pierce ECL Western Blotting Substrate (Thermo) and imaged by Tanon-5200 automatic chemiluminescence imaging and analysis system (Tanon, China). The bands were analyzed using ImageJ software.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> SiRNA Transfection</h3><div class="NLM_p last">MDA-MB-231 cells (2 × 10<sup>5</sup> cells/well) and MDA-MB-468 cells (3 × 10<sup>5</sup> cells/well) were seeded in 6-well plates for 24 h. Later, the cells were transfected with 50 nM Akt1 siRNA (Synbio Technologies, China) or negative control for 6 h using the DharmaFECT 1 Transfection reagent (Dharmacon) in Opti-MEM medium (Gibco). Then, the mixed medium was removed and replaced by the normal complete medium for the rest of the incubation time (totally 72 h), and the cells were exposed to different concentrations of <b>6</b> for an additional 24 h. The siRNA sequence was listed as previously reported.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Akt1 siRNA, forward: UGCCCUUCUACAACCAGGATT; reverse: UCCUGGUUGUAGAAGGGCATT.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Cellular Thermal Shift Assay (CETSA)</h3><div class="NLM_p last">MDA-MB-231 and MDA-MB-468 cells with 90% confluence in 10 cm cultured dishes were treated with or without <b>6</b> (2 μM) for 2 h. The cells were collected and washed with PBS and suspended in 700 μL of PBS supplemented with proteinase, phosphatase inhibitors, and the same dose of <b>6</b> or DMSO. Later, the cells were distributed into seven 200 μL PCR tubes with 100 μL volume and each tube was designated a temperature point. Samples were heated at certain temperatures for 2 min and incubated at rt for 3 min; then, the samples were immediately subjected to three freeze and thaw cycles in liquid nitrogen for cell lysis. Finally, the lysates were centrifugated at 20 000<i>g</i>, 4 °C, for 20 min, and the supernatants were boiled at 90 °C for 5 min and the loading buffer was added. Western blot analysis was performed to detect the protein level.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Tumor Xenografts Growth Inhibition Assay</h3><div class="NLM_p last">All animal experiments were performed in accordance with the Guidelines of Animal Experiments from the Ethical Committee for Animal Research of Sun Yat-sen University. Female NOD/SCID mice (5–6 weeks, 19–21 g) were purchased from GemPharmatech (Jiangsu, China) and housed at the Laboratory Animal Service Center of Sun Yat-sen University (Guangzhou, China) in pathogen-free conditions, maintained at constant rt, and fed with standard rodent chow and water. Mice were subcutaneously injected with MDA-MB-468 cells (1 × 10<sup>6</sup>) and later divided into four groups (vehicle group, normal saline per day; low-dose group, 5 mg/kg <b>6</b> per day; high-dose group, 10 mg/kg <b>6</b> per day; positive control group, 5 mg/kg doxorubicin per week) In addition, it had been confirmed that there were no side effects on mice when given 50 mg/kg <b>6</b>. After 7 days of tumor transplantation, all the compounds were dissolved in normal saline and given by intraperitoneal injections. During the treatment, the weight of mice and the size of the tumor were recorded every 2 days. The tumors and organ tissues were harvested and immediately frozen in liquid nitrogen or fixed in 4% paraformaldehyde for further experiments.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Histopathology and Immunohistochemistry</h3><div class="NLM_p last">The tissues fixed in 4% paraformaldehyde were embedded in paraffin and sectioned at 4 μm thickness. The tumor and organ tissues were stained with hematoxylin and eosin (H&E) for routine histological examinations and morphometric analysis. Tumor slices were also immunostained with Ki67, CD31, and LC3B. For the TUNEL assay, DAB (SA-HRP) TUNEL Cell Apoptosis Detection Kit (Servicebio, China) was used, and the procedures were performed according to the corresponding manufacturer’s instructions. Images were taken under EVOS FL Auto Cell Imaging System.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Statistical Analysis</h3><div class="NLM_p">All the presented data and results were confirmed by at least three independent experiments. The data were expressed as mean ± standard deviation (SD) and analyzed with GraphPad Prism 7.0 software (GraphPad Software).</div><div class="NLM_p last">Statistical differences between two groups were determined using Student’s <i>t-</i>test, and statistical differences between multiple groups were determined using one-way analysis of variance. A value of <i>P</i> < 0.05 was accepted as statistically significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67"><a href="/doi/suppl/10.1021/acs.jmedchem.1c00166" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48210" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48210" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.1c00166?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00166</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H–<sup>1</sup>H COSY and key HMBC correlations of <b>1</b> and <b>2</b> (Figure S1); key NOE correlations of compound <b>1</b> (Figure S2); proliferation inhibition of <b>6</b> on TNBC cells incubated under different conditions (Figure S3); PI3Kα kinase assay performed by ADP-Glo assay (Figure S4); survival curve of mice during the treatments1D and 2D NMR spectra and the purity analyses by HPLC or TLC of <b>1</b>–<b>25</b> (Figure S5); IR and HRESIMS spectra of new compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00166/suppl_file/jm1c00166_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings for compounds <b>1</b>–<b>25</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00166/suppl_file/jm1c00166_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00166/suppl_file/jm1c00166_si_001.pdf">jm1c00166_si_001.pdf (15.92 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00166/suppl_file/jm1c00166_si_002.csv">jm1c00166_si_002.csv (3.23 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.1c00166" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52230" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52230" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sheng Yin</span> - <span class="hlFld-Affiliation affiliation">School of Pharmaceutical
Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-5678-6634" title="Orcid link">https://orcid.org/0000-0002-5678-6634</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f88191968b90cab895999194d68b818b8dd69d9c8dd69b96"><span class="__cf_email__" data-cfemail="7e0717100d164c3e131f1712500d070d0b501b1a0b501d10">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Run-Zhu Fan</span> - <span class="hlFld-Affiliation affiliation">School of Pharmaceutical
Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lin Chen</span> - <span class="hlFld-Affiliation affiliation">School of Pharmaceutical
Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tong Su</span> - <span class="hlFld-Affiliation affiliation">School of Pharmaceutical
Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Li</span> - <span class="hlFld-Affiliation affiliation">School of Pharmaceutical
Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jia-Luo Huang</span> - <span class="hlFld-Affiliation affiliation">School of Pharmaceutical
Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jun Sang</span> - <span class="hlFld-Affiliation affiliation">School of Pharmaceutical
Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0003-1446-7501" title="Orcid link">https://orcid.org/0000-0003-1446-7501</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gui-Hua Tang</span> - <span class="hlFld-Affiliation affiliation">School of Pharmaceutical
Sciences, Sun Yat-sen University, Guangzhou 510006, P. R. China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-8831-7154" title="Orcid link">https://orcid.org/0000-0002-8831-7154</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>R.-Z.F. and L.C. contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e5622-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17034" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17034" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank the Natural Science Foundation of China (Nos. 81722042, 81973195, and 81973203), the Fundamental Research Funds for the Central Universities (20ykjc04), the Guangdong Provincial Key Laboratory of Construction Foundation (No. 2017B030314030), and the China Postdoctoral Science Foundation (2020M683138) for providing financial support for this work.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">Akt</td><td class="NLM_def"><p class="first last">protein kinase B</p></td></tr><tr><td class="NLM_term">BC</td><td class="NLM_def"><p class="first last">breast cancer</p></td></tr><tr><td class="NLM_term">CC</td><td class="NLM_def"><p class="first last">column chromatography</p></td></tr><tr><td class="NLM_term">CETSA</td><td class="NLM_def"><p class="first last">cellular thermal shift assay</p></td></tr><tr><td class="NLM_term">Dox</td><td class="NLM_def"><p class="first last">doxorubicin</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">estrogen receptor</p></td></tr><tr><td class="NLM_term">ERK</td><td class="NLM_def"><p class="first last">extracellular-regulated kinase</p></td></tr><tr><td class="NLM_term">HER2</td><td class="NLM_def"><p class="first last">human epidermal growth factor receptor 2</p></td></tr><tr><td class="NLM_term">H&E</td><td class="NLM_def"><p class="first last">hematoxylin and eosin</p></td></tr><tr><td class="NLM_term">m-CPBA</td><td class="NLM_def"><p class="first last">meta-chloroperoxybenzoic acid</p></td></tr><tr><td class="NLM_term">MMP</td><td class="NLM_def"><p class="first last">mitochondrial membrane potential</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mechanistic target of rapamycin</p></td></tr><tr><td class="NLM_term">PE</td><td class="NLM_def"><p class="first last">petroleum ether</p></td></tr><tr><td class="NLM_term">PI</td><td class="NLM_def"><p class="first last">propidium iodide</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphatidylinositol 3-kinase</p></td></tr><tr><td class="NLM_term">PR</td><td class="NLM_def"><p class="first last">progesterone receptor</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SI</td><td class="NLM_def"><p class="first last">selectivity index</p></td></tr><tr><td class="NLM_term">TNBC</td><td class="NLM_def"><p class="first last">triple-negative breast cancer</p></td></tr><tr><td class="NLM_term">TUNEL</td><td class="NLM_def"><p class="first last">TdT-mediated dUTP nick end labeling</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i71">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53276" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53276" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 42 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harbeck, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnant, M.</span></span> <span> </span><span class="NLM_article-title">Breast cancer</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>389</i></span>,  <span class="NLM_fpage">1134</span>– <span class="NLM_lpage">1150</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(16)31891-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2FS0140-6736%2816%2931891-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=27865536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A280%3ADC%252BC2snot1Chsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2017&pages=1134-1150&author=N.+Harbeckauthor=M.+Gnant&title=Breast+cancer&doi=10.1016%2FS0140-6736%2816%2931891-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Breast cancer</span></div><div class="casAuthors">Harbeck Nadia; Gnant Michael</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">389</span>
        (<span class="NLM_cas:issue">10074</span>),
    <span class="NLM_cas:pages">1134-1150</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Breast cancer is one of the three most common cancers worldwide.  Early breast cancer is considered potentially curable.  Therapy has progressed substantially over the past years with a reduction in therapy intensity, both for locoregional and systemic therapy; avoiding overtreatment but also undertreatment has become a major focus.  Therapy concepts follow a curative intent and need to be decided in a multidisciplinary setting, taking molecular subtype and locoregional tumour load into account.  Primary conventional surgery is not the optimal choice for all patients any more.  In triple-negative and HER2-positive early breast cancer, neoadjuvant therapy has become a commonly used option.  Depending on clinical tumour subtype, therapeutic backbones include endocrine therapy, anti-HER2 targeting, and chemotherapy.  In metastatic breast cancer, therapy goals are prolongation of survival and maintaining quality of life.  Advances in endocrine therapies and combinations, as well as targeting of HER2, and the promise of newer targeted therapies make the prospect of long-term disease control in metastatic breast cancer an increasing reality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRi64LuFKtexLHHuJhbyicZfW6udTcc2eakNk-PjDxBTrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2snot1Chsg%253D%253D&md5=7dfc3265e0dce226e0c129726e97f407</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2816%2931891-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252816%252931891-8%26sid%3Dliteratum%253Aachs%26aulast%3DHarbeck%26aufirst%3DN.%26aulast%3DGnant%26aufirst%3DM.%26atitle%3DBreast%2520cancer%26jtitle%3DLancet%26date%3D2017%26volume%3D389%26spage%3D1134%26epage%3D1150%26doi%3D10.1016%2FS0140-6736%2816%2931891-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djamgoz, M. B. A.</span></span> <span> </span><span class="NLM_article-title">Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2017.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2Fj.ctrv.2017.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=29202431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvValtbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&pages=110-122&author=A.+Leeauthor=M.+B.+A.+Djamgoz&title=Triple+negative+breast+cancer%3A+Emerging+therapeutic+modalities+and+novel+combination+therapies&doi=10.1016%2Fj.ctrv.2017.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies</span></div><div class="casAuthors">Lee, Alice; Djamgoz, Mustafa B. A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">110-122</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Triple neg. breast cancer (TNBC) is a complex and aggressive subtype of breast cancer which lacks estrogen receptors, progesterone receptors and HER2 amplification, thereby making it difficult to target therapeutically.  In addn., TNBC has the highest rates of metastatic disease and the poorest overall survival of all breast cancer subtypes.  Resultantly, development of targeted therapies for TNBC is urgently needed.  Recent efforts aimed at mol. characterization of TNBCs have revealed various emerging therapeutic targets including PARP1, receptor and non-receptor tyrosine kinases, immune-checkpoints, androgen receptor and epigenetic proteins.  Key successes include that of the PARP inhibitor, olaparib, which prolonged progression-free survival in a trial of BRCA-mutated breast cancer and for which clin. approval (in this setting) appears imminent.  Nevertheless, the heterogeneity of TNBC has limited the clin. benefits of many trialled therapies in 'unselected' patients.  Further, drug resistance develops following use of many targeted monotherapies due to upregulation of compensatory signalling pathways.  In this review, we evaluate the current status of investigational targeted treatments and present evidence for the role of novel biomarkers and combination therapies in increasing response rates and circumventing drug-induced resistance.  Addnl., we discuss promising novel targets in metastatic TNBC identified through preclin. and/or epidemiol. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraUe6qPPRyzbVg90H21EOLACvtfcHk0liU6wM5cO7F1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvValtbnK&md5=738b63405e3d6c1a3541982a6987a2dd</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2017.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2017.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DA.%26aulast%3DDjamgoz%26aufirst%3DM.%2BB.%2BA.%26atitle%3DTriple%2520negative%2520breast%2520cancer%253A%2520Emerging%2520therapeutic%2520modalities%2520and%2520novel%2520combination%2520therapies%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2018%26volume%3D62%26spage%3D110%26epage%3D122%26doi%3D10.1016%2Fj.ctrv.2017.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viale, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Criscitiello, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curigliano, G.</span></span> <span> </span><span class="NLM_article-title">Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies</span>. <i>NPJ Breast Cancer</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">54</span> <span class="refDoi"> DOI: 10.1038/s41523-020-00197-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1038%2Fs41523-020-00197-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=33088912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A280%3ADC%252BB3s7ks1ynsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2020&author=A.+Marraauthor=D.+Trapaniauthor=G.+Vialeauthor=C.+Criscitielloauthor=G.+Curigliano&title=Practical+classification+of+triple-negative+breast+cancer%3A+intratumoral+heterogeneity%2C+mechanisms+of+drug+resistance%2C+and+novel+therapies&doi=10.1038%2Fs41523-020-00197-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies</span></div><div class="casAuthors">Marra Antonio; Trapani Dario; Viale Giulia; Criscitiello Carmen; Curigliano Giuseppe; Marra Antonio; Curigliano Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">NPJ breast cancer</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">54</span>
        ISSN:<span class="NLM_cas:issn">2374-4677</span>.
    </div><div class="casAbstract">Triple-negative breast cancer (TNBC) is not a unique disease, encompassing multiple entities with marked histopathological, transcriptomic and genomic heterogeneity.  Despite several efforts, transcriptomic and genomic classifications have remained merely theoretic and most of the patients are being treated with chemotherapy.  Driver alterations in potentially targetable genes, including PIK3CA and AKT, have been identified across TNBC subtypes, prompting the implementation of biomarker-driven therapeutic approaches.  However, biomarker-based treatments as well as immune checkpoint inhibitor-based immunotherapy have provided contrasting and limited results so far.  Accordingly, a better characterization of the genomic and immune contexture underpinning TNBC, as well as the translation of the lessons learnt in the metastatic disease to the early setting would improve patients' outcomes.  The application of multi-omics technologies, biocomputational algorithms, assays for minimal residual disease monitoring and novel clinical trial designs are strongly warranted to pave the way toward personalized anticancer treatment for patients with TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOpTEiCRQyPv69nzq6467DfW6udTcc2eakNk-PjDxBTrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3s7ks1ynsA%253D%253D&md5=c7bd36d028330c5995b6cc522f62a7cd</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fs41523-020-00197-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41523-020-00197-2%26sid%3Dliteratum%253Aachs%26aulast%3DMarra%26aufirst%3DA.%26aulast%3DTrapani%26aufirst%3DD.%26aulast%3DViale%26aufirst%3DG.%26aulast%3DCriscitiello%26aufirst%3DC.%26aulast%3DCurigliano%26aufirst%3DG.%26atitle%3DPractical%2520classification%2520of%2520triple-negative%2520breast%2520cancer%253A%2520intratumoral%2520heterogeneity%252C%2520mechanisms%2520of%2520drug%2520resistance%252C%2520and%2520novel%2520therapies%26jtitle%3DNPJ%2520Breast%2520Cancer%26date%3D2020%26volume%3D6%26doi%3D10.1038%2Fs41523-020-00197-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pawar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhu, P.</span></span> <span> </span><span class="NLM_article-title">Nanosoldiers: A promising strategy to combat triple negative breast cancer</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2018.11.122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2Fj.biopha.2018.11.122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=30529766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVWju73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2019&pages=319-341&author=A.+Pawarauthor=P.+Prabhu&title=Nanosoldiers%3A+A+promising+strategy+to+combat+triple+negative+breast+cancer&doi=10.1016%2Fj.biopha.2018.11.122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Nanosoldiers: A promising strategy to combat triple negative breast cancer</span></div><div class="casAuthors">Pawar, Akshayya; Prabhu, Priyanka</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">319-341</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  The phenomenal rise in cancer over the past few years has made it the second leading cause of death worldwide.  Breast cancer constitutes the predominant cancer encountered in women.  Triple neg. breast cancer (TNBC) is the most notorious form of breast cancer which involves absence of the estrogen, progesterone and human epidermal growth factor receptor (EGFR) on breast cancer cells.  It is a real challenge for oncologists owing to the recurrence and metastasis which result in poor prognosis.  Conventional therapies employed in treatment of TNBC suffer from issues of poor bioavailability, poor cellular uptake, resistance, and undesirable off-site toxicities.  Nanosized delivery systems, herein designated as nanosoldiers can be smartly designed to be equipped with multiple weapons (drugs, genetic materials, photosensitizers, etc.) to fight the battle against recalcitrant TNBC in a myriad of ways such as bioavailability enhancement, targeted uptake by the TNBC cells, on-demand drug delivery at tumor site, combination therapy, multimodal therapy, photodynamic therapy, photothermal therapy, anti-metastatic approaches, theranostics, etc.  The versatility of nanosoldiers with respect to their material of compn., their mechanism of drug loading and release, ability to modify in vivo drug disposition, multifunctional characteristics enabling detection, treatment, and monitoring, etc. endows them with incredible potential to destroy the intractable TNBC cells.  The focus of the review is to highlight the extraordinary potential of nanocarriers in treatment of TNBC and few challenges which need to be overcome for these nanosoldiers to form a part of the clin. armamentarium of anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotqXiS8TS2tbVg90H21EOLACvtfcHk0lhhYtk4zjYV8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVWju73L&md5=1e757c2bc3d10681f3e0a0a93e949e9a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2018.11.122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2018.11.122%26sid%3Dliteratum%253Aachs%26aulast%3DPawar%26aufirst%3DA.%26aulast%3DPrabhu%26aufirst%3DP.%26atitle%3DNanosoldiers%253A%2520A%2520promising%2520strategy%2520to%2520combat%2520triple%2520negative%2520breast%2520cancer%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2019%26volume%3D110%26spage%3D319%26epage%3D341%26doi%3D10.1016%2Fj.biopha.2018.11.122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bianchini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balko, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gianni, L.</span></span> <span> </span><span class="NLM_article-title">Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease</span>. <i>Nat. Rev. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">674</span>– <span class="NLM_lpage">690</span>, <span class="refDoi"> DOI: 10.1038/nrclinonc.2016.66</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1038%2Fnrclinonc.2016.66" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=27184417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC28XotFOhtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=674-690&author=G.+Bianchiniauthor=J.+M.+Balkoauthor=I.+A.+Mayerauthor=M.+E.+Sandersauthor=L.+Gianni&title=Triple-negative+breast+cancer%3A+challenges+and+opportunities+of+a+heterogeneous+disease&doi=10.1038%2Fnrclinonc.2016.66"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease</span></div><div class="casAuthors">Bianchini, Giampaolo; Balko, Justin M.; Mayer, Ingrid A.; Sanders, Melinda E.; Gianni, Luca</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">674-690</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chemotherapy is the primary established systemic treatment for patients with triple-neg. breast cancer (TNBC) in both the early and advanced-stages of the disease.  The lack of targeted therapies and the poor prognosis of patients with TNBC have fostered a major effort to discover actionable mol. targets to treat patients with these tumors.  Massively parallel sequencing and other 'omics' technologies have revealed an unexpected level of heterogeneity of TNBCs and have led to the identification of potentially actionable mol. features in some TNBCs, such as germline BRCA1/2 mutations or 'BRCAness', the presence of the androgen receptor, and several rare genomic alterations.  Whether these alterations are mol. 'drivers', however, has not been clearly established.  A subgroup of TNBCs shows a high degree of tumor-infiltrating lymphocytes that also correlates with a lower risk of disease relapse and a higher likelihood of benefit from chemotherapy.  Proof-of-principle studies with immune-checkpoint inhibitors in advanced-stage TNBC have yielded promising results, indicating the potential benefit of immunotherapy for patients with TNBC.  In this Review, we discuss the most relevant mol. findings in TNBC from the past decade and the most promising therapeutic opportunities derived from these data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHF3dPbmmkIbVg90H21EOLACvtfcHk0lhhYtk4zjYV8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotFOhtbs%253D&md5=1844e2d72f6321238d275cddc745ba1c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2016.66&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2016.66%26sid%3Dliteratum%253Aachs%26aulast%3DBianchini%26aufirst%3DG.%26aulast%3DBalko%26aufirst%3DJ.%2BM.%26aulast%3DMayer%26aufirst%3DI.%2BA.%26aulast%3DSanders%26aufirst%3DM.%2BE.%26aulast%3DGianni%26aufirst%3DL.%26atitle%3DTriple-negative%2520breast%2520cancer%253A%2520challenges%2520and%2520opportunities%2520of%2520a%2520heterogeneous%2520disease%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2016%26volume%3D13%26spage%3D674%26epage%3D690%26doi%3D10.1038%2Fnrclinonc.2016.66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vidula, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellisen, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardia, A.</span></span> <span> </span><span class="NLM_article-title">Novel Agents for Metastatic Triple-Negative Breast Cancer: Finding the Positive in the Negative</span>. <i>J. Natl. Compr. Cancer Network</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">1179</span>, <span class="refDoi"> DOI: 10.6004/jnccn.2020.7600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.6004%2Fjnccn.2020.7600" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2021&pages=109-1179&author=N.+Vidulaauthor=L.+W.+Ellisenauthor=A.+Bardia&title=Novel+Agents+for+Metastatic+Triple-Negative+Breast+Cancer%3A+Finding+the+Positive+in+the+Negative&doi=10.6004%2Fjnccn.2020.7600"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.6004%2Fjnccn.2020.7600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.6004%252Fjnccn.2020.7600%26sid%3Dliteratum%253Aachs%26aulast%3DVidula%26aufirst%3DN.%26aulast%3DEllisen%26aufirst%3DL.%2BW.%26aulast%3DBardia%26aufirst%3DA.%26atitle%3DNovel%2520Agents%2520for%2520Metastatic%2520Triple-Negative%2520Breast%2520Cancer%253A%2520Finding%2520the%2520Positive%2520in%2520the%2520Negative%26jtitle%3DJ.%2520Natl.%2520Compr.%2520Cancer%2520Network%26date%3D2021%26volume%3D19%26spage%3D109%26epage%3D1179%26doi%3D10.6004%2Fjnccn.2020.7600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCann, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurvitz, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAndrew, N.</span></span> <span> </span><span class="NLM_article-title">Advances in Targeted Therapies for Triple-Negative Breast Cancer</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">1217</span>– <span class="NLM_lpage">1230</span>, <span class="refDoi"> DOI: 10.1007/s40265-019-01155-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1007%2Fs40265-019-01155-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=31254268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A280%3ADC%252BB3Mzit1Cisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2019&pages=1217-1230&author=K.+E.+McCannauthor=S.+A.+Hurvitzauthor=N.+McAndrew&title=Advances+in+Targeted+Therapies+for+Triple-Negative+Breast+Cancer&doi=10.1007%2Fs40265-019-01155-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in Targeted Therapies for Triple-Negative Breast Cancer</span></div><div class="casAuthors">McCann Kelly E; Hurvitz Sara A; McAndrew Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1217-1230</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">While the outcomes for patients diagnosed with hormone receptor positive (HR+) and/or human epidermal growth factor receptor 2-positive (HER2+) breast cancers have continued to improve with the development of targeted therapies, the same cannot be said yet for those affected with triple-negative breast cancer (TNBC).  Currently, the mainstay of treatment for the 10-15% of patients diagnosed with TNBC remains cytotoxic chemotherapy, but it is hoped that through an enhanced characterization of TNBC biology, this disease will be molecularly delineated into subgroups with targetable oncogenic drivers.  This review will focus on recent therapeutic innovations for TNBC, including poly-ADP-ribosyl polymerase (PARP) inhibitors, phosphoinositide 3-kinase (PI3K) pathway inhibitors, immune checkpoint inhibitors, and cyclin-dependent kinase (CDK) inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTGRwqiCBdI45SWdIdmEou5fW6udTcc2eYunNFyHvqRxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3Mzit1Cisw%253D%253D&md5=60faeeed79b8728a66ffd80f331d2bca</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs40265-019-01155-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-019-01155-4%26sid%3Dliteratum%253Aachs%26aulast%3DMcCann%26aufirst%3DK.%2BE.%26aulast%3DHurvitz%26aufirst%3DS.%2BA.%26aulast%3DMcAndrew%26aufirst%3DN.%26atitle%3DAdvances%2520in%2520Targeted%2520Therapies%2520for%2520Triple-Negative%2520Breast%2520Cancer%26jtitle%3DDrugs%26date%3D2019%26volume%3D79%26spage%3D1217%26epage%3D1230%26doi%3D10.1007%2Fs40265-019-01155-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span> <span> </span><span class="NLM_article-title">Natural products as leads to potential drugs: An old process or the new hope for drug discovery?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2589</span>– <span class="NLM_lpage">2599</span>, <span class="refDoi"> DOI: 10.1021/jm0704090</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0704090" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktlCis7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2589-2599&author=D.+J.+Newman&title=Natural+products+as+leads+to+potential+drugs%3A+An+old+process+or+the+new+hope+for+drug+discovery%3F&doi=10.1021%2Fjm0704090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Products as Leads to Potential Drugs: An Old Process or the New Hope for Drug Discovery?</span></div><div class="casAuthors">Newman, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2589-2599</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This review reports the potential use of natural pharmaceutical products in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPLHbnhB1dULVg90H21EOLACvtfcHk0li-fb3yjI-YUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktlCis7g%253D&md5=dbb052c64835db6f919c0ea3cf3e8fbe</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm0704090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0704090%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26atitle%3DNatural%2520products%2520as%2520leads%2520to%2520potential%2520drugs%253A%2520An%2520old%2520process%2520or%2520the%2520new%2520hope%2520for%2520drug%2520discovery%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2589%26epage%3D2599%26doi%3D10.1021%2Fjm0704090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. H.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">500</span>– <span class="NLM_lpage">516</span>, <span class="refDoi"> DOI: 10.1021/np900821e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np900821e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVOqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2010&pages=500-516&author=K.+H.+Lee&title=Discovery+and+development+of+natural+product-derived+chemotherapeutic+agents+based+on+a+medicinal+chemistry+approach&doi=10.1021%2Fnp900821e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Natural Product-Derived Chemotherapeutic Agents Based on a Medicinal Chemistry Approach</span></div><div class="casAuthors">Lee, Kuo-Hsiung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">500-516</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A review.  Medicinal plants have long been an excellent source of pharmaceutical agents.  Accordingly, the long-term objectives of the author's research program are to discover and design new chemotherapeutic agents based on plant-derived compd. leads by using a medicinal chem. approach, which is a combination of chem. and biol.  Different examples of promising bioactive natural products and their synthetic analogs, including sesquiterpene lactones, quassinoids, naphthoquinones, phenylquinolones, dithiophenediones, neo-tanshinlactone, tylophorine, suksdorfin, DCK, and DCP, will be presented with respect to their discovery and preclin. development as potential clin. trial candidates.  Research approaches include bioactivity- or mechanism of action-directed isolation and characterization of active compds., rational drug design-based modification and analog synthesis, and structure-activity relationship and mechanism of action studies.  Current clin. trial agents discovered by the Natural Products Research Labs., University of North Carolina, include bevirimat (di-Me succinyl betulinic acid), which is now in phase IIb trials for treating AIDS.  Bevirimat is also the first in a new class of HIV drug candidates called "maturation inhibitors".  In addn., an etoposide analog, GL-331, progressed to anticancer phase II clin. trials, and the curcumin analog JC-9 is in phase II clin. trials for treating acne and in development for trials against prostate cancer.  The discovery and development of these clin. trial candidates will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmO67UJvZKHLVg90H21EOLACvtfcHk0li-fb3yjI-YUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVOqsLc%253D&md5=9775ba3d4776a5d2de9c6dde29782cc8</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fnp900821e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp900821e%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DDiscovery%2520and%2520development%2520of%2520natural%2520product-derived%2520chemotherapeutic%2520agents%2520based%2520on%2520a%2520medicinal%2520chemistry%2520approach%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2010%26volume%3D73%26spage%3D500%26epage%3D516%26doi%3D10.1021%2Fnp900821e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cragg, G. M.</span></span> <span> </span><span class="NLM_article-title">Natural Products as Sources of New Drugs from 1981 to 2014</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">629</span>– <span class="NLM_lpage">661</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.5b01055</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.5b01055" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit1Kqu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=629-661&author=D.+J.+Newmanauthor=G.+M.+Cragg&title=Natural+Products+as+Sources+of+New+Drugs+from+1981+to+2014&doi=10.1021%2Facs.jnatprod.5b01055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Products as Sources of New Drugs from 1981 to 2014</span></div><div class="casAuthors">Newman, David J.; Cragg, Gordon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">629-661</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">This contribution is a completely updated and expanded version of the four prior analogous reviews that were published in this journal in 1997, 2003, 2007, and 2012.  In the case of all approved therapeutic agents, the time frame has been extended to cover the 34 years from Jan. 1, 1981, to Dec. 31, 2014, for all diseases worldwide, and from 1950 (earliest so far identified) to Dec. 2014 for all approved antitumor drugs worldwide.  As mentioned in the 2012 review, we have continued to utilize our secondary subdivision of a "natural product mimic", or "NM", to join the original primary divisions and the designation "natural product botanical", or "NB", to cover those botanical "defined mixts." now recognized as drug entities by the U.S. FDA (and similar organizations).  From the data presented in this review, the utilization of natural products and/or their novel structures, in order to discover and develop the final drug entity, is still alive and well.  For example, in the area of cancer, over the time frame from around the 1940s to the end of 2014, of the 175 small mols. approved, 131, or 75%, are other than "S" (synthetic), with 85, or 49%, actually being either natural products or directly derived therefrom.  In other areas, the influence of natural product structures is quite marked, with, as expected from prior information, the anti-infective area being dependent on natural products and their structures.  We wish to draw the attention of readers to the rapidly evolving recognition that a significant no. of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated", and therefore it is considered that this area of natural product research should be expanded significantly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMgEvq9fVY8bVg90H21EOLACvtfcHk0liInJWxw3lcEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit1Kqu7k%253D&md5=c9f2a44ab6b66331b7ef6ca64029328a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.5b01055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.5b01055%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26atitle%3DNatural%2520Products%2520as%2520Sources%2520of%2520New%2520Drugs%2520from%25201981%2520to%25202014%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2016%26volume%3D79%26spage%3D629%26epage%3D661%26doi%3D10.1021%2Facs.jnatprod.5b01055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, S.</span></span> <span> </span><span class="NLM_article-title">Jatrophane Diterpenoids as Modulators of P-Glycoprotein-Dependent Multidrug Resistance (MDR): Advances of Structure-Activity Relationships and Discovery of Promising MDR Reversal Agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6353</span>– <span class="NLM_lpage">6369</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00605</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00605" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVSrtb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6353-6369&author=J.+Zhuauthor=R.+Wangauthor=L.+Louauthor=W.+Liauthor=G.+Tangauthor=X.+Buauthor=S.+Yin&title=Jatrophane+Diterpenoids+as+Modulators+of+P-Glycoprotein-Dependent+Multidrug+Resistance+%28MDR%29%3A+Advances+of+Structure-Activity+Relationships+and+Discovery+of+Promising+MDR+Reversal+Agents&doi=10.1021%2Facs.jmedchem.6b00605"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Jatrophane Diterpenoids as Modulators of P-Glycoprotein-Dependent Multidrug Resistance (MDR): Advances of Structure-Activity Relationships and Discovery of Promising MDR Reversal Agents</span></div><div class="casAuthors">Zhu, Jianyong; Wang, Ruimin; Lou, Lanlan; Li, Wei; Tang, Guihua; Bu, Xianzhang; Yin, Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6353-6369</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The phytochem. study of Pedilanthus tithymaloides led to the isolation of 13 jatrophane diterpenoids (1-13), of which eight (1-8) are new.  Subsequent structural modification of the major components by esterification, hydrolysis, hydrogenation, or epoxidn. yielded 22 new derivs. (14-35).  Thus, a jatrophane library contg. two series of compds. was established to screen for P-glycoprotein (Pgp)-dependent MDR modulators.  The activity was evaluated through a combination of Rho123 efflux and chemoreversal assays on adriamycin resistant human hepatocellular carcinoma cell line HepG2 (HepG2/ADR) and adriamycin resistant human breast adenocarcinoma cell line MCF-7 (MCF-7/ADR).  Compds. 19, 25, and 26 were identified as potent MDR modulators with greater chemoreversal ability and less cytotoxicity than the third-generation drug tariquidar.  The structure-activity relationship (SAR) was discussed, which showed that modifications beyond just increasing the lipophilicity of this class of Pgp inhibitors are beneficial to the activity.  Compd. 26, which exhibited a remarkable metabolic stability in vitro and a favorable antitumor effect in vivo, would serve as a promising lead for the development of new MDR reversal agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobYTCdHUEwx7Vg90H21EOLACvtfcHk0liInJWxw3lcEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVSrtb%252FI&md5=3980b1349ffea40674e82fff3fba2f5d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00605%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DLou%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DG.%26aulast%3DBu%26aufirst%3DX.%26aulast%3DYin%26aufirst%3DS.%26atitle%3DJatrophane%2520Diterpenoids%2520as%2520Modulators%2520of%2520P-Glycoprotein-Dependent%2520Multidrug%2520Resistance%2520%2528MDR%2529%253A%2520Advances%2520of%2520Structure-Activity%2520Relationships%2520and%2520Discovery%2520of%2520Promising%2520MDR%2520Reversal%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6353%26epage%3D6369%26doi%3D10.1021%2Facs.jmedchem.6b00605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, S.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic macrocyclic diterpenoids from <i>Jatropha multifida</i></span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">518</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2018.06.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2Fj.bioorg.2018.06.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=30005201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlentr%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2018&pages=511-518&author=J.+S.+Zhangauthor=Y.+Zhangauthor=S.+Liauthor=A.+Ahmedauthor=G.+H.+Tangauthor=S.+Yin&title=Cytotoxic+macrocyclic+diterpenoids+from+Jatropha+multifida&doi=10.1016%2Fj.bioorg.2018.06.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic macrocyclic diterpenoids from Jatropha multifida</span></div><div class="casAuthors">Zhang, Jun-Sheng; Zhang, Yao; Li, Shen; Ahmed, Abrar; Tang, Gui-Hua; Yin, Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">511-518</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nine new macrocyclic diterpenoids (1-9), jatromultones A-I, along with eight known analogs (10-17) were isolated from the trunks of Jatropha multifida.  The structures of the new compds., including their abs. configurations, were elucidated by combination of spectroscopic anal., single crystal X-ray diffraction, Rh2(OCOCF3)4-induced CD method, and chem. correlations.  All compds. were screened for the cytotoxicity against five cancer cell lines, including one drug-resistant cell line, and seven compds. exhibited significant activity with IC50 values less than 10 μM.  Compd. 4 with IC50 values ranging from 2.69 to 6.44 μM toward all cell lines was selected for further mechanistic study, which showed that 4 could arrest cell cycle at G2/M phase and induce apoptosis.  The brief structure-activity relationships (SARs) of these macrocyclic diterpenoids were also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlB9-GK3NzvbVg90H21EOLACvtfcHk0liInJWxw3lcEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlentr%252FI&md5=b3e180d58446e87ce5c2bf65a28d0a81</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2018.06.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2018.06.025%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%2BS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DAhmed%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DG.%2BH.%26aulast%3DYin%26aufirst%3DS.%26atitle%3DCytotoxic%2520macrocyclic%2520diterpenoids%2520from%2520Jatropha%2520multifida%26jtitle%3DBioorg.%2520Chem.%26date%3D2018%26volume%3D80%26spage%3D511%26epage%3D518%26doi%3D10.1016%2Fj.bioorg.2018.06.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Node, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuji, K.</span></span> <span> </span><span class="NLM_article-title">Terpenoids. XLVIII. New diterpenoids from <i>Rabdosia shikokiana</i> var. occidentalis</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1029</span>– <span class="NLM_lpage">1033</span>, <span class="refDoi"> DOI: 10.1248/cpb.33.1029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1248%2Fcpb.33.1029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADyaL2MXktVelur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1985&pages=1029-1033&author=M.+Nodeauthor=N.+Itoauthor=I.+Uchidaauthor=E.+Fujitaauthor=K.+Fuji&title=Terpenoids.+XLVIII.+New+diterpenoids+from+Rabdosia+shikokiana+var.+occidentalis&doi=10.1248%2Fcpb.33.1029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Terpenoids.  XLVIII.  New diterpenoids from Rabdosia shikokiana var. occidentalis</span></div><div class="casAuthors">Node, Manabu; Ito, Nozomu; Uchida, Itsuo; Fujita, Eiichi; Fuji, Kaoru</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1029-33</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    </div><div class="casAbstract">Five new kaurene-type diterpenoids, shikoccin (I), O-methylshikoccin, epoxyshikoccin, O-methylepoxyshikoccin, and shikoccidin (II) were isolated from Rabdpsoa shikokiana var occidentalis.  All these compds. except for II possess a previously unknown 8,9-seco-ent-kaurene skeleton.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrArIegtsKJsLVg90H21EOLACvtfcHk0ljIWHgPFzcp0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXktVelur4%253D&md5=7dc060d687720981b31be61612858a6f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1248%2Fcpb.33.1029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.33.1029%26sid%3Dliteratum%253Aachs%26aulast%3DNode%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DUchida%26aufirst%3DI.%26aulast%3DFujita%26aufirst%3DE.%26aulast%3DFuji%26aufirst%3DK.%26atitle%3DTerpenoids.%2520XLVIII.%2520New%2520diterpenoids%2520from%2520Rabdosia%2520shikokiana%2520var.%2520occidentalis%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1985%26volume%3D33%26spage%3D1029%26epage%3D1033%26doi%3D10.1248%2Fcpb.33.1029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, S. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, J. M.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic 8,9-seco-ent-kaurane diterpenoids from <i>Croton kongensis</i></span>. <i>J. Asian Nat. Prod. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">920</span>– <span class="NLM_lpage">927</span>, <span class="refDoi"> DOI: 10.1080/10286020.2017.1373100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1080%2F10286020.2017.1373100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=28895443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFajs7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=920-927&author=S.+Q.+Shiauthor=Y.+Y.+Fanauthor=C.+H.+Xuauthor=J.+Dingauthor=G.+W.+Wangauthor=J.+M.+Yue&title=Cytotoxic+8%2C9-seco-ent-kaurane+diterpenoids+from+Croton+kongensis&doi=10.1080%2F10286020.2017.1373100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic 8,9-seco-ent-kaurane diterpenoids from Croton kongensis</span></div><div class="casAuthors">Shi, Shu-Qin; Fan, Yao-Yue; Xu, Cheng-Hui; Ding, Jian; Wang, Guan-Wu; Yue, Jian-Min</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Asian Natural Products Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">920-927</span>CODEN:
                <span class="NLM_cas:coden">JANRFI</span>;
        ISSN:<span class="NLM_cas:issn">1028-6020</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Chem. study on the ethanolic ext. generated from the aerial parts of Croton kongensis led to the isolation of three new 8,9-seco-ent-kaurane diterpenoids, kongeniods A-C (1-3), together with seven known analogs (4-10).  The structures of these compds. were assigned by spectroscopic data anal.  The vitro cytotoxic tests showed that compds. 1-3 exhibited strong activities against HL-60 cell lines with IC50 values of 0.47, 0.58, and 1.27 μM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVJGbUHvx2CbVg90H21EOLACvtfcHk0ljIWHgPFzcp0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFajs7jI&md5=ffccb48b9e5c7efd7c680585a0665368</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1080%2F10286020.2017.1373100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10286020.2017.1373100%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DS.%2BQ.%26aulast%3DFan%26aufirst%3DY.%2BY.%26aulast%3DXu%26aufirst%3DC.%2BH.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DG.%2BW.%26aulast%3DYue%26aufirst%3DJ.%2BM.%26atitle%3DCytotoxic%25208%252C9-seco-ent-kaurane%2520diterpenoids%2520from%2520Croton%2520kongensis%26jtitle%3DJ.%2520Asian%2520Nat.%2520Prod.%2520Res.%26date%3D2018%26volume%3D20%26spage%3D920%26epage%3D927%26doi%3D10.1080%2F10286020.2017.1373100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Z.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span> <span> </span><span class="NLM_article-title">ent-Kaurane Diterpenoids from <i>Euphorbia wangii</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">811</span>– <span class="NLM_lpage">816</span>, <span class="refDoi"> DOI: 10.1021/np50108a019</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np50108a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADyaK2cXlslGiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1994&pages=811-816&author=Z.-J.+Jiaauthor=J.-G.+Shiauthor=L.+Yang&title=ent-Kaurane+Diterpenoids+from+Euphorbia+wangii&doi=10.1021%2Fnp50108a019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Ent-kaurane diterpenoids from Euphorbia wangii</span></div><div class="casAuthors">Jia, Zhong-Jian; Shi, Jian-Gong; Yang, Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">811-16</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    </div><div class="casAbstract">Four new diterpenoids having the ent-kaurane skeleton, euphoranginol A 11-acetate, euphoranginol B (I), euphoranginol C (II, R = OH; R1 = H), and euphoranginone D II (RR1 = O), together with a known compd. ent-kaur-16-en-3β-ol, were isolated from the whole plant of Euphorbia wangii.  Their structures were elucidated by spectroscopic methods and chem. transformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptwgxY-u5okrVg90H21EOLACvtfcHk0lhZQjEIa-rlSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlslGiur4%253D&md5=d8e6e6e546c1c0db0809040f6080fe33</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fnp50108a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp50108a019%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DZ.-J.%26aulast%3DShi%26aufirst%3DJ.-G.%26aulast%3DYang%26aufirst%3DL.%26atitle%3Dent-Kaurane%2520Diterpenoids%2520from%2520Euphorbia%2520wangii%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1994%26volume%3D57%26spage%3D811%26epage%3D816%26doi%3D10.1021%2Fnp50108a019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mu, S.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X.-J.</span></span> <span> </span><span class="NLM_article-title">Study on chemical constituents of <i>Euphorbia helioscopia</i> and their antitumor activities</span>. <i>ZhongYaoCai</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1092</span>– <span class="NLM_lpage">1096</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=24417144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC2cXks1ejtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2013&pages=1092-1096&author=S.-Z.+Muauthor=S.+Shangauthor=C.+Yanauthor=F.-M.+Yangauthor=X.-J.+Hao&title=Study+on+chemical+constituents+of+Euphorbia+helioscopia+and+their+antitumor+activities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical constituents of Euphorbia helioscopia and their antitumor activities</span></div><div class="casAuthors">Mu, Shu-zhen; Shang, Shang; Yan, Chen; Yang, Fu-mei; Hao, Xiao-jiang</div><div class="citationInfo"><span class="NLM_cas:title">Zhongyaocai</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1092-1096</span>CODEN:
                <span class="NLM_cas:coden">ZHONAR</span>;
        ISSN:<span class="NLM_cas:issn">1001-4454</span>.
    
            (<span class="NLM_cas:orgname">Guojia Shipin Yaopin Jiandu Guanliju, Zhongyaocai Xinxi Zhongxinzhan</span>)
        </div><div class="casAbstract">The chem. constituents of Euphorbia helioscopia and their antitumor activities were investigated.  Normal phase silica gel, RP-18 silica gel and Sephadex LH-20 column chromatogs. combined with recrystn. were used to isolate and purify the constituents.  Their structures were identified by spectroscopic methods, including 1H-NMR, 13C-NMR, ESI-MS and EI-MS.  And the antitumor activities of some of chem. constituents in vitro were detected by sulforhodamine B protein staining.  Nine compds. were isolated and their structures were identified as euphohelioscopin A (1), euphoscopin (2), 9,19-cyclolanost-23E-ene-3,25-diol (3), euphoscopin C (4), euphornin A (5), euphoheliosnoid A (6), ent-kaurane-3-oxo-16β,17-diol (7), 9,19-cyclolanost-25-ene-3β,22-diol (8) and helioscopinolide A (9).  Compd. 9 showed effect on inhibiting the cell proliferations of MCF-7 cell line.  Compds. 3, 7, 8 and 9 are obtained from this plant for the first time, and compd. 9 shows the potential antitumor activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnUqcjhAPUlbVg90H21EOLACvtfcHk0lhZQjEIa-rlSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXks1ejtrc%253D&md5=99f8a889fc8adf4767d69bd343210418</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMu%26aufirst%3DS.-Z.%26aulast%3DShang%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DF.-M.%26aulast%3DHao%26aufirst%3DX.-J.%26atitle%3DStudy%2520on%2520chemical%2520constituents%2520of%2520Euphorbia%2520helioscopia%2520and%2520their%2520antitumor%2520activities%26jtitle%3DZhongYaoCai%26date%3D2013%26volume%3D36%26spage%3D1092%26epage%3D1096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dräger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeske, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunst, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, H. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsichritzis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirschning, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakupovicldl, J.</span></span> <span> </span><span class="NLM_article-title">Tonantzitlolone and other diterpenes from <i>Stillingia sanguinolenta</i></span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2007</i></span>,  <span class="NLM_fpage">5020</span>– <span class="NLM_lpage">5026</span>, <span class="refDoi"> DOI: 10.1002/ejoc.200700184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1002%2Fejoc.200700184" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2007&publication_year=2007&pages=5020-5026&author=G.+Dr%C3%A4gerauthor=F.+Jeskeauthor=E.+Kunstauthor=E.+G.+Lopezauthor=H.+V.+Sanchezauthor=F.+Tsichritzisauthor=A.+Kirschningauthor=J.+Jakupovicldl&title=Tonantzitlolone+and+other+diterpenes+from+Stillingia+sanguinolenta&doi=10.1002%2Fejoc.200700184"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fejoc.200700184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.200700184%26sid%3Dliteratum%253Aachs%26aulast%3DDr%25C3%25A4ger%26aufirst%3DG.%26aulast%3DJeske%26aufirst%3DF.%26aulast%3DKunst%26aufirst%3DE.%26aulast%3DLopez%26aufirst%3DE.%2BG.%26aulast%3DSanchez%26aufirst%3DH.%2BV.%26aulast%3DTsichritzis%26aufirst%3DF.%26aulast%3DKirschning%26aufirst%3DA.%26aulast%3DJakupovicldl%26aufirst%3DJ.%26atitle%3DTonantzitlolone%2520and%2520other%2520diterpenes%2520from%2520Stillingia%2520sanguinolenta%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2007%26volume%3D2007%26spage%3D5020%26epage%3D5026%26doi%3D10.1002%2Fejoc.200700184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span> <span> </span><span class="NLM_article-title">Three new, 1-oxygenated ent-8,9-secokaurane diterpenes from <i>Croton kongensis</i></span>. <i>Helv. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1002/hlca.200690057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1002%2Fhlca.200690057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsVWjs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2006&pages=537-541&author=W.+Chenauthor=X.+D.+Yangauthor=J.+F.+Zhaoauthor=J.+H.+Yangauthor=H.+B.+Zhangauthor=Z.+Y.+Liauthor=L.+Li&title=Three+new%2C+1-oxygenated+ent-8%2C9-secokaurane+diterpenes+from+Croton+kongensis&doi=10.1002%2Fhlca.200690057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Three new, 1-oxygenated ent-8,9-secokaurane diterpenes from Croton kongensis</span></div><div class="casAuthors">Chen, Wei; Yang, Xiao-Dong; Zhao, Jing-Feng; Yang, Jing-Hua; Zhang, Hong-Bin; Li, Zi-Yan; Li, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Helvetica Chimica Acta</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">537-541</span>CODEN:
                <span class="NLM_cas:coden">HCACAV</span>;
        ISSN:<span class="NLM_cas:issn">0018-019X</span>.
    
            (<span class="NLM_cas:orgname">Verlag Helvetica Chimica Acta</span>)
        </div><div class="casAbstract">Three new ent-8,9-secokaurane diterpenes, kongensins A-C (I-III), were isolated from the aerial parts of Croton kongensis, together with two known compds., rabdoumbrosanin and (7α,14β)-7,14-dihydroxy-ent-kaur-16-en-15-one.  The structures of the new compds. were elucidated by HR-MS as well as in-depth 1D- and 2D-NMR analyses.  Kongensins A-C showed an unusual oxygenation pattern, with an AcO or OH group at C(1), in combination with a Δ8(14) unsatn. (kongensin A) or an 8,14-epoxide function (kongensin B,C).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8NQ0EPssNqLVg90H21EOLACvtfcHk0lhZQjEIa-rlSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsVWjs7w%253D&md5=e244f2bd03bb9b0fe545100bb52c430f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fhlca.200690057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhlca.200690057%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DX.%2BD.%26aulast%3DZhao%26aufirst%3DJ.%2BF.%26aulast%3DYang%26aufirst%3DJ.%2BH.%26aulast%3DZhang%26aufirst%3DH.%2BB.%26aulast%3DLi%26aufirst%3DZ.%2BY.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DThree%2520new%252C%25201-oxygenated%2520ent-8%252C9-secokaurane%2520diterpenes%2520from%2520Croton%2520kongensis%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D2006%26volume%3D89%26spage%3D537%26epage%3D541%26doi%3D10.1002%2Fhlca.200690057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span> <span> </span><span class="NLM_article-title">Ent-kaurane diterpenes and phenolic compounds from <i>Croton kongensis</i> (Euphorbiaceae)</span>. <i>Biochem. Syst. Ecol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1016/j.bse.2009.03.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2Fj.bse.2009.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtlyisbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=237-240&author=X.+D.+Yangauthor=W.+Chenauthor=J.+F.+Zhaoauthor=L.+J.+Yangauthor=H.+B.+Zhangauthor=L.+Li&title=Ent-kaurane+diterpenes+and+phenolic+compounds+from+Croton+kongensis+%28Euphorbiaceae%29&doi=10.1016%2Fj.bse.2009.03.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Ent-kaurane diterpenes and phenolic compounds from Croton kongensis (Euphorbiaceae)</span></div><div class="casAuthors">Yang, Xiao-Dong; Chen, Wei; Zhao, Jing-Feng; Yang, Li-Juan; Zhang, Hong-Bin; Li, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Systematics and Ecology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">237-240</span>CODEN:
                <span class="NLM_cas:coden">BSECBU</span>;
        ISSN:<span class="NLM_cas:issn">0305-1978</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A new ent-kaurene diterpene, kongensin F (I), three known ent-kaurane diterpenes, and five known phenolics were isolated from leaves of Croton kongensis.  Kongensin F was characterized by it's mass and NMR spectra.  The known ent-kaurane diterpenes isolated were: rabdoumbrosanin, ent-(7α,14β)-7,14-dihydroxy-ent-kaur-16-en-15-one, and ent-7β-hydroxy-15-oxokaur-16-en-18-yl acetate.  The phenolics isolated were: vanillin, vanillic acid, 4-hydroxybenzoic acid, 4-Methoxybenzoic acid and 2,6-ditert-butyl-4-methyl-phenol.  The chemotaxonomic significance of these results were discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod-_5X5bV6IbVg90H21EOLACvtfcHk0lguk7U7cp2dkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtlyisbw%253D&md5=32fba7c9d1791c64a0a9d921974f2d5a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bse.2009.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bse.2009.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%2BD.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DJ.%2BF.%26aulast%3DYang%26aufirst%3DL.%2BJ.%26aulast%3DZhang%26aufirst%3DH.%2BB.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DEnt-kaurane%2520diterpenes%2520and%2520phenolic%2520compounds%2520from%2520Croton%2520kongensis%2520%2528Euphorbiaceae%2529%26jtitle%3DBiochem.%2520Syst.%2520Ecol.%26date%3D2009%26volume%3D37%26spage%3D237%26epage%3D240%26doi%3D10.1016%2Fj.bse.2009.03.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riaz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zubair, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samiullah, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarfraz, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabeen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sultana, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sultana, S.</span></span> <span> </span><span class="NLM_article-title">Eriocalyxin B induces apoptosis in human triple negative breast cancer cells via inhibiting STAT3 activation and mitochondrial dysfunction</span>. <i>Pak. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">2843</span>– <span class="NLM_lpage">2848</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=32024623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhslGktLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2019&pages=2843-2848&author=A.+Riazauthor=A.+Rasulauthor=G.+Hussainauthor=M.+Zubairauthor=K.+Samiullahauthor=I.+Sarfrazauthor=M.+Masoodauthor=F.+Jabeenauthor=T.+Sultanaauthor=S.+Sultana&title=Eriocalyxin+B+induces+apoptosis+in+human+triple+negative+breast+cancer+cells+via+inhibiting+STAT3+activation+and+mitochondrial+dysfunction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Eriocalyxin B induces apoptosis in human triple negative breast cancer cells via inhibiting STAT3 activation and mitochondrial dysfunction</span></div><div class="casAuthors">Riaz, Anunara; Rasul, Azhar; Hussain, Gluilam; Zubair, Muhammad; Samiullah, Khizar; Sarfraz, Iqra; Masood, Muqaddas; Jabeen, Farhat; Sultana, Tayyaba; Sultana, Salma</div><div class="citationInfo"><span class="NLM_cas:title">Pakistan Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6, Suppl.</span>),
    <span class="NLM_cas:pages">2843-2848</span>CODEN:
                <span class="NLM_cas:coden">PJPSEN</span>;
        ISSN:<span class="NLM_cas:issn">1011-601X</span>.
    
            (<span class="NLM_cas:orgname">University of Karachi, Faculty of Pharmacy</span>)
        </div><div class="casAbstract">Eriocalyxin B (EriB), a potent ent-kaurene extd. from Isodon eriocalyx, has turned up as novel anti-cancer agent during recent years against a range of cancer types.  TNBC (Triple neg. breast cancer) is highly aggressive breast cancer, which is resistant towards current therapeutics due to absence of drug targets.  Here, we have probed the mol. mechanism of EriB-induced apoptosis in TNBC (MDA-MB231) cells to check whether its anticancer activity is mediated by modulation of STAT3 and NF-κB.  EriB induced apoptosis in MDA-MB231 cells via inhibiting NF-κBp65, STAT3 phosphorylation, increasing Bax/Bcl-2 ratio, MMP dissipation, and activation ofcaspase-3.  These results provide a rationale for further in vivo investigations on EriB. which might also prove to be a potential drug candidate for developing novel therapeutics against TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAvUNGZ094x7Vg90H21EOLACvtfcHk0lguk7U7cp2dkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhslGktLbM&md5=e603620b85e02c795fd9dec5c07e04df</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiaz%26aufirst%3DA.%26aulast%3DRasul%26aufirst%3DA.%26aulast%3DHussain%26aufirst%3DG.%26aulast%3DZubair%26aufirst%3DM.%26aulast%3DSamiullah%26aufirst%3DK.%26aulast%3DSarfraz%26aufirst%3DI.%26aulast%3DMasood%26aufirst%3DM.%26aulast%3DJabeen%26aufirst%3DF.%26aulast%3DSultana%26aufirst%3DT.%26aulast%3DSultana%26aufirst%3DS.%26atitle%3DEriocalyxin%2520B%2520induces%2520apoptosis%2520in%2520human%2520triple%2520negative%2520breast%2520cancer%2520cells%2520via%2520inhibiting%2520STAT3%2520activation%2520and%2520mitochondrial%2520dysfunction%26jtitle%3DPak.%2520J.%2520Pharm.%2520Sci.%26date%3D2019%26volume%3D32%26spage%3D2843%26epage%3D2848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">Identification of a Potent Oridonin Analogue for Treatment of Triple-Negative Breast Cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">8157</span>– <span class="NLM_lpage">8178</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00408</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00408" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtlSisLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=8157-8178&author=H.+Yaoauthor=S.+Xieauthor=X.+Maauthor=J.+Liuauthor=H.+Wuauthor=A.+Linauthor=H.+Yaoauthor=D.+Liauthor=S.+Xuauthor=D.+H.+Yangauthor=Z.+S.+Chenauthor=J.+Xu&title=Identification+of+a+Potent+Oridonin+Analogue+for+Treatment+of+Triple-Negative+Breast+Cancer&doi=10.1021%2Facs.jmedchem.0c00408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Potent Oridonin Analogue for Treatment of Triple-Negative Breast Cancer</span></div><div class="casAuthors">Yao, Hong; Xie, Shaowen; Ma, Xiaoqian; Liu, Junkai; Wu, Hongyu; Lin, Aijun; Yao, Hequan; Li, Dahong; Xu, Shengtao; Yang, Dong-Hua; Chen, Zhe-Sheng; Xu, Jinyi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8157-8178</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Triple-neg. breast cancer (TNBC) is one of the most highly invasive and metastatic breast cancers without safe and effective therapeutic drugs.  The natural product oridonin is reported to be a potential anti-TNBC agent.  However, its moderate activity and complex structure hampered its clin. application.  In this study, the novel oridonin analogs were first identified by removal of multiple hydroxyl groups and structural simplification of oridonin.  The representative analog 20 exhibited potent anticancer effects.  Further structural modification on 20 generated the most potent deriv. 56(I), which possessed 120-fold more potent antiproliferative activity than oridonin in the TNBC cell line HCC1806.  Importantly, compd. 56 exhibited more potent anticancer activity than paclitaxel in TNBC xenograft nude mice.  Moreover, 56 could attenuate the expression of MMP-2, MMP-9, p-FAK, and integrin β1 to inhibit TNBC cell metastasis.  All results suggest that compd. 56 may warrant further investigation as a promising candidate agent for the treatment of TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGnnn_26w0F7Vg90H21EOLACvtfcHk0lgOOvTbYPr2gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtlSisLvO&md5=b4e9b8257dbdfe0873608d2258e8f2aa</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00408%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DH.%26aulast%3DXie%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DYao%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DD.%2BH.%26aulast%3DChen%26aufirst%3DZ.%2BS.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520a%2520Potent%2520Oridonin%2520Analogue%2520for%2520Treatment%2520of%2520Triple-Negative%2520Breast%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D8157%26epage%3D8178%26doi%3D10.1021%2Facs.jmedchem.0c00408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Candas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eldridge, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wachsmann-Hogiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chromy, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nantajit, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duru, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finkel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. J.</span></span> <span> </span><span class="NLM_article-title">Cyclin B1/Cdk1 coordinates mitochondrial respiration for cell-cycle G2/M progression</span>. <i>Dev. Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1016/j.devcel.2014.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2Fj.devcel.2014.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=24746669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsVCht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2014&pages=217-232&author=Z.+Wangauthor=M.+Fanauthor=D.+Candasauthor=T.+Q.+Zhangauthor=L.+Qinauthor=A.+Eldridgeauthor=S.+Wachsmann-Hogiuauthor=K.+M.+Ahmedauthor=B.+A.+Chromyauthor=D.+Nantajitauthor=N.+Duruauthor=F.+Heauthor=M.+Chenauthor=T.+Finkelauthor=L.+S.+Weinsteinauthor=J.+J.+Li&title=Cyclin+B1%2FCdk1+coordinates+mitochondrial+respiration+for+cell-cycle+G2%2FM+progression&doi=10.1016%2Fj.devcel.2014.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin B1/Cdk1 Coordinates Mitochondrial Respiration for Cell-Cycle G2/M Progression</span></div><div class="casAuthors">Wang, Zhaoqing; Fan, Ming; Candas, Demet; Zhang, Tie-Qiao; Qin, Lili; Eldridge, Angela; Wachsmann-Hogiu, Sebastian; Ahmed, Kazi M.; Chromy, Brett A.; Nantajit, Danupon; Duru, Nadire; He, Fuchu; Chen, Min; Finkel, Toren; Weinstein, Lee S.; Li, Jian Jian</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">217-232</span>CODEN:
                <span class="NLM_cas:coden">DCEEBE</span>;
        ISSN:<span class="NLM_cas:issn">1534-5807</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A substantial amt. of mitochondrial energy is required for cell-cycle progression.  The mechanisms underlying the coordination of the mitochondrial respiration with cell-cycle progression, esp. the G2/M transition, remain to be elucidated.  Here, we show that a fraction of cyclin B1/Cdk1 proteins localizes to the matrix of mitochondria and phosphorylates a cluster of mitochondrial proteins, including the complex I (CI) subunits in the respiratory chain.  Cyclin B1/Cdk1-mediated CI phosphorylation enhances CI activity, whereas deficiency of such phosphorylation in each of the relevant CI subunits results in impairment of CI function.  Mitochondria-targeted cyclin B1/Cdk1 increases mitochondrial respiration with enhanced oxygen consumption and ATP generation, which provides cells with efficient bioenergy for G2/M transition and shortens overall cell-cycle time.  Thus, cyclin B1/Cdk1-mediated phosphorylation of mitochondrial substrates allows cells to sense and respond to increased energy demand for G2/M transition and, subsequently, to upregulate mitochondrial respiration for successful cell-cycle progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8A5dc209Mm7Vg90H21EOLACvtfcHk0lgOOvTbYPr2gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsVCht7Y%253D&md5=2f95e9ad8d22502a7ce640f02fc0ecea</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.devcel.2014.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.devcel.2014.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DM.%26aulast%3DCandas%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DT.%2BQ.%26aulast%3DQin%26aufirst%3DL.%26aulast%3DEldridge%26aufirst%3DA.%26aulast%3DWachsmann-Hogiu%26aufirst%3DS.%26aulast%3DAhmed%26aufirst%3DK.%2BM.%26aulast%3DChromy%26aufirst%3DB.%2BA.%26aulast%3DNantajit%26aufirst%3DD.%26aulast%3DDuru%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DFinkel%26aufirst%3DT.%26aulast%3DWeinstein%26aufirst%3DL.%2BS.%26aulast%3DLi%26aufirst%3DJ.%2BJ.%26atitle%3DCyclin%2520B1%252FCdk1%2520coordinates%2520mitochondrial%2520respiration%2520for%2520cell-cycle%2520G2%252FM%2520progression%26jtitle%3DDev.%2520Cell%26date%3D2014%26volume%3D29%26spage%3D217%26epage%3D232%26doi%3D10.1016%2Fj.devcel.2014.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engeland, K.</span></span> <span> </span><span class="NLM_article-title">The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1093/nar/gkv927</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1093%2Fnar%2Fgkv927" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=26384566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvFCktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=164-174&author=M.+Fischerauthor=M.+Quaasauthor=L.+Steinerauthor=K.+Engeland&title=The+p53-p21-DREAM-CDE%2FCHR+pathway+regulates+G2%2FM+cell+cycle+genes&doi=10.1093%2Fnar%2Fgkv927"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes</span></div><div class="casAuthors">Fischer, Martin; Quaas, Marianne; Steiner, Lydia; Engeland, Kurt</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">164-174</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The tumor suppressor p53 functions predominantly as a transcription factor by activating and downregulating gene expression, leading to cell cycle arrest or apoptosis.  P53 was shown to indirectly repress transcription of the CCNB2, KIF23 and PLK4 cell cycle genes through the recently discovered p53-p21-DREAM-CDE/CHR pathway.  However, it remained unclear whether this pathway is commonly used.  Here, we identify genes regulated by p53 through this pathway in a genome-wide computational approach.  The bioinformatic anal. is based on genome-wide DREAM complex binding data, p53-dependent mRNA expression data and a genome-wide definition of phylogenetically conserved CHR promoter elements.  We find 210 target genes that are expected to be regulated by the p53-p21-DREAM-CDE/CHR pathway.  The target gene list was verified by detailed anal. of p53-dependent repression of the cell cycle genes B-MYB (MYBL2), BUB1, CCNA2, CCNB1, CHEK2, MELK, POLD1, RAD18 and RAD54L.  Most of the 210 target genes are essential regulators of G2 phase and mitosis.  Thus, downregulation of these genes through the p53-p21-DREAM-CDE/CHR pathway appears to be a principal mechanism for G2/M cell cycle arrest by p53.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolH70n7R6cHbVg90H21EOLACvtfcHk0lgOOvTbYPr2gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvFCktrk%253D&md5=6a5999c8a37fb9fd77832aeb9a3cd60a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkv927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkv927%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DM.%26aulast%3DQuaas%26aufirst%3DM.%26aulast%3DSteiner%26aufirst%3DL.%26aulast%3DEngeland%26aufirst%3DK.%26atitle%3DThe%2520p53-p21-DREAM-CDE%252FCHR%2520pathway%2520regulates%2520G2%252FM%2520cell%2520cycle%2520genes%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2016%26volume%3D44%26spage%3D164%26epage%3D174%26doi%3D10.1093%2Fnar%2Fgkv927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surman, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diggs, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurusamy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLoughlin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drake, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feingold, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wangsa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wangsa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ried, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souza, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrump, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor
Ripley, R.</span></span> <span> </span><span class="NLM_article-title">Bile acid-induced ″Minority MOMP″ promotes esophageal carcinogenesis while maintaining apoptotic resistance via Mcl-1</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">877</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/s41388-019-1029-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1038%2Fs41388-019-1029-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=31570787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVOlur7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2020&pages=877-890&author=Y.+Xuauthor=D.+R.+Surmanauthor=L.+Diggsauthor=S.+Xiauthor=S.+Gaoauthor=D.+Gurusamyauthor=K.+McLoughlinauthor=J.+Drakeauthor=P.+Feingoldauthor=K.+Brownauthor=D.+Wangsaauthor=D.+Wangsaauthor=X.+Zhangauthor=T.+Riedauthor=J.+L.+Davisauthor=J.+Hernandezauthor=C.+D.+Hoangauthor=R.+F.+Souzaauthor=D.+S.+Schrumpauthor=R.+Taylor%0ARipley&title=Bile+acid-induced+%E2%80%B3Minority+MOMP%E2%80%B3+promotes+esophageal+carcinogenesis+while+maintaining+apoptotic+resistance+via+Mcl-1&doi=10.1038%2Fs41388-019-1029-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Bile acid-induced "Minority MOMP" promotes esophageal carcinogenesis while maintaining apoptotic resistance via Mcl-1</span></div><div class="casAuthors">Xu, Yuan; Surman, Deborah R.; Diggs, Laurence; Xi, Sichuan; Gao, Shaojian; Gurusamy, Devikala; McLoughlin, Kaitlin; Drake, Justin; Feingold, Paul; Brown, Kate; Wangsa, Danny; Wangsa, Darawalee; Zhang, Xi; Ried, Thomas; Davis, Jeremy L.; Hernandez, Jonathan; Hoang, Chuong; Souza, Rhonda F.; Schrump, David S.; Taylor Ripley, R.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">877-890</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Barrett's esophagus (BE) is assocd. with reflux and is implicated the development of esophageal adenocarcinoma (EAC).  Apoptosis induces cell death through mitochondrial outer membrane permeabilization (MOMP), which is considered an irreversible step in apoptosis.  Activation of MOMP to levels that fail to reach the apoptotic threshold may paradoxically promote cancer - a phenomenon called "Minority MOMP.".  We asked whether reflux-induced esophageal carcinogenesis occurred via minority MOMP and whether compensatory resistance mechanisms prevented cell death during this process.  We exposed preneoplastic, hTERT-immortalized Barrett's cell, CP-C and CP-A, to the oncogenic bile acid, deoxycholic acid (DCA), for 1 yr.  Induction of minority MOMP was tested via comet assay, CyQuant, annexin V, JC-1, cytochrome C subcellular localization, caspase 3 activation, and immunoblots.  We used bcl-2 homol. domain-3 (BH3) profiling to test the mitochondrial apoptotic threshold.  One-year exposure of Barrett's cells to DCA induced a malignant phenotype noted by clone and tumor formation.  DCA promoted minority MOMP noted by minimal release of cytochrome C and limited caspase 3 activation, which resulted in DNA damage without apoptosis.  Upregulation of the antiapoptotic protein, Mcl-1, ROS generation, and NF-κB activation occurred in conjunction with minority MOMP.  Inhibition of ROS blocked minority MOMP and Mcl-1 upregulation.  Knockdown of Mcl-1 shifted minority MOMP to complete MOMP as noted by dynamic BH3 profiling and increased apoptosis.  Minority MOMP contributes to DCA induced carcinogenesis in preneoplastic BE.  Mcl-1 provided a balance within the mitochondria that induced resistance complete MOMP and cell death.  Targeting Mcl-1 may be a therapeutic strategy in EAC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj1vg15qLl6LVg90H21EOLACvtfcHk0lipYrApSDDXkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVOlur7O&md5=25c8ad40b5c92a8e792139ff65057e74</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fs41388-019-1029-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41388-019-1029-6%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26aulast%3DSurman%26aufirst%3DD.%2BR.%26aulast%3DDiggs%26aufirst%3DL.%26aulast%3DXi%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DS.%26aulast%3DGurusamy%26aufirst%3DD.%26aulast%3DMcLoughlin%26aufirst%3DK.%26aulast%3DDrake%26aufirst%3DJ.%26aulast%3DFeingold%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DK.%26aulast%3DWangsa%26aufirst%3DD.%26aulast%3DWangsa%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DRied%26aufirst%3DT.%26aulast%3DDavis%26aufirst%3DJ.%2BL.%26aulast%3DHernandez%26aufirst%3DJ.%26aulast%3DHoang%26aufirst%3DC.%2BD.%26aulast%3DSouza%26aufirst%3DR.%2BF.%26aulast%3DSchrump%26aufirst%3DD.%2BS.%26aulast%3DTaylor%2BRipley%26aufirst%3DR.%26atitle%3DBile%2520acid-induced%2520%25E2%2580%25B3Minority%2520MOMP%25E2%2580%25B3%2520promotes%2520esophageal%2520carcinogenesis%2520while%2520maintaining%2520apoptotic%2520resistance%2520via%2520Mcl-1%26jtitle%3DOncogene%26date%3D2020%26volume%3D39%26spage%3D877%26epage%3D890%26doi%3D10.1038%2Fs41388-019-1029-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span> <span> </span><span class="NLM_article-title">Hypocrellin A-based photodynamic action induces apoptosis in A549 cells through ROS-mediated mitochondrial signaling pathway</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">293</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2018.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2Fj.apsb.2018.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=30972277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A280%3ADC%252BB3M%252FktFKktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=279-293&author=S.+Qiauthor=L.+Guoauthor=S.+Yanauthor=R.+J.+Leeauthor=S.+Yuauthor=S.+Chen&title=Hypocrellin+A-based+photodynamic+action+induces+apoptosis+in+A549+cells+through+ROS-mediated+mitochondrial+signaling+pathway&doi=10.1016%2Fj.apsb.2018.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Hypocrellin A-based photodynamic action induces apoptosis in A549 cells through ROS-mediated mitochondrial signaling pathway</span></div><div class="casAuthors">Qi Shanshan; Guo Lingyuan; Yan Shuzhen; Chen Shuanglin; Qi Shanshan; Lee Robert J; Yu Shuqin</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">279-293</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">Over recent decades, many studies have reported that hypocrellin A (HA) can eliminate cancer cells with proper irradiation in several cancer cell lines.  However, the precise molecular mechanism underlying its anticancer effect has not been fully defined.  HA-mediated cytotoxicity and apoptosis in human lung adenocarcinoma A549 cells were evaluated after photodynamic therapy (PDT).  A temporal quantitative proteomics approach by isobaric tag for relative and absolute quantitation (iTRAQ) 2D liquid chromatography with tandem mass spectrometric (LC-MS/MS) was introduced to help clarify molecular cytotoxic mechanisms and identify candidate targets of HA-induced apoptotic cell death.  Specific caspase inhibitors were used to further elucidate the molecular pathway underlying apoptosis in PDT-treated A549 cells.  Finally, down-stream apoptosis-related protein was evaluated.  Apoptosis induced by HA was associated with cell shrinkage, externalization of cell membrane phosphatidylserine, DNA fragmentation, and mitochondrial disruption, which were preceded by increased intracellular reactive oxygen species (ROS) generations.  Further studies showed that PDT treatment with 0.08 μmol/L HA resulted in mitochondrial disruption, pronounced release of cytochrome c, and activation of caspase-3, -9, and -7.  Together, HA may be a possible therapeutic agent directed toward mitochondria and a promising photodynamic anticancer candidate for further evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSB60VxKgx5l6-9TkgmBqTqfW6udTcc2ea-gqWzCZfUebntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M%252FktFKktg%253D%253D&md5=b7d40109224eb4b6bc534625aec24fd0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2018.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2018.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DS.%26atitle%3DHypocrellin%2520A-based%2520photodynamic%2520action%2520induces%2520apoptosis%2520in%2520A549%2520cells%2520through%2520ROS-mediated%2520mitochondrial%2520signaling%2520pathway%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2019%26volume%3D9%26spage%3D279%26epage%3D293%26doi%3D10.1016%2Fj.apsb.2018.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Denton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span> <span> </span><span class="NLM_article-title">Autophagy-dependent cell death</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">616</span>, <span class="refDoi"> DOI: 10.1038/s41418-018-0252-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1038%2Fs41418-018-0252-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=30568239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFKrt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=605-616&author=D.+Dentonauthor=S.+Kumar&title=Autophagy-dependent+cell+death&doi=10.1038%2Fs41418-018-0252-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy-dependent cell death</span></div><div class="casAuthors">Denton, Donna; Kumar, Sharad</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">605-616</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Autophagy-dependent cell death can be defined as cell demise that has a strict requirement of autophagy.  Although autophagy often accompanies cell death following many toxic insults, the requirement of autophagic machinery for cell death execution, as established through specific genetic or chem. inhibition of the process, is highly contextual.  During animal development, perhaps the best validated model of autophagy-dependent cell death is the degrdn. of the larval midgut during larval-pupal metamorphosis, where a no. of key autophagy genes are required for the removal of the tissues.  Surprisingly though, even in the midgut, not all of the canonical autophagic machinery appears to be required.  In other organisms and cancer cells many variations of autophagy-dependent cell death are apparent, pointing to the lack of a unifying cell death pathway.  It is thus possible that components of the autophagy machinery are selectively utilized or repurposed for this type of cell death.  In this review, we discuss examples of cell death that utilize autophagy machinery (or part thereof), the current knowledge of the complexity of autophagy-dependent cellular demise and the potential mechanisms and regulatory pathways involved in such cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8KGUmkO-q37Vg90H21EOLACvtfcHk0lhRfXhNYYySyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFKrt77K&md5=ebf1b6451cb66f3fb0a9c2b96254458e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fs41418-018-0252-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41418-018-0252-y%26sid%3Dliteratum%253Aachs%26aulast%3DDenton%26aufirst%3DD.%26aulast%3DKumar%26aufirst%3DS.%26atitle%3DAutophagy-dependent%2520cell%2520death%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2019%26volume%3D26%26spage%3D605%26epage%3D616%26doi%3D10.1038%2Fs41418-018-0252-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kocaturk, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkoc, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayraktar, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gozuacik, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutlu, O.</span></span> <span> </span><span class="NLM_article-title">Autophagy as a molecular target for cancer treatment</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">116</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2019.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2Fj.ejps.2019.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=30981885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC1MXoslWkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2019&pages=116-137&author=N.+M.+Kocaturkauthor=Y.+Akkocauthor=C.+Kigauthor=O.+Bayraktarauthor=D.+Gozuacikauthor=O.+Kutlu&title=Autophagy+as+a+molecular+target+for+cancer+treatment&doi=10.1016%2Fj.ejps.2019.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy as a molecular target for cancer treatment</span></div><div class="casAuthors">Kocaturk, Nur Mehpare; Akkoc, Yunus; Kig, Cenk; Bayraktar, Oznur; Gozuacik, Devrim; Kutlu, Ozlem</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">116-137</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Autophagy is an evolutionarily conserved catabolic mechanism, by which eukaryotic cells recycle or degrades internal constituents through membrane-trafficking pathway.  Thus, autophagy provides the cells with a sustainable source of biomols. and energy for the maintenance of homeostasis under stressful conditions such as tumor microenvironment.  Recent findings revealed a close relationship between autophagy and malignant transformation.  However, due to the complex dual role of autophagy in tumor survival or cell death, efforts to develop efficient treatment strategies targeting the autophagy/cancer relation have largely been unsuccessful.  Here we review the two-faced role of autophagy in cancer as a tumor suppressor or as a pro-oncogenic mechanism.  In this sense, we also review the shared regulatory pathways that play a role in autophagy and malignant transformation.  Finally, anti-cancer therapeutic agents used as either inhibitors or inducers of autophagy have been discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9c81uabGR9LVg90H21EOLACvtfcHk0lgETxyrUTDDuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXoslWkt74%253D&md5=3b1ca71f8bb483d3372d485b54ea1386</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2019.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2019.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKocaturk%26aufirst%3DN.%2BM.%26aulast%3DAkkoc%26aufirst%3DY.%26aulast%3DKig%26aufirst%3DC.%26aulast%3DBayraktar%26aufirst%3DO.%26aulast%3DGozuacik%26aufirst%3DD.%26aulast%3DKutlu%26aufirst%3DO.%26atitle%3DAutophagy%2520as%2520a%2520molecular%2520target%2520for%2520cancer%2520treatment%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2019%26volume%3D134%26spage%3D116%26epage%3D137%26doi%3D10.1016%2Fj.ejps.2019.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guntuku, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gangasani, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thummuri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borkar, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manavathi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragampeta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaidya, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sistla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vegi, N. G. M.</span></span> <span> </span><span class="NLM_article-title">IITZ-01, a novel potent lysosomotropic autophagy inhibitor, has single-agent antitumor efficacy in triple-negative breast cancer in vitro and in vivo</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">595</span>, <span class="refDoi"> DOI: 10.1038/s41388-018-0446-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1038%2Fs41388-018-0446-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=30166591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Wkt7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2019&pages=581-595&author=L.+Guntukuauthor=J.+K.+Gangasaniauthor=D.+Thummuriauthor=R.+M.+Borkarauthor=B.+Manavathiauthor=S.+Ragampetaauthor=J.+R.+Vaidyaauthor=R.+Sistlaauthor=N.+G.+M.+Vegi&title=IITZ-01%2C+a+novel+potent+lysosomotropic+autophagy+inhibitor%2C+has+single-agent+antitumor+efficacy+in+triple-negative+breast+cancer+in+vitro+and+in+vivo&doi=10.1038%2Fs41388-018-0446-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">IITZ-01, a novel potent lysosomotropic autophagy inhibitor, has single-agent antitumor efficacy in triple-negative breast cancer in vitro and in vivo</span></div><div class="casAuthors">Guntuku, Lalita; Gangasani, Jagadeesh Kumar; Thummuri, Dinesh; Borkar, Roshan M.; Manavathi, Bramanandam; Ragampeta, Srinivas; Vaidya, Jayathirtha Rao; Sistla, Ramakrishna; Vegi, Naidu G. M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">581-595</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Autophagy is a homeostatic process that recycles damaged organelles and long-lived proteins by delivering them in double-membrane vesicles to lysosomes for degrdn.  Autophagy has a prominent role in survival, proliferation, and resistance of tumors in metabolic and chemotherapeutic stress conditions.  Clin. trials with chloroquine-a known autophagy inhibitor-were unable to achieve complete autophagy inhibition in vivo, warranting the search for more potent autophagy inhibitors.  In a process of exploring the mechanism of action of previously identified cytotoxic s-triazine analogs, we discovered that both IITZ-01 and IITZ-02 act as potent autophagy inhibitors.  Treatment with these compds. resulted in the vacuolated appearance of cells due to their specific accumulation in lysosomes.  In addn., these basic compds. also deacidify lysosomes as evidenced by the decrease in lysotracker red staining and inhibit maturation of lysosomal enzymes leading to lysosomal dysfunction.  IITZ-01 and IITZ-02 enhance autophagosome accumulation but inhibit autophagosomal degrdn. by impairing lysosomal function, finally resulting in the inhibition of autophagy.  Interestingly, compd. IITZ-01 exhibited more than 10-fold potent autophagy inhibition along with 12- to 20-fold better cytotoxic action than CQ.  IITZ-01 and IITZ-02 also abolished mitochondrial membrane potential and triggered apoptosis through the mitochondria-mediated pathway.  Furthermore, IITZ-01 and IITZ-02 displayed potent antitumor action in vivo through autophagy inhibition and apoptosis induction in MDA-MB-231 breast cancer xenograft model with IITZ-01 exhibiting superior anticancer efficacy.  Overall, these data demonstrate that IITZ-01 is potent autophagy inhibitor with single-agent anticancer activity and awaits further preclin. development as potential anticancer therapeutic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCsXE4ORp_orVg90H21EOLACvtfcHk0lgETxyrUTDDuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Wkt7fL&md5=9c57f666aa58f2719178b4e3ddcd7923</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fs41388-018-0446-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41388-018-0446-2%26sid%3Dliteratum%253Aachs%26aulast%3DGuntuku%26aufirst%3DL.%26aulast%3DGangasani%26aufirst%3DJ.%2BK.%26aulast%3DThummuri%26aufirst%3DD.%26aulast%3DBorkar%26aufirst%3DR.%2BM.%26aulast%3DManavathi%26aufirst%3DB.%26aulast%3DRagampeta%26aufirst%3DS.%26aulast%3DVaidya%26aufirst%3DJ.%2BR.%26aulast%3DSistla%26aufirst%3DR.%26aulast%3DVegi%26aufirst%3DN.%2BG.%2BM.%26atitle%3DIITZ-01%252C%2520a%2520novel%2520potent%2520lysosomotropic%2520autophagy%2520inhibitor%252C%2520has%2520single-agent%2520antitumor%2520efficacy%2520in%2520triple-negative%2520breast%2520cancer%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DOncogene%26date%3D2019%26volume%3D38%26spage%3D581%26epage%3D595%26doi%3D10.1038%2Fs41388-018-0446-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gombart, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. W.</span></span> <span> </span><span class="NLM_article-title">Chloroquine treatment of ARPE-19 cells leads to lysosome dilation and intracellular lipid accumulation: possible implications of lysosomal dysfunction in macular degeneration</span>. <i>Cell Biosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">10</span>, <span class="refDoi"> DOI: 10.1186/2045-3701-1-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1186%2F2045-3701-1-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=21711726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVWgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=10&author=P.+M.+Chenauthor=Z.+J.+Gombartauthor=J.+W.+Chen&title=Chloroquine+treatment+of+ARPE-19+cells+leads+to+lysosome+dilation+and+intracellular+lipid+accumulation%3A+possible+implications+of+lysosomal+dysfunction+in+macular+degeneration&doi=10.1186%2F2045-3701-1-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Chloroquine treatment of ARPE-19 cells leads to lysosome dilation and intracellular lipid accumulation: possible implications of lysosomal dysfunction in macular degeneration</span></div><div class="casAuthors">Chen, Patrick M.; Gombart, Zoe J.; Chen, Jefferson W.</div><div class="citationInfo"><span class="NLM_cas:title">Cell & Bioscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10</span>CODEN:
                <span class="NLM_cas:coden">CBEIB8</span>;
        ISSN:<span class="NLM_cas:issn">2045-3701</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Age-related macular degeneration (AMD) is the leading cause of vision loss in elderly people over 60.  The pathogenesis is still unclear.  It has been suggested that lysosomal stress may lead to drusen formation.  In this study, ARPE-19 cells were treated with chloroquine to inhibit lysosomal function.  Results: Chloroquine treated ARPE-19 cells demonstrate a marked increase in vacuolation and dense intracellular debris.  These are identified as chloroquine dilated lysosomes and lipid bodies with LAMP-2 and LIPIDtox co-localization resp.  Dilation is an indicator of successful lysosomal dysfunction.  Chloroquine disrupts uptake of exogenously applied rhodamine labeled dextran by these cells.  This suggests a disruption in the phagocytic pathway.  The increase in LAMP protein levels as assessed by Western Blots suggests the possible involvement in autophagy.  Oxidative stress with H2O2 does not induce vacuolation or lipid accumulation.  Conclusion: These findings suggest a role for lysosomes in AMD.  Chloroquine treatment of RPE cells may provide an in vitro model of AMD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1FM4g527b0LVg90H21EOLACvtfcHk0lgETxyrUTDDuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVWgs7c%253D&md5=00e3bc51e8a163191be1f412eaefa3e6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1186%2F2045-3701-1-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2045-3701-1-10%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%2BM.%26aulast%3DGombart%26aufirst%3DZ.%2BJ.%26aulast%3DChen%26aufirst%3DJ.%2BW.%26atitle%3DChloroquine%2520treatment%2520of%2520ARPE-19%2520cells%2520leads%2520to%2520lysosome%2520dilation%2520and%2520intracellular%2520lipid%2520accumulation%253A%2520possible%2520implications%2520of%2520lysosomal%2520dysfunction%2520in%2520macular%2520degeneration%26jtitle%3DCell%2520Biosci.%26date%3D2011%26volume%3D1%26spage%3D10%26doi%3D10.1186%2F2045-3701-1-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Florey, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gammoh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overholtzer, M.</span></span> <span> </span><span class="NLM_article-title">V-ATPase and osmotic imbalances activate endolysosomal LC3 lipidation</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.4161/15548627.2014.984277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.4161%2F15548627.2014.984277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=25484071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A280%3ADC%252BC2MzmtVynsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=88-99&author=O.+Floreyauthor=N.+Gammohauthor=S.+E.+Kimauthor=X.+Jiangauthor=M.+Overholtzer&title=V-ATPase+and+osmotic+imbalances+activate+endolysosomal+LC3+lipidation&doi=10.4161%2F15548627.2014.984277"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">V-ATPase and osmotic imbalances activate endolysosomal LC3 lipidation</span></div><div class="casAuthors">Florey Oliver; Gammoh Noor; Kim Sung Eun; Jiang Xuejun; Overholtzer Michael</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">88-99</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Recently a noncanonical activity of autophagy proteins has been discovered that targets lipidation of microtubule-associated protein 1 light chain 3 (LC3) onto macroendocytic vacuoles, including macropinosomes, phagosomes, and entotic vacuoles.  While this pathway is distinct from canonical autophagy, the mechanism of how these nonautophagic membranes are targeted for LC3 lipidation remains unclear.  Here we present evidence that this pathway requires activity of the vacuolar-type H(+)-ATPase (V-ATPase) and is induced by osmotic imbalances within endolysosomal compartments.  LC3 lipidation by this mechanism is induced by treatment of cells with the lysosomotropic agent chloroquine, and through exposure to the Heliobacter pylori pore-forming toxin VacA.  These data add novel mechanistic insights into the regulation of noncanonical LC3 lipidation and its associated processes, including LC3-associated phagocytosis (LAP), and demonstrate that the widely and therapeutically used drug chloroquine, which is conventionally used to inhibit autophagy flux, is an inducer of LC3 lipidation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3XZd4i2M3Sv6xYuD7tu2XfW6udTcc2eaeaZ5cMPTWIbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MzmtVynsg%253D%253D&md5=0f3e78cc0dfbde641583c6326a8843db</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.4161%2F15548627.2014.984277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252F15548627.2014.984277%26sid%3Dliteratum%253Aachs%26aulast%3DFlorey%26aufirst%3DO.%26aulast%3DGammoh%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DS.%2BE.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DOverholtzer%26aufirst%3DM.%26atitle%3DV-ATPase%2520and%2520osmotic%2520imbalances%2520activate%2520endolysosomal%2520LC3%2520lipidation%26jtitle%3DAutophagy%26date%3D2015%26volume%3D11%26spage%3D88%26epage%3D99%26doi%3D10.4161%2F15548627.2014.984277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kessenbrock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plaks, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werb, Z.</span></span> <span> </span><span class="NLM_article-title">Matrix metalloproteinases: regulators of the tumor microenvironment</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2010.03.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2Fj.cell.2010.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=20371345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2010&pages=52-67&author=K.+Kessenbrockauthor=V.+Plaksauthor=Z.+Werb&title=Matrix+metalloproteinases%3A+regulators+of+the+tumor+microenvironment&doi=10.1016%2Fj.cell.2010.03.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases: regulators of the tumor microenvironment</span></div><div class="casAuthors">Kessenbrock, Kai; Plaks, Vicki; Werb, Zena</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-67</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Extracellular proteolysis mediates tissue homeostasis.  In cancer, altered proteolysis leads to unregulated tumor growth, tissue remodeling, inflammation, tissue invasion, and metastasis.  The matrix metalloproteinases (MMPs) represent the most prominent family of proteinases assocd. with tumorigenesis.  Recent technol. developments have markedly advanced our understanding of MMPs as modulators of the tumor microenvironment.  In addn. to their role in extracellular matrix turnover and cancer cell migration, MMPs regulate signaling pathways that control cell growth, inflammation, or angiogenesis and may even work in a nonproteolytic manner.  These aspects of MMP function are reorienting our approaches to cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAwNenyy027LVg90H21EOLACvtfcHk0ljI1O5usxJbHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSgtb4%253D&md5=fb7ee4c41ef31db0310b985e87bcdb94</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DKessenbrock%26aufirst%3DK.%26aulast%3DPlaks%26aufirst%3DV.%26aulast%3DWerb%26aufirst%3DZ.%26atitle%3DMatrix%2520metalloproteinases%253A%2520regulators%2520of%2520the%2520tumor%2520microenvironment%26jtitle%3DCell%26date%3D2010%26volume%3D141%26spage%3D52%26epage%3D67%26doi%3D10.1016%2Fj.cell.2010.03.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizwanullah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, K.</span></span> <span> </span><span class="NLM_article-title">PI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2181</span>– <span class="NLM_lpage">2191</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2019.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2Fj.drudis.2019.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=31520748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVWju7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2019&pages=2181-2191&author=M.+A.+Khanauthor=V.+K.+Jainauthor=M.+Rizwanullahauthor=J.+Ahmadauthor=K.+Jain&title=PI3K%2FAKT%2FmTOR+pathway+inhibitors+in+triple-negative+breast+cancer%3A+a+review+on+drug+discovery+and+future+challenges&doi=10.1016%2Fj.drudis.2019.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">PI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges</span></div><div class="casAuthors">Khan, Mohammad A.; Jain, Vineet K.; Rizwanullah, Md.; Ahmad, Javed; Jain, Keerti</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2181-2191</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Triple-neg. breast cancer (TNBC) is a highly malignant subtype of breast cancer assocd. with poor prognosis.  Although conventional chemotherapy regimens have shown some effectiveness in early TNBC cases, the outcome in advanced stages is poor.  The PI3K/AKT/mTOR pathway is one of the important and active pathways involved in chemoresistance and survival of TNBC.  This pathway is speculated to play an important part in malignant transformation and has been considered as a potential mol. target for the design of therapeutic agents to treat TNBC.  This review discusses the potentials and drug discovery perspectives of PI3K/AKT/mTOR as a therapeutic target for effective management of TNBC with anticipated challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4h1LPJcV0U7Vg90H21EOLACvtfcHk0ljI1O5usxJbHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVWju7rF&md5=dbde097d9af193befbd393d8b62a9136</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2019.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2019.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DM.%2BA.%26aulast%3DJain%26aufirst%3DV.%2BK.%26aulast%3DRizwanullah%26aufirst%3DM.%26aulast%3DAhmad%26aufirst%3DJ.%26aulast%3DJain%26aufirst%3DK.%26atitle%3DPI3K%252FAKT%252FmTOR%2520pathway%2520inhibitors%2520in%2520triple-negative%2520breast%2520cancer%253A%2520a%2520review%2520on%2520drug%2520discovery%2520and%2520future%2520challenges%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2019%26volume%3D24%26spage%3D2181%26epage%3D2191%26doi%3D10.1016%2Fj.drudis.2019.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manning, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toker, A.</span></span> <span> </span><span class="NLM_article-title">AKT/PKB Signaling: Navigating the Network</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">405</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2Fj.cell.2017.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=28431241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsVamuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2017&pages=381-405&author=B.+D.+Manningauthor=A.+Toker&title=AKT%2FPKB+Signaling%3A+Navigating+the+Network&doi=10.1016%2Fj.cell.2017.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">AKT/PKB signaling: Navigating the network</span></div><div class="casAuthors">Manning, Brendan D.; Toker, Alex</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">381-405</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The Ser and Thr kinase AKT, also known as protein kinase B (PKB), was discovered 25 years ago and has been the focus of tens of thousands of studies in diverse fields of biol. and medicine.  There have been many advances in our knowledge of the upstream regulatory inputs into AKT, key multifunctional downstream signaling nodes (GSK3, FoxO, mTORC1), which greatly expand the functional repertoire of AKT, and the complex circuitry of this dynamically branching and looping signaling network that is ubiquitous to nearly every cell in our body.  Mouse and human genetic studies have also revealed physiol. roles for the AKT network in nearly every organ system.  Our comprehension of AKT regulation and functions is particularly important given the consequences of AKT dysfunction in diverse pathol. settings, including developmental and overgrowth syndromes, cancer, cardiovascular disease, insulin resistance and type 2 diabetes, inflammatory and autoimmune disorders, and neurol. disorders.  There has also been much progress in developing AKT-selective small mol. inhibitors.  Improved understanding of the mol. wiring of the AKT signaling network continues to make an impact that cuts across most disciplines of the biomedical sciences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-kLW6vEG_DrVg90H21EOLACvtfcHk0limwnkUsOf5Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsVamuro%253D&md5=46302014c33b00c447f187eeaf0162c4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DB.%2BD.%26aulast%3DToker%26aufirst%3DA.%26atitle%3DAKT%252FPKB%2520Signaling%253A%2520Navigating%2520the%2520Network%26jtitle%3DCell%26date%3D2017%26volume%3D169%26spage%3D381%26epage%3D405%26doi%3D10.1016%2Fj.cell.2017.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voegtli, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturgis, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dizon, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigers, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandhuber, B. J.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e12913</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0012913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1371%2Fjournal.pone.0012913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=20886116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A280%3ADC%252BC3cfmvVehsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&author=W.+I.+Wuauthor=W.+C.+Voegtliauthor=H.+L.+Sturgisauthor=F.+P.+Dizonauthor=G.+P.+Vigersauthor=B.+J.+Brandhuber&title=Crystal+structure+of+human+AKT1+with+an+allosteric+inhibitor+reveals+a+new+mode+of+kinase+inhibition&doi=10.1371%2Fjournal.pone.0012913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition</span></div><div class="casAuthors">Wu Wen-I; Voegtli Walter C; Sturgis Hillary L; Dizon Faith P; Vigers Guy P A; Brandhuber Barbara J</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e12913</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AKT1 (NP_005154.2) is a member of the serine/threonine AGC protein kinase family involved in cellular metabolism, growth, proliferation and survival.  The three human AKT isozymes are highly homologous multi-domain proteins with both overlapping and distinct cellular functions.  Dysregulation of the AKT pathway has been identified in multiple human cancers.  Several clinical trials are in progress to test the efficacy of AKT pathway inhibitors in treating cancer.  Recently, a series of AKT isozyme-selective allosteric inhibitors have been reported.  They require the presence of both the pleckstrin-homology (PH) and kinase domains of AKT, but their binding mode has not yet been elucidated.  We present here a 2.7 Å resolution co-crystal structure of human AKT1 containing both the PH and kinase domains with a selective allosteric inhibitor bound in the interface.  The structure reveals the interactions between the PH and kinase domains, as well as the critical amino residues that mediate binding of the inhibitor to AKT1.  Our work also reveals an intricate balance in the enzymatic regulation of AKT, where the PH domain appears to lock the kinase in an inactive conformation and the kinase domain disrupts the phospholipid binding site of the PH domain.  This information advances our knowledge in AKT1 structure and regulation, thereby providing a structural foundation for interpreting the effects of different classes of AKT inhibitors and designing selective ones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSn0Rujn_TlTKcY7HFp97qMfW6udTcc2eZS5lpNc_gFUrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfmvVehsw%253D%253D&md5=133c82c3c9f5c3cf6f5a34cf2b4881a3</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0012913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0012913%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.%2BI.%26aulast%3DVoegtli%26aufirst%3DW.%2BC.%26aulast%3DSturgis%26aufirst%3DH.%2BL.%26aulast%3DDizon%26aufirst%3DF.%2BP.%26aulast%3DVigers%26aufirst%3DG.%2BP.%26aulast%3DBrandhuber%26aufirst%3DB.%2BJ.%26atitle%3DCrystal%2520structure%2520of%2520human%2520AKT1%2520with%2520an%2520allosteric%2520inhibitor%2520reveals%2520a%2520new%2520mode%2520of%2520kinase%2520inhibition%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26doi%3D10.1371%2Fjournal.pone.0012913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcomer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kevala, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnaeva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patnaik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southall, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marugan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. Y.</span></span> <span> </span><span class="NLM_article-title">Identification of 4-phenylquinolin-2(1H)-one as a specific allosteric inhibitor of Akt</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">11673</span> <span class="refDoi"> DOI: 10.1038/s41598-017-11870-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1038%2Fs41598-017-11870-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=28916818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A280%3ADC%252BC1cbptF2rsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&author=B.+X.+Huangauthor=K.+Newcomerauthor=K.+Kevalaauthor=E.+Barnaevaauthor=W.+Zhengauthor=X.+Huauthor=S.+Patnaikauthor=N.+Southallauthor=J.+Maruganauthor=M.+Ferrerauthor=H.+Y.+Kim&title=Identification+of+4-phenylquinolin-2%281H%29-one+as+a+specific+allosteric+inhibitor+of+Akt&doi=10.1038%2Fs41598-017-11870-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of 4-phenylquinolin-2(1H)-one as a specific allosteric inhibitor of Akt</span></div><div class="casAuthors">Huang Bill X; Newcomer Kenny; Kevala Karl; Kim Hee-Yong; Barnaeva Elena; Zheng Wei; Hu Xin; Patnaik Samarjit; Southall Noel; Marugan Juan; Ferrer Marc</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11673</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Akt plays a major role in tumorigenesis and the development of specific Akt inhibitors as effective cancer therapeutics has been challenging.  Here, we report the identification of a highly specific allosteric inhibitor of Akt through a FRET-based high-throughput screening, and characterization of its inhibitory mechanism.  Out of 373,868 compounds screened, 4-phenylquinolin-2(1H)-one specifically decreased Akt phosphorylation at both T308 and S473, and inhibited Akt kinase activity (IC50 = 6 μM) and downstream signaling. 4-Phenylquinolin-2(1H)-one did not alter the activity of upstream kinases including PI3K, PDK1, and mTORC2 as well as closely related kinases that affect cell proliferation and survival such as SGK1, PKA, PKC, or ERK1/2.  This compound inhibited the proliferation of cancer cells but displayed less toxicity compared to inhibitors of PI3K or mTOR.  Kinase profiling efforts revealed that 4-phenylquinolin-2(1H)-one does not bind to the kinase active site of over 380 human kinases including Akt.  However, 4-phenylquinolin-2(1H)-one interacted with the PH domain of Akt, apparently inducing a conformation that hinders S473 and T308 phosphorylation by mTORC2 and PDK1.  In conclusion, we demonstrate that 4-phenylquinolin-2(1H)-one is an exquisitely selective Akt inhibitor with a distinctive molecular mechanism, and a promising lead compound for further optimization toward the development of novel cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQbbUFiOf_cY4qdXsLcGTEUfW6udTcc2eZS5lpNc_gFUrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cbptF2rsA%253D%253D&md5=6c4dfc2d1a5aa44b506a6470c34caadc</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-11870-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-11870-1%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DB.%2BX.%26aulast%3DNewcomer%26aufirst%3DK.%26aulast%3DKevala%26aufirst%3DK.%26aulast%3DBarnaeva%26aufirst%3DE.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DPatnaik%26aufirst%3DS.%26aulast%3DSouthall%26aufirst%3DN.%26aulast%3DMarugan%26aufirst%3DJ.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DH.%2BY.%26atitle%3DIdentification%2520of%25204-phenylquinolin-2%25281H%2529-one%2520as%2520a%2520specific%2520allosteric%2520inhibitor%2520of%2520Akt%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26doi%3D10.1038%2Fs41598-017-11870-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jucker, M.</span></span> <span> </span><span class="NLM_article-title">Distinct functions of AKT isoforms in breast cancer: a comprehensive review</span>. <i>Cell Commun. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span>, <span class="NLM_elocation-id">154</span> <span class="refDoi"> DOI: 10.1186/s12964-019-0450-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1186%2Fs12964-019-0450-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=31752925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlKiu7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&author=N.+Hinzauthor=M.+Jucker&title=Distinct+functions+of+AKT+isoforms+in+breast+cancer%3A+a+comprehensive+review&doi=10.1186%2Fs12964-019-0450-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct functions of AKT isoforms in breast cancer: a comprehensive review</span></div><div class="casAuthors">Hinz, Nico; Juecker, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Cell Communication and Signaling</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">154</span>CODEN:
                <span class="NLM_cas:coden">CCSEC6</span>;
        ISSN:<span class="NLM_cas:issn">1478-811X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Background: AKT, also known as protein kinase B, is a key element of the PI3K/AKT signaling pathway.  Moreover, AKT regulates the hallmarks of cancer, e.g. tumor growth, survival and invasiveness of tumor cells.  After AKT was discovered in the early 1990s, further studies revealed that there are three different AKT isoforms, namely AKT1, AKT2 and AKT3.  Despite their high similarity of 80%, the distinct AKT isoforms exert non-redundant, partly even opposing effects under physiol. and pathol. conditions.  Breast cancer as the most common cancer entity in women, frequently shows alterations of the PI3K/AKT signaling.  Main content: A plethora of studies addressed the impact of AKT isoforms on tumor growth, metastasis and angiogenesis of breast cancer as well as on therapy response and overall survival in patients.  Therefore, this review aimed to give a comprehensive overview about the isoform-specific effects of AKT in breast cancer and to summarize known downstream and upstream mechanisms.  Taking account of conflicting findings among the studies, the majority of the studies reported a tumor initiating role of AKT1, whereas AKT2 is mainly responsible for tumor progression and metastasis.  In detail, AKT1 increases cell proliferation through cell cycle proteins like p21, p27 and cyclin D1 and impairs apoptosis e.g. via p53.  On the downside AKT1 decreases migration of breast cancer cells, for instance by regulating TSC2, palladin and EMT-proteins.  However, AKT2 promotes migration and invasion most notably through regulation of β-integrins, EMT-proteins and F-actin.  While AKT3 is assocd. with a neg. ER-status, findings about the role of AKT3 in regulation of the key properties of breast cancer are sparse.  Accordingly, AKT1 is mutated and AKT2 is amplified in some cases of breast cancer and AKT isoforms are assocd. with overall survival and therapy response in an isoform-specific manner.  Conclusions: Although there are several discussed hypotheses how isoform specificity is achieved, the mechanisms behind the isoform-specific effects remain mostly unrevealed.  As a consequence, further effort is necessary to achieve deeper insights into an isoform-specific AKT signaling in breast cancer and the mechanism behind it.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6J0u0yDk2N7Vg90H21EOLACvtfcHk0lglswXffMQlzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlKiu7rK&md5=778c10b62fbf43b381479463a29a6ee4</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1186%2Fs12964-019-0450-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12964-019-0450-3%26sid%3Dliteratum%253Aachs%26aulast%3DHinz%26aufirst%3DN.%26aulast%3DJucker%26aufirst%3DM.%26atitle%3DDistinct%2520functions%2520of%2520AKT%2520isoforms%2520in%2520breast%2520cancer%253A%2520a%2520comprehensive%2520review%26jtitle%3DCell%2520Commun.%2520Signaling%26date%3D2019%26volume%3D17%26doi%3D10.1186%2Fs12964-019-0450-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Molina, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jafari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignatushchenko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sreekumar, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordlund, P.</span></span> <span> </span><span class="NLM_article-title">Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>341</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1126/science.1233606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1126%2Fscience.1233606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=23828940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVCgs7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2013&pages=84-87&author=D.+M.+Molinaauthor=R.+Jafariauthor=M.+Ignatushchenkoauthor=T.+Sekiauthor=E.+A.+Larssonauthor=C.+Danauthor=L.+Sreekumarauthor=Y.+Caoauthor=P.+Nordlund&title=Monitoring+drug+target+engagement+in+cells+and+tissues+using+the+cellular+thermal+shift+assay&doi=10.1126%2Fscience.1233606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay</span></div><div class="casAuthors">Molina, Daniel Martinez; Jafari, Rozbeh; Ignatushchenko, Marina; Seki, Takahiro; Larsson, E. Andreas; Dan, Chen; Sreekumar, Lekshmy; Cao, Yihai; Nordlund, Paer</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">6141</span>),
    <span class="NLM_cas:pages">84-87</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The efficacy of therapeutics is dependent on a drug binding to its cognate target.  Optimization of target engagement by drugs in cells is often challenging, because drug binding cannot be monitored inside cells.  We have developed a method for evaluating drug binding to target proteins in cells and tissue samples.  This cellular thermal shift assay (CETSA) is based on the biophys. principle of ligand-induced thermal stabilization of target proteins.  Using this assay, we validated drug binding for a set of important clin. targets and monitored processes of drug transport and activation, off-target effects and drug resistance in cancer cell lines, as well as drug distribution in tissues.  CETSA is likely to become a valuable tool for the validation and optimization of drug target engagement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaaWSoozY7ObVg90H21EOLACvtfcHk0lglswXffMQlzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVCgs7rP&md5=f8ba686ba38b67dbdf366c49eb7375b4</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1126%2Fscience.1233606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1233606%26sid%3Dliteratum%253Aachs%26aulast%3DMolina%26aufirst%3DD.%2BM.%26aulast%3DJafari%26aufirst%3DR.%26aulast%3DIgnatushchenko%26aufirst%3DM.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DLarsson%26aufirst%3DE.%2BA.%26aulast%3DDan%26aufirst%3DC.%26aulast%3DSreekumar%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DNordlund%26aufirst%3DP.%26atitle%3DMonitoring%2520drug%2520target%2520engagement%2520in%2520cells%2520and%2520tissues%2520using%2520the%2520cellular%2520thermal%2520shift%2520assay%26jtitle%3DScience%26date%3D2013%26volume%3D341%26spage%3D84%26epage%3D87%26doi%3D10.1126%2Fscience.1233606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, D.</span></span> <span> </span><span class="NLM_article-title">AKT and ERK dual inhibitors: The way forward?</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>459</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2019.05.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2Fj.canlet.2019.05.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=31128213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFensLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=459&publication_year=2019&pages=30-40&author=Z.+Caoauthor=Q.+Liaoauthor=M.+Suauthor=K.+Huangauthor=J.+Jinauthor=D.+Cao&title=AKT+and+ERK+dual+inhibitors%3A+The+way+forward%3F&doi=10.1016%2Fj.canlet.2019.05.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">AKT and ERK dual inhibitors: The way forward?</span></div><div class="casAuthors">Cao, Zhe; Liao, Qianjin; Su, Min; Huang, Kai; Jin, Junfei; Cao, Deliang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">459</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">30-40</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Phosphatidylinositol 3-kinase (PI3K)/AKT pathway regulates cell growth, proliferation, survival, mobility and invasion.  Mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) pathway is also an important mitogenic signaling pathway involved in various cellular progresses.  AKT, also named protein kinase B (PKB), is a primary mediator of the PI3K signaling pathway; and ERK at the end of MAPK signaling is the unique substrate and downstream effector of mitogen-activated protein/extracellular signal-regulated kinase (MEK).  The AKT and ERK signaling are both aberrantly activated in a wide range of human cancers and have long been targeted for cancer therapy, but the clin. benefits of these targeted therapies have been limited due to complex cross-talk.  Novel strategies, such as AKT/ERK dual inhibitors, may be needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2mQop_AQFH7Vg90H21EOLACvtfcHk0li66YkFTzThRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFensLnE&md5=bdb7fd9232b6f75f46b0800a2627a4e1</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2019.05.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2019.05.025%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DLiao%26aufirst%3DQ.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DK.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DD.%26atitle%3DAKT%2520and%2520ERK%2520dual%2520inhibitors%253A%2520The%2520way%2520forward%253F%26jtitle%3DCancer%2520Lett.%26date%3D2019%26volume%3D459%26spage%3D30%26epage%3D40%26doi%3D10.1016%2Fj.canlet.2019.05.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, G.</span></span> <span> </span><span class="NLM_article-title">Dual inhibition of Akt and ERK signaling induces cell senescence in triple-negative breast cancer</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>448</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2019.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2Fj.canlet.2019.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=30742942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjt1Clsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=448&publication_year=2019&pages=94-104&author=Q.+Heauthor=S.+Xueauthor=Y.+Tanauthor=L.+Zhangauthor=Q.+Shaoauthor=L.+Xingauthor=Y.+Liauthor=T.+Xiangauthor=X.+Luoauthor=G.+Ren&title=Dual+inhibition+of+Akt+and+ERK+signaling+induces+cell+senescence+in+triple-negative+breast+cancer&doi=10.1016%2Fj.canlet.2019.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Dual inhibition of Akt and ERK signaling induces cell senescence in triple-negative breast cancer</span></div><div class="casAuthors">He, Qiang; Xue, Shuyin; Tan, Yiqing; Zhang, Ling; Shao, Qing; Xing, Lei; Li, Yunhai; Xiang, Tingxiu; Luo, Xinrong; Ren, Guosheng</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">448</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">94-104</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Activated Akt and ERK signaling pathways are closely related to breast cancer progression, and Akt or ERK inhibition induces cell senescence.  However, the crosstalk between the Akt and ERK signaling pathways in cell senescence and how to simultaneously suppress Akt and ERK signaling in triple-neg. breast cancer (TNBC) are undefined.  In this study, we found that norcantharidin (NCTD) effectively induced cell senescence and cell cycle arrest in TNBC in vitro, which was accompanied by a decline in phosphorylated Akt and ERK1/2 and a rise in p21 and p16.  The inhibitors LY294002 and U0126 imitated the effect of NCTD when these two inhibitors were combined regardless of crosstalk between these two signaling pathways.  In addn., NCTD inhibited the growth of xenografts via downregulation of phosphorylated Akt and ERK1/2 and upregulation of p21 in vivo.  However, NCTD upregulated the level of sol. signaling factors of the senescence-assocd. secretory phenotype (SASP) in a NF-κB-independent manner.  Collectively, these findings demonstrate that NCTD induced cell senescence and cell cycle arrest mainly by simultaneously blocking Akt and ERK signaling in TNBC, suggesting that NCTD may be used as a potential adjuvant therapy in TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCyKsXlTOVZLVg90H21EOLACvtfcHk0li66YkFTzThRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjt1Clsbo%253D&md5=22793342d13431bd800588b9ec09545c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2019.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2019.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DQ.%26aulast%3DXue%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DShao%26aufirst%3DQ.%26aulast%3DXing%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXiang%26aufirst%3DT.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DRen%26aufirst%3DG.%26atitle%3DDual%2520inhibition%2520of%2520Akt%2520and%2520ERK%2520signaling%2520induces%2520cell%2520senescence%2520in%2520triple-negative%2520breast%2520cancer%26jtitle%3DCancer%2520Lett.%26date%3D2019%26volume%3D448%26spage%3D94%26epage%3D104%26doi%3D10.1016%2Fj.canlet.2019.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yerushalmi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravdin, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelmon, K. A.</span></span> <span> </span><span class="NLM_article-title">Ki67 in breast cancer: prognostic and predictive potential</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">174</span>– <span class="NLM_lpage">183</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(09)70262-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2FS1470-2045%2809%2970262-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=20152769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGgtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=174-183&author=R.+Yerushalmiauthor=R.+Woodsauthor=P.+M.+Ravdinauthor=M.+M.+Hayesauthor=K.+A.+Gelmon&title=Ki67+in+breast+cancer%3A+prognostic+and+predictive+potential&doi=10.1016%2FS1470-2045%2809%2970262-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Ki67 in breast cancer: prognostic and predictive potential</span></div><div class="casAuthors">Yerushalmi, Rinat; Woods, Ryan; Ravdin, Peter M.; Hayes, Malcolm M.; Gelmon, Karen A.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">174-183</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The leading parameters that define treatment recommendations in early breast cancer are estrogen-receptor, progesterone-receptor, and human epidermal growth-factor status.  Although some pathologists report Ki67 in addn. to other biol. markers, the existing guidelines of the American Society of Clin. Oncol. do not include Ki67 in the list of required routine biol. markers.  The advent of new genetic tests has emphasized the role of proliferative genes, including Ki67, as prognostic and predictive markers.  Addnl., randomized studies have retrospectively reviewed data and reported on the role of Ki67 in breast cancer.  In light of new data, we have re-assessed evidence that could change guidelines to include Ki67 in the std. pathol. assessment of early breast cancers.  This review provides an update on the current knowledge on Ki67 and of the evidence in the published work about the prognostic and predictive role of this marker, and provides information on the lab. techniques used to det. Ki67.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR3zXY3j2qZLVg90H21EOLACvtfcHk0li66YkFTzThRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGgtbc%253D&md5=ddda49417249c3505a39b116155ac751</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2809%2970262-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252809%252970262-1%26sid%3Dliteratum%253Aachs%26aulast%3DYerushalmi%26aufirst%3DR.%26aulast%3DWoods%26aufirst%3DR.%26aulast%3DRavdin%26aufirst%3DP.%2BM.%26aulast%3DHayes%26aufirst%3DM.%2BM.%26aulast%3DGelmon%26aufirst%3DK.%2BA.%26atitle%3DKi67%2520in%2520breast%2520cancer%253A%2520prognostic%2520and%2520predictive%2520potential%26jtitle%3DLancet%2520Oncol.%26date%3D2010%26volume%3D11%26spage%3D174%26epage%3D183%26doi%3D10.1016%2FS1470-2045%2809%2970262-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindley, D. N.</span></span> <span> </span><span class="NLM_article-title">Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-kappaB activation</span>. <i>Mol. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>, <span class="NLM_elocation-id">36</span> <span class="refDoi"> DOI: 10.1186/s12943-017-0607-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1186%2Fs12943-017-0607-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=28178994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjt1CrsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&author=X.+Tangauthor=X.+Wangauthor=Y.+Y.+Zhaoauthor=J.+M.+Curtisauthor=D.+N.+Brindley&title=Doxycycline+attenuates+breast+cancer+related+inflammation+by+decreasing+plasma+lysophosphatidate+concentrations+and+inhibiting+NF-kappaB+activation&doi=10.1186%2Fs12943-017-0607-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Doxycycline attenuates breast cancer related inflammation by decreasing plasmalysophosphatidate concentrations andinhibiting NF-κB activation</span></div><div class="casAuthors">Tang, Xiaoyun; Wang, Xianyan; Zhao, Yuan Y.; Curtis, Jonathan M.; Brindley, David N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36/1-36/13</span>CODEN:
                <span class="NLM_cas:coden">MCOACG</span>;
        ISSN:<span class="NLM_cas:issn">1476-4598</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">We previously discovered that tetracyclines increase the expression of lipid phosphate phosphatases at the surface of cells.  These enzymes degrade circulating lysophosphatidate and therefore doxycycline increases the turnover of plasma lysophosphatidate and decreases its concn.  Extracellular lysophosphatidate signals through six G protein-coupled receptors and it is a potent promoter of tumor growth, metastasis and chemo-resistance.  These effects depend partly on the stimulation of inflammation that lysophosphatidate produces.  In this work, we used a syngeneic orthotopic mouse model of breast cancer to det. the impact of doxycycline on circulating lysophosphatidate concns. and tumor growth.  Cytokine/chemokine concns. in tumor tissue and plasma were measured by multiplexing laser bead technol.  Leukocyte infiltration in tumors was analyzed by immunohistochem.  The expression of IL-6 in breast cancer cell lines was detd. by RT-PCR.  Cell growth was measured in MatrigelTM 3D culture.  The effects of doxycycline on NF-κB-dependent signaling were analyzed by Western blotting.  Doxycycline decreased plasma lysophosphatidate concns., delayed tumor growth and decreased the concns. of several cytokines/chemokines (IL-1β, IL-6, IL-9, CCL2, CCL11, CXCL1, CXCL2, CXCL9, G-CSF, LIF, VEGF) in the tumor.  These results were compatible with the effects of doxycycline in decreasing the nos. of F4/80 + macrophages and CD31 + blood vessel endothelial cells in the tumor.  Doxycycline also decreased the lysophosphatidate-induced growth of breast cancer cells in three-dimensional culture.  Lysophosphatidate- induced Ki-67 expression was inhibited by doxycycline.  NF-κB activity in HEK293 cells transiently expressing a NF- κB-luciferase reporter vectors was also inhibited by doxycycline.  Treatment of breast cancer cells with doxycycline also decreased the translocation of NF-κB to the nucleus and the mRNA levels for IL-6 in the presence or absence of lysophosphatidate.  These results contribute a new dimension for understanding the anti-inflammatory effects of tetracyclines, which make them potential candidates for adjuvant therapy of cancers and other inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoB_4y4uJ3yubVg90H21EOLACvtfcHk0liv9Qip2AU9Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjt1CrsLY%253D&md5=f98326254031c757329f74d7a70851da</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1186%2Fs12943-017-0607-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12943-017-0607-x%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DY.%2BY.%26aulast%3DCurtis%26aufirst%3DJ.%2BM.%26aulast%3DBrindley%26aufirst%3DD.%2BN.%26atitle%3DDoxycycline%2520attenuates%2520breast%2520cancer%2520related%2520inflammation%2520by%2520decreasing%2520plasma%2520lysophosphatidate%2520concentrations%2520and%2520inhibiting%2520NF-kappaB%2520activation%26jtitle%3DMol.%2520Cancer%26date%3D2017%26volume%3D16%26doi%3D10.1186%2Fs12943-017-0607-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Si, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, J.</span></span> <span> </span><span class="NLM_article-title">Potent effects of dioscin against pancreatic cancer via miR-149-3P-mediated inhibition of the Akt1 signalling pathway</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">553</span>– <span class="NLM_lpage">568</span>, <span class="refDoi"> DOI: 10.1111/bph.13718</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1111%2Fbph.13718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=28095588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC2sXis1Wqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2017&pages=553-568&author=L.+Siauthor=L.+Xuauthor=L.+Yinauthor=Y.+Qiauthor=X.+Hanauthor=Y.+Xuauthor=Y.+Zhaoauthor=K.+Liuauthor=J.+Peng&title=Potent+effects+of+dioscin+against+pancreatic+cancer+via+miR-149-3P-mediated+inhibition+of+the+Akt1+signalling+pathway&doi=10.1111%2Fbph.13718"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Potent effects of dioscin against pancreatic cancer via miR-149-3P-mediated inhibition of the Akt1 signalling pathway</span></div><div class="casAuthors">Si, Lingling; Xu, Lina; Yin, Lianhong; Qi, Yan; Han, Xu; Xu, Youwei; Zhao, Yanyan; Liu, Kexin; Peng, Jinyong</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">553-568</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : The aim of the present study was to investigate the effects and possible underlying mechanisms of dioscin against pancreatic cancer in vitro and in vivo.  Exptl. Approach : In vitro actions of dioscin on viability of ASPC-1 and PANC-1 cells, and in vivo effects to suppress the tumor growth of cell xenografts in nude mice were assessed.  In addn., microRNA microarray anal. detd. which microRNAs were affected by dioscin.  The mechanisms underlying the actions of dioscin against pancreatic cancer were elucidated in terms of Akt1 and other proteins related to apoptosis.  Key Results : Dioscin markedly induced apoptosis and significantly suppressed the tumor growth of ASPC-1 and PANC-1 cell xenografts, in nude mice.  Total of 107 microRNAs with differential changes were found, in which miR-149-3P targeted with Akt1 was markedly up-regulated by dioscin.  Further studies showed that dioscin significantly down-regulated Akt1 levels, and thus induced cell apoptosis by increasing the levels of Bax, Apaf-1, cleaved caspase-3/9, cleaved PARP, suppressing Bcl-2 levels, and causing cytochrome c release.  The effects of an inhibitor of miR-149-3P and of siRNA of testicular Akt1 suggested that dioscin showed excellent activity against pancreatic cancer via miR- 149-3P-mediated inhibition of Akt1 signalling pathway.  Conclusions and Implications : Collectively, these findings confirmed the potent effects of dioscin against pancreatic cancer and also provided novel insights into the mechanisms of the compd. as a potential candidate for the treatment of pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwPhYBUV2sSLVg90H21EOLACvtfcHk0liv9Qip2AU9Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXis1Wqsbg%253D&md5=cce37dbc551bd956bfa888bab926991f</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1111%2Fbph.13718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13718%26sid%3Dliteratum%253Aachs%26aulast%3DSi%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DYin%26aufirst%3DL.%26aulast%3DQi%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DPeng%26aufirst%3DJ.%26atitle%3DPotent%2520effects%2520of%2520dioscin%2520against%2520pancreatic%2520cancer%2520via%2520miR-149-3P-mediated%2520inhibition%2520of%2520the%2520Akt1%2520signalling%2520pathway%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D174%26spage%3D553%26epage%3D568%26doi%3D10.1111%2Fbph.13718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00166&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of compounds <b>1</b>–<b>25</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00166&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. ORTEP diagram of compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00166&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0012.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 8,9-seco-<i>ent</i>-Kaurane Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00166&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) CH<sub>3</sub>OH, rt, overnight; (b) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, rt, overnight; (c) Dess–Martin periodinane, CH<sub>2</sub>Cl<sub>2</sub>, rt, 4 h; (d) benzoyl/ethanoyl/chloroacetyl chlorides, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 4 h; (e) benzoyl/ethanoyl/propionyl/acryloyl/chloroacetyl/3-butenoyl chlorides, CH<sub>2</sub>Cl<sub>2</sub>, rt, 5 h; (f) ethanoyl/chloroacetyl chlorides, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 5 h; (g) 10% Pd/C, H<sub>2</sub>, EtOAc, rt, 2 h; and (h) 10% Pd/C, H<sub>2</sub>, CH<sub>3</sub>OH, rt, 2 h.</p></p></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Colony formation assay of MDA-MB-231 and MDA-MB-468 cells treated with or without different concentrations of <b>6</b> (0.05, 0.1, and 0.2 μM) for 2 weeks. The corresponding quantitative analysis is included. Data represented the mean ± SD of at least three independent experiments. *<i>P</i> < 0.05, <sup>**</sup><i>P</i> < 0.01, and <sup>***</sup><i>P</i> < 0.001 vs the solvent control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00166&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>6</b> induced G2/M cell cycle arrest in TNBC cells. MDA-MB-231 and MDA-MB-468 cells were treated with or without <b>6</b> at different concentrations (1, 2, and 5 μM) for 24 h. (A) Flow cytometry analysis of cell cycle assay. (B) Western blot analysis of protein expression related to the cell cycle. The corresponding quantitative analysis is included. Data represented the mean ± SD of at least three independent experiments. *<i>P</i> < 0.05, <sup>**</sup><i>P</i> < 0.01, and <sup>***</sup><i>P</i> < 0.001 vs the solvent control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00166&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>6</b> induced apoptosis in TNBC cells. MDA-MB-231 and MDA-MB-468 cells were treated with or without <b>6</b> at different concentrations (1, 2, and 5 μM) for 24 h. Flow cytometry analysis of (A) apoptotic cells and (B) ΔΨ<i>m</i> with JC-10. (C) Western blot analysis of protein expression related to apoptosis. The quantitative analysis is included. Data represented the mean ± SD of at least three independent experiments. *<i>P</i> < 0.05, <sup>**</sup><i>P</i> < 0.01, and <sup>***</sup><i>P</i> < 0.001 vs the solvent control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00166&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>6</b> induced autophagy to promote apoptosis in TNBC cells. (A) Western blot analysis of protein expression related to autophagy in MDA-MB-231 and MDA-MB-468 cells induced by <b>6</b> at different concentrations (1, 2, and 5 μM) for 24 h. (B) Western blot analysis of protein expression in MDA-MB-231 cells induced by 5 μM <b>6</b> with or without co-treatment of chloroquine (20 μM) for 24 h. The corresponding quantitative analysis is included. Data represented the mean ± SD of at least three independent experiments. *<i>P</i> < 0.05, <sup>**</sup><i>P</i> < 0.01, and <sup>***</sup><i>P</i> < 0.001 vs the solvent control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00166&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>6</b> inhibited the migration and invasion of MDA-MB-231 cells. (A) Scratch assay for migration capability on MDA-MB-231 cells induced by <b>6</b> at different concentrations (0.1 and 0.2 μM) for 24, 48, and 72 h. (B) Transwell invasion assay on MDA-MB-231 cells induced by <b>6</b> at different concentrations (0.1 and 0.2 μM) for 48 h. (C) Western blot analysis of protein expression related to migration and invasion in MDA-MB-231 cells induced by <b>6</b> at different concentrations (0.1 and 0.2 μM) for 24 h. The corresponding quantitative analysis is included. Data represented the mean ± SD of at least three independent experiments. The migration rate was calculated by % migration rate<sub>24h/48h/72h</sub> = (width<sub>0h</sub> – width<sub>24h/48h/72h</sub>)/width<sub>0h</sub> × 100%. *<i>P</i> < 0.05, <sup>**</sup><i>P</i> < 0.01, and <sup>***</sup><i>P</i> < 0.001 vs the solvent control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00166&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Compound <b>6</b> inhibited Akt signaling in TNBC cells. (A) Western blot analysis of protein expression related to Akt signaling in MDA-MB-231 and MDA-MB-468 cells induced by <b>6</b> at different concentrations (1, 2, and 5 μM) for 24 h. (B) CETSA of Akt1 in MDA-MB-231 and MDA-MB-468 cells incubated with <b>6</b> (2 μM) for 2 h. (C) Western blot analysis of protein expression of Akt1 in MDA-MB-231 and MDA-MB-468 cells with transfection of negative control or Akt1 siRNA. (D) Proliferation inhibition induced by different concentrations of  <b>6</b> on MDA-MB-231 and MDA-MB-468 cells for 24 h with transfection of negative control (CsiRNA) or Akt1 siRNA (Akt1siRNA). The corresponding quantitative analysis is included. Data represented the mean ± SD of at least three independent experiments. *<i>P</i> < 0.05, <sup>**</sup><i>P</i> < 0.01, and <sup>***</sup><i>P</i> < 0.001 vs solvent control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00166&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Compound <b>6</b> suppressed the TNBC xenograft tumor growth in female NOD/SCID mice. Vehicle (normal saline per day), <b>6</b> (5 mg/kg per day), <b>6</b> (10 mg/kg per day), and doxorubicin (Dox, 5 mg/kg per week) were administrated intraperitoneally for 33 days. Then, the mice were sacrificed, and the tumors were photographed and weighed. (A) The image of isolated tumors derived from mice. (B) The body weight changes of each group during the treatment period measured every 2 days. (C) The weight of isolated tumors derived from mice. (D) The tumor volume changes of each group during the treatment period measured every 2 days. The tumor volume was calculated according to the formula <i>V</i> = (π/6) × <i>L</i> × <i>W</i><sup>2</sup>, where <i>L</i> is the length (mm) and <i>W</i> is the width (mm). (E) Representative images of hematoxylin and eosin (H&E) staining in hearts, livers, spleens, lungs, and kidneys chosen from slices of 3 randomly chosen mice. Data represented the mean ± SD of 8 mice. *<i>P</i> < 0.05 and <sup>**</sup><i>P</i> < 0.01, and <sup>***</sup><i>P</i> < 0.001 vs vehicle group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00166&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/medium/jm1c00166_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Immunohistochemical staining of TNBC xenograft tumors. Representative images of H&E, Ki67, TUNEL, CD31, and LC3B staining in tumors. Images were captured and chosen from slices of 3 randomly chosen mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/acs.jmedchem.1c00166/20210716/images/large/jm1c00166_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00166&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i71">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60037" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60037" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 42 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harbeck, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnant, M.</span></span> <span> </span><span class="NLM_article-title">Breast cancer</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>389</i></span>,  <span class="NLM_fpage">1134</span>– <span class="NLM_lpage">1150</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(16)31891-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2FS0140-6736%2816%2931891-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=27865536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A280%3ADC%252BC2snot1Chsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2017&pages=1134-1150&author=N.+Harbeckauthor=M.+Gnant&title=Breast+cancer&doi=10.1016%2FS0140-6736%2816%2931891-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Breast cancer</span></div><div class="casAuthors">Harbeck Nadia; Gnant Michael</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">389</span>
        (<span class="NLM_cas:issue">10074</span>),
    <span class="NLM_cas:pages">1134-1150</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Breast cancer is one of the three most common cancers worldwide.  Early breast cancer is considered potentially curable.  Therapy has progressed substantially over the past years with a reduction in therapy intensity, both for locoregional and systemic therapy; avoiding overtreatment but also undertreatment has become a major focus.  Therapy concepts follow a curative intent and need to be decided in a multidisciplinary setting, taking molecular subtype and locoregional tumour load into account.  Primary conventional surgery is not the optimal choice for all patients any more.  In triple-negative and HER2-positive early breast cancer, neoadjuvant therapy has become a commonly used option.  Depending on clinical tumour subtype, therapeutic backbones include endocrine therapy, anti-HER2 targeting, and chemotherapy.  In metastatic breast cancer, therapy goals are prolongation of survival and maintaining quality of life.  Advances in endocrine therapies and combinations, as well as targeting of HER2, and the promise of newer targeted therapies make the prospect of long-term disease control in metastatic breast cancer an increasing reality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRi64LuFKtexLHHuJhbyicZfW6udTcc2eZg4-YLbfKtK7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2snot1Chsg%253D%253D&md5=7dfc3265e0dce226e0c129726e97f407</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2816%2931891-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252816%252931891-8%26sid%3Dliteratum%253Aachs%26aulast%3DHarbeck%26aufirst%3DN.%26aulast%3DGnant%26aufirst%3DM.%26atitle%3DBreast%2520cancer%26jtitle%3DLancet%26date%3D2017%26volume%3D389%26spage%3D1134%26epage%3D1150%26doi%3D10.1016%2FS0140-6736%2816%2931891-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djamgoz, M. B. A.</span></span> <span> </span><span class="NLM_article-title">Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2017.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2Fj.ctrv.2017.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=29202431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvValtbnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&pages=110-122&author=A.+Leeauthor=M.+B.+A.+Djamgoz&title=Triple+negative+breast+cancer%3A+Emerging+therapeutic+modalities+and+novel+combination+therapies&doi=10.1016%2Fj.ctrv.2017.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies</span></div><div class="casAuthors">Lee, Alice; Djamgoz, Mustafa B. A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">110-122</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Triple neg. breast cancer (TNBC) is a complex and aggressive subtype of breast cancer which lacks estrogen receptors, progesterone receptors and HER2 amplification, thereby making it difficult to target therapeutically.  In addn., TNBC has the highest rates of metastatic disease and the poorest overall survival of all breast cancer subtypes.  Resultantly, development of targeted therapies for TNBC is urgently needed.  Recent efforts aimed at mol. characterization of TNBCs have revealed various emerging therapeutic targets including PARP1, receptor and non-receptor tyrosine kinases, immune-checkpoints, androgen receptor and epigenetic proteins.  Key successes include that of the PARP inhibitor, olaparib, which prolonged progression-free survival in a trial of BRCA-mutated breast cancer and for which clin. approval (in this setting) appears imminent.  Nevertheless, the heterogeneity of TNBC has limited the clin. benefits of many trialled therapies in 'unselected' patients.  Further, drug resistance develops following use of many targeted monotherapies due to upregulation of compensatory signalling pathways.  In this review, we evaluate the current status of investigational targeted treatments and present evidence for the role of novel biomarkers and combination therapies in increasing response rates and circumventing drug-induced resistance.  Addnl., we discuss promising novel targets in metastatic TNBC identified through preclin. and/or epidemiol. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraUe6qPPRyzbVg90H21EOLACvtfcHk0lih5benqlsUTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvValtbnK&md5=738b63405e3d6c1a3541982a6987a2dd</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2017.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2017.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DA.%26aulast%3DDjamgoz%26aufirst%3DM.%2BB.%2BA.%26atitle%3DTriple%2520negative%2520breast%2520cancer%253A%2520Emerging%2520therapeutic%2520modalities%2520and%2520novel%2520combination%2520therapies%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2018%26volume%3D62%26spage%3D110%26epage%3D122%26doi%3D10.1016%2Fj.ctrv.2017.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viale, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Criscitiello, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curigliano, G.</span></span> <span> </span><span class="NLM_article-title">Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies</span>. <i>NPJ Breast Cancer</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">54</span> <span class="refDoi"> DOI: 10.1038/s41523-020-00197-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1038%2Fs41523-020-00197-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=33088912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A280%3ADC%252BB3s7ks1ynsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2020&author=A.+Marraauthor=D.+Trapaniauthor=G.+Vialeauthor=C.+Criscitielloauthor=G.+Curigliano&title=Practical+classification+of+triple-negative+breast+cancer%3A+intratumoral+heterogeneity%2C+mechanisms+of+drug+resistance%2C+and+novel+therapies&doi=10.1038%2Fs41523-020-00197-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies</span></div><div class="casAuthors">Marra Antonio; Trapani Dario; Viale Giulia; Criscitiello Carmen; Curigliano Giuseppe; Marra Antonio; Curigliano Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">NPJ breast cancer</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">54</span>
        ISSN:<span class="NLM_cas:issn">2374-4677</span>.
    </div><div class="casAbstract">Triple-negative breast cancer (TNBC) is not a unique disease, encompassing multiple entities with marked histopathological, transcriptomic and genomic heterogeneity.  Despite several efforts, transcriptomic and genomic classifications have remained merely theoretic and most of the patients are being treated with chemotherapy.  Driver alterations in potentially targetable genes, including PIK3CA and AKT, have been identified across TNBC subtypes, prompting the implementation of biomarker-driven therapeutic approaches.  However, biomarker-based treatments as well as immune checkpoint inhibitor-based immunotherapy have provided contrasting and limited results so far.  Accordingly, a better characterization of the genomic and immune contexture underpinning TNBC, as well as the translation of the lessons learnt in the metastatic disease to the early setting would improve patients' outcomes.  The application of multi-omics technologies, biocomputational algorithms, assays for minimal residual disease monitoring and novel clinical trial designs are strongly warranted to pave the way toward personalized anticancer treatment for patients with TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOpTEiCRQyPv69nzq6467DfW6udTcc2eaVEHM-M2YC_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3s7ks1ynsA%253D%253D&md5=c7bd36d028330c5995b6cc522f62a7cd</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fs41523-020-00197-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41523-020-00197-2%26sid%3Dliteratum%253Aachs%26aulast%3DMarra%26aufirst%3DA.%26aulast%3DTrapani%26aufirst%3DD.%26aulast%3DViale%26aufirst%3DG.%26aulast%3DCriscitiello%26aufirst%3DC.%26aulast%3DCurigliano%26aufirst%3DG.%26atitle%3DPractical%2520classification%2520of%2520triple-negative%2520breast%2520cancer%253A%2520intratumoral%2520heterogeneity%252C%2520mechanisms%2520of%2520drug%2520resistance%252C%2520and%2520novel%2520therapies%26jtitle%3DNPJ%2520Breast%2520Cancer%26date%3D2020%26volume%3D6%26doi%3D10.1038%2Fs41523-020-00197-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pawar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhu, P.</span></span> <span> </span><span class="NLM_article-title">Nanosoldiers: A promising strategy to combat triple negative breast cancer</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2018.11.122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2Fj.biopha.2018.11.122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=30529766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVWju73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2019&pages=319-341&author=A.+Pawarauthor=P.+Prabhu&title=Nanosoldiers%3A+A+promising+strategy+to+combat+triple+negative+breast+cancer&doi=10.1016%2Fj.biopha.2018.11.122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Nanosoldiers: A promising strategy to combat triple negative breast cancer</span></div><div class="casAuthors">Pawar, Akshayya; Prabhu, Priyanka</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">319-341</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  The phenomenal rise in cancer over the past few years has made it the second leading cause of death worldwide.  Breast cancer constitutes the predominant cancer encountered in women.  Triple neg. breast cancer (TNBC) is the most notorious form of breast cancer which involves absence of the estrogen, progesterone and human epidermal growth factor receptor (EGFR) on breast cancer cells.  It is a real challenge for oncologists owing to the recurrence and metastasis which result in poor prognosis.  Conventional therapies employed in treatment of TNBC suffer from issues of poor bioavailability, poor cellular uptake, resistance, and undesirable off-site toxicities.  Nanosized delivery systems, herein designated as nanosoldiers can be smartly designed to be equipped with multiple weapons (drugs, genetic materials, photosensitizers, etc.) to fight the battle against recalcitrant TNBC in a myriad of ways such as bioavailability enhancement, targeted uptake by the TNBC cells, on-demand drug delivery at tumor site, combination therapy, multimodal therapy, photodynamic therapy, photothermal therapy, anti-metastatic approaches, theranostics, etc.  The versatility of nanosoldiers with respect to their material of compn., their mechanism of drug loading and release, ability to modify in vivo drug disposition, multifunctional characteristics enabling detection, treatment, and monitoring, etc. endows them with incredible potential to destroy the intractable TNBC cells.  The focus of the review is to highlight the extraordinary potential of nanocarriers in treatment of TNBC and few challenges which need to be overcome for these nanosoldiers to form a part of the clin. armamentarium of anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotqXiS8TS2tbVg90H21EOLACvtfcHk0ljP8VRsb6a3YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVWju73L&md5=1e757c2bc3d10681f3e0a0a93e949e9a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2018.11.122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2018.11.122%26sid%3Dliteratum%253Aachs%26aulast%3DPawar%26aufirst%3DA.%26aulast%3DPrabhu%26aufirst%3DP.%26atitle%3DNanosoldiers%253A%2520A%2520promising%2520strategy%2520to%2520combat%2520triple%2520negative%2520breast%2520cancer%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2019%26volume%3D110%26spage%3D319%26epage%3D341%26doi%3D10.1016%2Fj.biopha.2018.11.122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bianchini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balko, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gianni, L.</span></span> <span> </span><span class="NLM_article-title">Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease</span>. <i>Nat. Rev. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">674</span>– <span class="NLM_lpage">690</span>, <span class="refDoi"> DOI: 10.1038/nrclinonc.2016.66</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1038%2Fnrclinonc.2016.66" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=27184417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC28XotFOhtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=674-690&author=G.+Bianchiniauthor=J.+M.+Balkoauthor=I.+A.+Mayerauthor=M.+E.+Sandersauthor=L.+Gianni&title=Triple-negative+breast+cancer%3A+challenges+and+opportunities+of+a+heterogeneous+disease&doi=10.1038%2Fnrclinonc.2016.66"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease</span></div><div class="casAuthors">Bianchini, Giampaolo; Balko, Justin M.; Mayer, Ingrid A.; Sanders, Melinda E.; Gianni, Luca</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">674-690</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chemotherapy is the primary established systemic treatment for patients with triple-neg. breast cancer (TNBC) in both the early and advanced-stages of the disease.  The lack of targeted therapies and the poor prognosis of patients with TNBC have fostered a major effort to discover actionable mol. targets to treat patients with these tumors.  Massively parallel sequencing and other 'omics' technologies have revealed an unexpected level of heterogeneity of TNBCs and have led to the identification of potentially actionable mol. features in some TNBCs, such as germline BRCA1/2 mutations or 'BRCAness', the presence of the androgen receptor, and several rare genomic alterations.  Whether these alterations are mol. 'drivers', however, has not been clearly established.  A subgroup of TNBCs shows a high degree of tumor-infiltrating lymphocytes that also correlates with a lower risk of disease relapse and a higher likelihood of benefit from chemotherapy.  Proof-of-principle studies with immune-checkpoint inhibitors in advanced-stage TNBC have yielded promising results, indicating the potential benefit of immunotherapy for patients with TNBC.  In this Review, we discuss the most relevant mol. findings in TNBC from the past decade and the most promising therapeutic opportunities derived from these data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHF3dPbmmkIbVg90H21EOLACvtfcHk0lg9V1KCNvLiYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotFOhtbs%253D&md5=1844e2d72f6321238d275cddc745ba1c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2016.66&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2016.66%26sid%3Dliteratum%253Aachs%26aulast%3DBianchini%26aufirst%3DG.%26aulast%3DBalko%26aufirst%3DJ.%2BM.%26aulast%3DMayer%26aufirst%3DI.%2BA.%26aulast%3DSanders%26aufirst%3DM.%2BE.%26aulast%3DGianni%26aufirst%3DL.%26atitle%3DTriple-negative%2520breast%2520cancer%253A%2520challenges%2520and%2520opportunities%2520of%2520a%2520heterogeneous%2520disease%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2016%26volume%3D13%26spage%3D674%26epage%3D690%26doi%3D10.1038%2Fnrclinonc.2016.66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vidula, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellisen, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardia, A.</span></span> <span> </span><span class="NLM_article-title">Novel Agents for Metastatic Triple-Negative Breast Cancer: Finding the Positive in the Negative</span>. <i>J. Natl. Compr. Cancer Network</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">1179</span>, <span class="refDoi"> DOI: 10.6004/jnccn.2020.7600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.6004%2Fjnccn.2020.7600" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2021&pages=109-1179&author=N.+Vidulaauthor=L.+W.+Ellisenauthor=A.+Bardia&title=Novel+Agents+for+Metastatic+Triple-Negative+Breast+Cancer%3A+Finding+the+Positive+in+the+Negative&doi=10.6004%2Fjnccn.2020.7600"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.6004%2Fjnccn.2020.7600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.6004%252Fjnccn.2020.7600%26sid%3Dliteratum%253Aachs%26aulast%3DVidula%26aufirst%3DN.%26aulast%3DEllisen%26aufirst%3DL.%2BW.%26aulast%3DBardia%26aufirst%3DA.%26atitle%3DNovel%2520Agents%2520for%2520Metastatic%2520Triple-Negative%2520Breast%2520Cancer%253A%2520Finding%2520the%2520Positive%2520in%2520the%2520Negative%26jtitle%3DJ.%2520Natl.%2520Compr.%2520Cancer%2520Network%26date%3D2021%26volume%3D19%26spage%3D109%26epage%3D1179%26doi%3D10.6004%2Fjnccn.2020.7600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCann, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurvitz, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAndrew, N.</span></span> <span> </span><span class="NLM_article-title">Advances in Targeted Therapies for Triple-Negative Breast Cancer</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">1217</span>– <span class="NLM_lpage">1230</span>, <span class="refDoi"> DOI: 10.1007/s40265-019-01155-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1007%2Fs40265-019-01155-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=31254268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A280%3ADC%252BB3Mzit1Cisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2019&pages=1217-1230&author=K.+E.+McCannauthor=S.+A.+Hurvitzauthor=N.+McAndrew&title=Advances+in+Targeted+Therapies+for+Triple-Negative+Breast+Cancer&doi=10.1007%2Fs40265-019-01155-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in Targeted Therapies for Triple-Negative Breast Cancer</span></div><div class="casAuthors">McCann Kelly E; Hurvitz Sara A; McAndrew Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1217-1230</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">While the outcomes for patients diagnosed with hormone receptor positive (HR+) and/or human epidermal growth factor receptor 2-positive (HER2+) breast cancers have continued to improve with the development of targeted therapies, the same cannot be said yet for those affected with triple-negative breast cancer (TNBC).  Currently, the mainstay of treatment for the 10-15% of patients diagnosed with TNBC remains cytotoxic chemotherapy, but it is hoped that through an enhanced characterization of TNBC biology, this disease will be molecularly delineated into subgroups with targetable oncogenic drivers.  This review will focus on recent therapeutic innovations for TNBC, including poly-ADP-ribosyl polymerase (PARP) inhibitors, phosphoinositide 3-kinase (PI3K) pathway inhibitors, immune checkpoint inhibitors, and cyclin-dependent kinase (CDK) inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTGRwqiCBdI45SWdIdmEou5fW6udTcc2eb1VdMSkuBeH7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3Mzit1Cisw%253D%253D&md5=60faeeed79b8728a66ffd80f331d2bca</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs40265-019-01155-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-019-01155-4%26sid%3Dliteratum%253Aachs%26aulast%3DMcCann%26aufirst%3DK.%2BE.%26aulast%3DHurvitz%26aufirst%3DS.%2BA.%26aulast%3DMcAndrew%26aufirst%3DN.%26atitle%3DAdvances%2520in%2520Targeted%2520Therapies%2520for%2520Triple-Negative%2520Breast%2520Cancer%26jtitle%3DDrugs%26date%3D2019%26volume%3D79%26spage%3D1217%26epage%3D1230%26doi%3D10.1007%2Fs40265-019-01155-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span> <span> </span><span class="NLM_article-title">Natural products as leads to potential drugs: An old process or the new hope for drug discovery?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2589</span>– <span class="NLM_lpage">2599</span>, <span class="refDoi"> DOI: 10.1021/jm0704090</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0704090" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktlCis7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2589-2599&author=D.+J.+Newman&title=Natural+products+as+leads+to+potential+drugs%3A+An+old+process+or+the+new+hope+for+drug+discovery%3F&doi=10.1021%2Fjm0704090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Products as Leads to Potential Drugs: An Old Process or the New Hope for Drug Discovery?</span></div><div class="casAuthors">Newman, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2589-2599</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This review reports the potential use of natural pharmaceutical products in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPLHbnhB1dULVg90H21EOLACvtfcHk0lg9V1KCNvLiYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktlCis7g%253D&md5=dbb052c64835db6f919c0ea3cf3e8fbe</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm0704090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0704090%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26atitle%3DNatural%2520products%2520as%2520leads%2520to%2520potential%2520drugs%253A%2520An%2520old%2520process%2520or%2520the%2520new%2520hope%2520for%2520drug%2520discovery%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2589%26epage%3D2599%26doi%3D10.1021%2Fjm0704090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. H.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">500</span>– <span class="NLM_lpage">516</span>, <span class="refDoi"> DOI: 10.1021/np900821e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np900821e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVOqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2010&pages=500-516&author=K.+H.+Lee&title=Discovery+and+development+of+natural+product-derived+chemotherapeutic+agents+based+on+a+medicinal+chemistry+approach&doi=10.1021%2Fnp900821e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Natural Product-Derived Chemotherapeutic Agents Based on a Medicinal Chemistry Approach</span></div><div class="casAuthors">Lee, Kuo-Hsiung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">500-516</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A review.  Medicinal plants have long been an excellent source of pharmaceutical agents.  Accordingly, the long-term objectives of the author's research program are to discover and design new chemotherapeutic agents based on plant-derived compd. leads by using a medicinal chem. approach, which is a combination of chem. and biol.  Different examples of promising bioactive natural products and their synthetic analogs, including sesquiterpene lactones, quassinoids, naphthoquinones, phenylquinolones, dithiophenediones, neo-tanshinlactone, tylophorine, suksdorfin, DCK, and DCP, will be presented with respect to their discovery and preclin. development as potential clin. trial candidates.  Research approaches include bioactivity- or mechanism of action-directed isolation and characterization of active compds., rational drug design-based modification and analog synthesis, and structure-activity relationship and mechanism of action studies.  Current clin. trial agents discovered by the Natural Products Research Labs., University of North Carolina, include bevirimat (di-Me succinyl betulinic acid), which is now in phase IIb trials for treating AIDS.  Bevirimat is also the first in a new class of HIV drug candidates called "maturation inhibitors".  In addn., an etoposide analog, GL-331, progressed to anticancer phase II clin. trials, and the curcumin analog JC-9 is in phase II clin. trials for treating acne and in development for trials against prostate cancer.  The discovery and development of these clin. trial candidates will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmO67UJvZKHLVg90H21EOLACvtfcHk0lh2cKDiuw1t8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVOqsLc%253D&md5=9775ba3d4776a5d2de9c6dde29782cc8</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fnp900821e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp900821e%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BH.%26atitle%3DDiscovery%2520and%2520development%2520of%2520natural%2520product-derived%2520chemotherapeutic%2520agents%2520based%2520on%2520a%2520medicinal%2520chemistry%2520approach%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2010%26volume%3D73%26spage%3D500%26epage%3D516%26doi%3D10.1021%2Fnp900821e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cragg, G. M.</span></span> <span> </span><span class="NLM_article-title">Natural Products as Sources of New Drugs from 1981 to 2014</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">629</span>– <span class="NLM_lpage">661</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.5b01055</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.5b01055" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit1Kqu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=629-661&author=D.+J.+Newmanauthor=G.+M.+Cragg&title=Natural+Products+as+Sources+of+New+Drugs+from+1981+to+2014&doi=10.1021%2Facs.jnatprod.5b01055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Products as Sources of New Drugs from 1981 to 2014</span></div><div class="casAuthors">Newman, David J.; Cragg, Gordon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">629-661</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">This contribution is a completely updated and expanded version of the four prior analogous reviews that were published in this journal in 1997, 2003, 2007, and 2012.  In the case of all approved therapeutic agents, the time frame has been extended to cover the 34 years from Jan. 1, 1981, to Dec. 31, 2014, for all diseases worldwide, and from 1950 (earliest so far identified) to Dec. 2014 for all approved antitumor drugs worldwide.  As mentioned in the 2012 review, we have continued to utilize our secondary subdivision of a "natural product mimic", or "NM", to join the original primary divisions and the designation "natural product botanical", or "NB", to cover those botanical "defined mixts." now recognized as drug entities by the U.S. FDA (and similar organizations).  From the data presented in this review, the utilization of natural products and/or their novel structures, in order to discover and develop the final drug entity, is still alive and well.  For example, in the area of cancer, over the time frame from around the 1940s to the end of 2014, of the 175 small mols. approved, 131, or 75%, are other than "S" (synthetic), with 85, or 49%, actually being either natural products or directly derived therefrom.  In other areas, the influence of natural product structures is quite marked, with, as expected from prior information, the anti-infective area being dependent on natural products and their structures.  We wish to draw the attention of readers to the rapidly evolving recognition that a significant no. of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated", and therefore it is considered that this area of natural product research should be expanded significantly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMgEvq9fVY8bVg90H21EOLACvtfcHk0lh2cKDiuw1t8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit1Kqu7k%253D&md5=c9f2a44ab6b66331b7ef6ca64029328a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.5b01055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.5b01055%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26atitle%3DNatural%2520Products%2520as%2520Sources%2520of%2520New%2520Drugs%2520from%25201981%2520to%25202014%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2016%26volume%3D79%26spage%3D629%26epage%3D661%26doi%3D10.1021%2Facs.jnatprod.5b01055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, S.</span></span> <span> </span><span class="NLM_article-title">Jatrophane Diterpenoids as Modulators of P-Glycoprotein-Dependent Multidrug Resistance (MDR): Advances of Structure-Activity Relationships and Discovery of Promising MDR Reversal Agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6353</span>– <span class="NLM_lpage">6369</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00605</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00605" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVSrtb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6353-6369&author=J.+Zhuauthor=R.+Wangauthor=L.+Louauthor=W.+Liauthor=G.+Tangauthor=X.+Buauthor=S.+Yin&title=Jatrophane+Diterpenoids+as+Modulators+of+P-Glycoprotein-Dependent+Multidrug+Resistance+%28MDR%29%3A+Advances+of+Structure-Activity+Relationships+and+Discovery+of+Promising+MDR+Reversal+Agents&doi=10.1021%2Facs.jmedchem.6b00605"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Jatrophane Diterpenoids as Modulators of P-Glycoprotein-Dependent Multidrug Resistance (MDR): Advances of Structure-Activity Relationships and Discovery of Promising MDR Reversal Agents</span></div><div class="casAuthors">Zhu, Jianyong; Wang, Ruimin; Lou, Lanlan; Li, Wei; Tang, Guihua; Bu, Xianzhang; Yin, Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6353-6369</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The phytochem. study of Pedilanthus tithymaloides led to the isolation of 13 jatrophane diterpenoids (1-13), of which eight (1-8) are new.  Subsequent structural modification of the major components by esterification, hydrolysis, hydrogenation, or epoxidn. yielded 22 new derivs. (14-35).  Thus, a jatrophane library contg. two series of compds. was established to screen for P-glycoprotein (Pgp)-dependent MDR modulators.  The activity was evaluated through a combination of Rho123 efflux and chemoreversal assays on adriamycin resistant human hepatocellular carcinoma cell line HepG2 (HepG2/ADR) and adriamycin resistant human breast adenocarcinoma cell line MCF-7 (MCF-7/ADR).  Compds. 19, 25, and 26 were identified as potent MDR modulators with greater chemoreversal ability and less cytotoxicity than the third-generation drug tariquidar.  The structure-activity relationship (SAR) was discussed, which showed that modifications beyond just increasing the lipophilicity of this class of Pgp inhibitors are beneficial to the activity.  Compd. 26, which exhibited a remarkable metabolic stability in vitro and a favorable antitumor effect in vivo, would serve as a promising lead for the development of new MDR reversal agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobYTCdHUEwx7Vg90H21EOLACvtfcHk0lh2cKDiuw1t8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVSrtb%252FI&md5=3980b1349ffea40674e82fff3fba2f5d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00605%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DLou%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DG.%26aulast%3DBu%26aufirst%3DX.%26aulast%3DYin%26aufirst%3DS.%26atitle%3DJatrophane%2520Diterpenoids%2520as%2520Modulators%2520of%2520P-Glycoprotein-Dependent%2520Multidrug%2520Resistance%2520%2528MDR%2529%253A%2520Advances%2520of%2520Structure-Activity%2520Relationships%2520and%2520Discovery%2520of%2520Promising%2520MDR%2520Reversal%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6353%26epage%3D6369%26doi%3D10.1021%2Facs.jmedchem.6b00605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, S.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic macrocyclic diterpenoids from <i>Jatropha multifida</i></span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">518</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2018.06.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2Fj.bioorg.2018.06.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=30005201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlentr%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2018&pages=511-518&author=J.+S.+Zhangauthor=Y.+Zhangauthor=S.+Liauthor=A.+Ahmedauthor=G.+H.+Tangauthor=S.+Yin&title=Cytotoxic+macrocyclic+diterpenoids+from+Jatropha+multifida&doi=10.1016%2Fj.bioorg.2018.06.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic macrocyclic diterpenoids from Jatropha multifida</span></div><div class="casAuthors">Zhang, Jun-Sheng; Zhang, Yao; Li, Shen; Ahmed, Abrar; Tang, Gui-Hua; Yin, Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">511-518</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nine new macrocyclic diterpenoids (1-9), jatromultones A-I, along with eight known analogs (10-17) were isolated from the trunks of Jatropha multifida.  The structures of the new compds., including their abs. configurations, were elucidated by combination of spectroscopic anal., single crystal X-ray diffraction, Rh2(OCOCF3)4-induced CD method, and chem. correlations.  All compds. were screened for the cytotoxicity against five cancer cell lines, including one drug-resistant cell line, and seven compds. exhibited significant activity with IC50 values less than 10 μM.  Compd. 4 with IC50 values ranging from 2.69 to 6.44 μM toward all cell lines was selected for further mechanistic study, which showed that 4 could arrest cell cycle at G2/M phase and induce apoptosis.  The brief structure-activity relationships (SARs) of these macrocyclic diterpenoids were also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlB9-GK3NzvbVg90H21EOLACvtfcHk0lgPWL8Fk0jG-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlentr%252FI&md5=b3e180d58446e87ce5c2bf65a28d0a81</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2018.06.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2018.06.025%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%2BS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DAhmed%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DG.%2BH.%26aulast%3DYin%26aufirst%3DS.%26atitle%3DCytotoxic%2520macrocyclic%2520diterpenoids%2520from%2520Jatropha%2520multifida%26jtitle%3DBioorg.%2520Chem.%26date%3D2018%26volume%3D80%26spage%3D511%26epage%3D518%26doi%3D10.1016%2Fj.bioorg.2018.06.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Node, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuji, K.</span></span> <span> </span><span class="NLM_article-title">Terpenoids. XLVIII. New diterpenoids from <i>Rabdosia shikokiana</i> var. occidentalis</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1029</span>– <span class="NLM_lpage">1033</span>, <span class="refDoi"> DOI: 10.1248/cpb.33.1029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1248%2Fcpb.33.1029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADyaL2MXktVelur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1985&pages=1029-1033&author=M.+Nodeauthor=N.+Itoauthor=I.+Uchidaauthor=E.+Fujitaauthor=K.+Fuji&title=Terpenoids.+XLVIII.+New+diterpenoids+from+Rabdosia+shikokiana+var.+occidentalis&doi=10.1248%2Fcpb.33.1029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Terpenoids.  XLVIII.  New diterpenoids from Rabdosia shikokiana var. occidentalis</span></div><div class="casAuthors">Node, Manabu; Ito, Nozomu; Uchida, Itsuo; Fujita, Eiichi; Fuji, Kaoru</div><div class="citationInfo"><span class="NLM_cas:title">Chemical & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1029-33</span>CODEN:
                <span class="NLM_cas:coden">CPBTAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-2363</span>.
    </div><div class="casAbstract">Five new kaurene-type diterpenoids, shikoccin (I), O-methylshikoccin, epoxyshikoccin, O-methylepoxyshikoccin, and shikoccidin (II) were isolated from Rabdpsoa shikokiana var occidentalis.  All these compds. except for II possess a previously unknown 8,9-seco-ent-kaurene skeleton.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrArIegtsKJsLVg90H21EOLACvtfcHk0lgPWL8Fk0jG-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXktVelur4%253D&md5=7dc060d687720981b31be61612858a6f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1248%2Fcpb.33.1029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.33.1029%26sid%3Dliteratum%253Aachs%26aulast%3DNode%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DUchida%26aufirst%3DI.%26aulast%3DFujita%26aufirst%3DE.%26aulast%3DFuji%26aufirst%3DK.%26atitle%3DTerpenoids.%2520XLVIII.%2520New%2520diterpenoids%2520from%2520Rabdosia%2520shikokiana%2520var.%2520occidentalis%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1985%26volume%3D33%26spage%3D1029%26epage%3D1033%26doi%3D10.1248%2Fcpb.33.1029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, S. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, J. M.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic 8,9-seco-ent-kaurane diterpenoids from <i>Croton kongensis</i></span>. <i>J. Asian Nat. Prod. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">920</span>– <span class="NLM_lpage">927</span>, <span class="refDoi"> DOI: 10.1080/10286020.2017.1373100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1080%2F10286020.2017.1373100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=28895443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFajs7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=920-927&author=S.+Q.+Shiauthor=Y.+Y.+Fanauthor=C.+H.+Xuauthor=J.+Dingauthor=G.+W.+Wangauthor=J.+M.+Yue&title=Cytotoxic+8%2C9-seco-ent-kaurane+diterpenoids+from+Croton+kongensis&doi=10.1080%2F10286020.2017.1373100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic 8,9-seco-ent-kaurane diterpenoids from Croton kongensis</span></div><div class="casAuthors">Shi, Shu-Qin; Fan, Yao-Yue; Xu, Cheng-Hui; Ding, Jian; Wang, Guan-Wu; Yue, Jian-Min</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Asian Natural Products Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">920-927</span>CODEN:
                <span class="NLM_cas:coden">JANRFI</span>;
        ISSN:<span class="NLM_cas:issn">1028-6020</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Chem. study on the ethanolic ext. generated from the aerial parts of Croton kongensis led to the isolation of three new 8,9-seco-ent-kaurane diterpenoids, kongeniods A-C (1-3), together with seven known analogs (4-10).  The structures of these compds. were assigned by spectroscopic data anal.  The vitro cytotoxic tests showed that compds. 1-3 exhibited strong activities against HL-60 cell lines with IC50 values of 0.47, 0.58, and 1.27 μM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVJGbUHvx2CbVg90H21EOLACvtfcHk0lilm5An46Ln1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFajs7jI&md5=ffccb48b9e5c7efd7c680585a0665368</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1080%2F10286020.2017.1373100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10286020.2017.1373100%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DS.%2BQ.%26aulast%3DFan%26aufirst%3DY.%2BY.%26aulast%3DXu%26aufirst%3DC.%2BH.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DG.%2BW.%26aulast%3DYue%26aufirst%3DJ.%2BM.%26atitle%3DCytotoxic%25208%252C9-seco-ent-kaurane%2520diterpenoids%2520from%2520Croton%2520kongensis%26jtitle%3DJ.%2520Asian%2520Nat.%2520Prod.%2520Res.%26date%3D2018%26volume%3D20%26spage%3D920%26epage%3D927%26doi%3D10.1080%2F10286020.2017.1373100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Z.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span> <span> </span><span class="NLM_article-title">ent-Kaurane Diterpenoids from <i>Euphorbia wangii</i></span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">811</span>– <span class="NLM_lpage">816</span>, <span class="refDoi"> DOI: 10.1021/np50108a019</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np50108a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADyaK2cXlslGiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1994&pages=811-816&author=Z.-J.+Jiaauthor=J.-G.+Shiauthor=L.+Yang&title=ent-Kaurane+Diterpenoids+from+Euphorbia+wangii&doi=10.1021%2Fnp50108a019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Ent-kaurane diterpenoids from Euphorbia wangii</span></div><div class="casAuthors">Jia, Zhong-Jian; Shi, Jian-Gong; Yang, Li</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">811-16</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    </div><div class="casAbstract">Four new diterpenoids having the ent-kaurane skeleton, euphoranginol A 11-acetate, euphoranginol B (I), euphoranginol C (II, R = OH; R1 = H), and euphoranginone D II (RR1 = O), together with a known compd. ent-kaur-16-en-3β-ol, were isolated from the whole plant of Euphorbia wangii.  Their structures were elucidated by spectroscopic methods and chem. transformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptwgxY-u5okrVg90H21EOLACvtfcHk0lilm5An46Ln1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlslGiur4%253D&md5=d8e6e6e546c1c0db0809040f6080fe33</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fnp50108a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp50108a019%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DZ.-J.%26aulast%3DShi%26aufirst%3DJ.-G.%26aulast%3DYang%26aufirst%3DL.%26atitle%3Dent-Kaurane%2520Diterpenoids%2520from%2520Euphorbia%2520wangii%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1994%26volume%3D57%26spage%3D811%26epage%3D816%26doi%3D10.1021%2Fnp50108a019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mu, S.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X.-J.</span></span> <span> </span><span class="NLM_article-title">Study on chemical constituents of <i>Euphorbia helioscopia</i> and their antitumor activities</span>. <i>ZhongYaoCai</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1092</span>– <span class="NLM_lpage">1096</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=24417144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC2cXks1ejtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2013&pages=1092-1096&author=S.-Z.+Muauthor=S.+Shangauthor=C.+Yanauthor=F.-M.+Yangauthor=X.-J.+Hao&title=Study+on+chemical+constituents+of+Euphorbia+helioscopia+and+their+antitumor+activities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical constituents of Euphorbia helioscopia and their antitumor activities</span></div><div class="casAuthors">Mu, Shu-zhen; Shang, Shang; Yan, Chen; Yang, Fu-mei; Hao, Xiao-jiang</div><div class="citationInfo"><span class="NLM_cas:title">Zhongyaocai</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1092-1096</span>CODEN:
                <span class="NLM_cas:coden">ZHONAR</span>;
        ISSN:<span class="NLM_cas:issn">1001-4454</span>.
    
            (<span class="NLM_cas:orgname">Guojia Shipin Yaopin Jiandu Guanliju, Zhongyaocai Xinxi Zhongxinzhan</span>)
        </div><div class="casAbstract">The chem. constituents of Euphorbia helioscopia and their antitumor activities were investigated.  Normal phase silica gel, RP-18 silica gel and Sephadex LH-20 column chromatogs. combined with recrystn. were used to isolate and purify the constituents.  Their structures were identified by spectroscopic methods, including 1H-NMR, 13C-NMR, ESI-MS and EI-MS.  And the antitumor activities of some of chem. constituents in vitro were detected by sulforhodamine B protein staining.  Nine compds. were isolated and their structures were identified as euphohelioscopin A (1), euphoscopin (2), 9,19-cyclolanost-23E-ene-3,25-diol (3), euphoscopin C (4), euphornin A (5), euphoheliosnoid A (6), ent-kaurane-3-oxo-16β,17-diol (7), 9,19-cyclolanost-25-ene-3β,22-diol (8) and helioscopinolide A (9).  Compd. 9 showed effect on inhibiting the cell proliferations of MCF-7 cell line.  Compds. 3, 7, 8 and 9 are obtained from this plant for the first time, and compd. 9 shows the potential antitumor activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnUqcjhAPUlbVg90H21EOLACvtfcHk0lilm5An46Ln1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXks1ejtrc%253D&md5=99f8a889fc8adf4767d69bd343210418</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMu%26aufirst%3DS.-Z.%26aulast%3DShang%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DF.-M.%26aulast%3DHao%26aufirst%3DX.-J.%26atitle%3DStudy%2520on%2520chemical%2520constituents%2520of%2520Euphorbia%2520helioscopia%2520and%2520their%2520antitumor%2520activities%26jtitle%3DZhongYaoCai%26date%3D2013%26volume%3D36%26spage%3D1092%26epage%3D1096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dräger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeske, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunst, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, H. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsichritzis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirschning, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakupovicldl, J.</span></span> <span> </span><span class="NLM_article-title">Tonantzitlolone and other diterpenes from <i>Stillingia sanguinolenta</i></span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2007</i></span>,  <span class="NLM_fpage">5020</span>– <span class="NLM_lpage">5026</span>, <span class="refDoi"> DOI: 10.1002/ejoc.200700184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1002%2Fejoc.200700184" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2007&publication_year=2007&pages=5020-5026&author=G.+Dr%C3%A4gerauthor=F.+Jeskeauthor=E.+Kunstauthor=E.+G.+Lopezauthor=H.+V.+Sanchezauthor=F.+Tsichritzisauthor=A.+Kirschningauthor=J.+Jakupovicldl&title=Tonantzitlolone+and+other+diterpenes+from+Stillingia+sanguinolenta&doi=10.1002%2Fejoc.200700184"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fejoc.200700184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.200700184%26sid%3Dliteratum%253Aachs%26aulast%3DDr%25C3%25A4ger%26aufirst%3DG.%26aulast%3DJeske%26aufirst%3DF.%26aulast%3DKunst%26aufirst%3DE.%26aulast%3DLopez%26aufirst%3DE.%2BG.%26aulast%3DSanchez%26aufirst%3DH.%2BV.%26aulast%3DTsichritzis%26aufirst%3DF.%26aulast%3DKirschning%26aufirst%3DA.%26aulast%3DJakupovicldl%26aufirst%3DJ.%26atitle%3DTonantzitlolone%2520and%2520other%2520diterpenes%2520from%2520Stillingia%2520sanguinolenta%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2007%26volume%3D2007%26spage%3D5020%26epage%3D5026%26doi%3D10.1002%2Fejoc.200700184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span> <span> </span><span class="NLM_article-title">Three new, 1-oxygenated ent-8,9-secokaurane diterpenes from <i>Croton kongensis</i></span>. <i>Helv. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1002/hlca.200690057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1002%2Fhlca.200690057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsVWjs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2006&pages=537-541&author=W.+Chenauthor=X.+D.+Yangauthor=J.+F.+Zhaoauthor=J.+H.+Yangauthor=H.+B.+Zhangauthor=Z.+Y.+Liauthor=L.+Li&title=Three+new%2C+1-oxygenated+ent-8%2C9-secokaurane+diterpenes+from+Croton+kongensis&doi=10.1002%2Fhlca.200690057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Three new, 1-oxygenated ent-8,9-secokaurane diterpenes from Croton kongensis</span></div><div class="casAuthors">Chen, Wei; Yang, Xiao-Dong; Zhao, Jing-Feng; Yang, Jing-Hua; Zhang, Hong-Bin; Li, Zi-Yan; Li, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Helvetica Chimica Acta</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">537-541</span>CODEN:
                <span class="NLM_cas:coden">HCACAV</span>;
        ISSN:<span class="NLM_cas:issn">0018-019X</span>.
    
            (<span class="NLM_cas:orgname">Verlag Helvetica Chimica Acta</span>)
        </div><div class="casAbstract">Three new ent-8,9-secokaurane diterpenes, kongensins A-C (I-III), were isolated from the aerial parts of Croton kongensis, together with two known compds., rabdoumbrosanin and (7α,14β)-7,14-dihydroxy-ent-kaur-16-en-15-one.  The structures of the new compds. were elucidated by HR-MS as well as in-depth 1D- and 2D-NMR analyses.  Kongensins A-C showed an unusual oxygenation pattern, with an AcO or OH group at C(1), in combination with a Δ8(14) unsatn. (kongensin A) or an 8,14-epoxide function (kongensin B,C).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8NQ0EPssNqLVg90H21EOLACvtfcHk0lic9hJceZVjeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsVWjs7w%253D&md5=e244f2bd03bb9b0fe545100bb52c430f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fhlca.200690057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhlca.200690057%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DX.%2BD.%26aulast%3DZhao%26aufirst%3DJ.%2BF.%26aulast%3DYang%26aufirst%3DJ.%2BH.%26aulast%3DZhang%26aufirst%3DH.%2BB.%26aulast%3DLi%26aufirst%3DZ.%2BY.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DThree%2520new%252C%25201-oxygenated%2520ent-8%252C9-secokaurane%2520diterpenes%2520from%2520Croton%2520kongensis%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D2006%26volume%3D89%26spage%3D537%26epage%3D541%26doi%3D10.1002%2Fhlca.200690057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span> <span> </span><span class="NLM_article-title">Ent-kaurane diterpenes and phenolic compounds from <i>Croton kongensis</i> (Euphorbiaceae)</span>. <i>Biochem. Syst. Ecol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1016/j.bse.2009.03.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2Fj.bse.2009.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtlyisbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=237-240&author=X.+D.+Yangauthor=W.+Chenauthor=J.+F.+Zhaoauthor=L.+J.+Yangauthor=H.+B.+Zhangauthor=L.+Li&title=Ent-kaurane+diterpenes+and+phenolic+compounds+from+Croton+kongensis+%28Euphorbiaceae%29&doi=10.1016%2Fj.bse.2009.03.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Ent-kaurane diterpenes and phenolic compounds from Croton kongensis (Euphorbiaceae)</span></div><div class="casAuthors">Yang, Xiao-Dong; Chen, Wei; Zhao, Jing-Feng; Yang, Li-Juan; Zhang, Hong-Bin; Li, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Systematics and Ecology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">237-240</span>CODEN:
                <span class="NLM_cas:coden">BSECBU</span>;
        ISSN:<span class="NLM_cas:issn">0305-1978</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A new ent-kaurene diterpene, kongensin F (I), three known ent-kaurane diterpenes, and five known phenolics were isolated from leaves of Croton kongensis.  Kongensin F was characterized by it's mass and NMR spectra.  The known ent-kaurane diterpenes isolated were: rabdoumbrosanin, ent-(7α,14β)-7,14-dihydroxy-ent-kaur-16-en-15-one, and ent-7β-hydroxy-15-oxokaur-16-en-18-yl acetate.  The phenolics isolated were: vanillin, vanillic acid, 4-hydroxybenzoic acid, 4-Methoxybenzoic acid and 2,6-ditert-butyl-4-methyl-phenol.  The chemotaxonomic significance of these results were discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod-_5X5bV6IbVg90H21EOLACvtfcHk0lic9hJceZVjeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtlyisbw%253D&md5=32fba7c9d1791c64a0a9d921974f2d5a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bse.2009.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bse.2009.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%2BD.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DJ.%2BF.%26aulast%3DYang%26aufirst%3DL.%2BJ.%26aulast%3DZhang%26aufirst%3DH.%2BB.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DEnt-kaurane%2520diterpenes%2520and%2520phenolic%2520compounds%2520from%2520Croton%2520kongensis%2520%2528Euphorbiaceae%2529%26jtitle%3DBiochem.%2520Syst.%2520Ecol.%26date%3D2009%26volume%3D37%26spage%3D237%26epage%3D240%26doi%3D10.1016%2Fj.bse.2009.03.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riaz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zubair, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samiullah, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarfraz, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabeen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sultana, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sultana, S.</span></span> <span> </span><span class="NLM_article-title">Eriocalyxin B induces apoptosis in human triple negative breast cancer cells via inhibiting STAT3 activation and mitochondrial dysfunction</span>. <i>Pak. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">2843</span>– <span class="NLM_lpage">2848</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=32024623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhslGktLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2019&pages=2843-2848&author=A.+Riazauthor=A.+Rasulauthor=G.+Hussainauthor=M.+Zubairauthor=K.+Samiullahauthor=I.+Sarfrazauthor=M.+Masoodauthor=F.+Jabeenauthor=T.+Sultanaauthor=S.+Sultana&title=Eriocalyxin+B+induces+apoptosis+in+human+triple+negative+breast+cancer+cells+via+inhibiting+STAT3+activation+and+mitochondrial+dysfunction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Eriocalyxin B induces apoptosis in human triple negative breast cancer cells via inhibiting STAT3 activation and mitochondrial dysfunction</span></div><div class="casAuthors">Riaz, Anunara; Rasul, Azhar; Hussain, Gluilam; Zubair, Muhammad; Samiullah, Khizar; Sarfraz, Iqra; Masood, Muqaddas; Jabeen, Farhat; Sultana, Tayyaba; Sultana, Salma</div><div class="citationInfo"><span class="NLM_cas:title">Pakistan Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6, Suppl.</span>),
    <span class="NLM_cas:pages">2843-2848</span>CODEN:
                <span class="NLM_cas:coden">PJPSEN</span>;
        ISSN:<span class="NLM_cas:issn">1011-601X</span>.
    
            (<span class="NLM_cas:orgname">University of Karachi, Faculty of Pharmacy</span>)
        </div><div class="casAbstract">Eriocalyxin B (EriB), a potent ent-kaurene extd. from Isodon eriocalyx, has turned up as novel anti-cancer agent during recent years against a range of cancer types.  TNBC (Triple neg. breast cancer) is highly aggressive breast cancer, which is resistant towards current therapeutics due to absence of drug targets.  Here, we have probed the mol. mechanism of EriB-induced apoptosis in TNBC (MDA-MB231) cells to check whether its anticancer activity is mediated by modulation of STAT3 and NF-κB.  EriB induced apoptosis in MDA-MB231 cells via inhibiting NF-κBp65, STAT3 phosphorylation, increasing Bax/Bcl-2 ratio, MMP dissipation, and activation ofcaspase-3.  These results provide a rationale for further in vivo investigations on EriB. which might also prove to be a potential drug candidate for developing novel therapeutics against TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAvUNGZ094x7Vg90H21EOLACvtfcHk0lhXTBxC0AFSog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhslGktLbM&md5=e603620b85e02c795fd9dec5c07e04df</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiaz%26aufirst%3DA.%26aulast%3DRasul%26aufirst%3DA.%26aulast%3DHussain%26aufirst%3DG.%26aulast%3DZubair%26aufirst%3DM.%26aulast%3DSamiullah%26aufirst%3DK.%26aulast%3DSarfraz%26aufirst%3DI.%26aulast%3DMasood%26aufirst%3DM.%26aulast%3DJabeen%26aufirst%3DF.%26aulast%3DSultana%26aufirst%3DT.%26aulast%3DSultana%26aufirst%3DS.%26atitle%3DEriocalyxin%2520B%2520induces%2520apoptosis%2520in%2520human%2520triple%2520negative%2520breast%2520cancer%2520cells%2520via%2520inhibiting%2520STAT3%2520activation%2520and%2520mitochondrial%2520dysfunction%26jtitle%3DPak.%2520J.%2520Pharm.%2520Sci.%26date%3D2019%26volume%3D32%26spage%3D2843%26epage%3D2848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">Identification of a Potent Oridonin Analogue for Treatment of Triple-Negative Breast Cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">8157</span>– <span class="NLM_lpage">8178</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00408</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00408" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtlSisLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=8157-8178&author=H.+Yaoauthor=S.+Xieauthor=X.+Maauthor=J.+Liuauthor=H.+Wuauthor=A.+Linauthor=H.+Yaoauthor=D.+Liauthor=S.+Xuauthor=D.+H.+Yangauthor=Z.+S.+Chenauthor=J.+Xu&title=Identification+of+a+Potent+Oridonin+Analogue+for+Treatment+of+Triple-Negative+Breast+Cancer&doi=10.1021%2Facs.jmedchem.0c00408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Potent Oridonin Analogue for Treatment of Triple-Negative Breast Cancer</span></div><div class="casAuthors">Yao, Hong; Xie, Shaowen; Ma, Xiaoqian; Liu, Junkai; Wu, Hongyu; Lin, Aijun; Yao, Hequan; Li, Dahong; Xu, Shengtao; Yang, Dong-Hua; Chen, Zhe-Sheng; Xu, Jinyi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8157-8178</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Triple-neg. breast cancer (TNBC) is one of the most highly invasive and metastatic breast cancers without safe and effective therapeutic drugs.  The natural product oridonin is reported to be a potential anti-TNBC agent.  However, its moderate activity and complex structure hampered its clin. application.  In this study, the novel oridonin analogs were first identified by removal of multiple hydroxyl groups and structural simplification of oridonin.  The representative analog 20 exhibited potent anticancer effects.  Further structural modification on 20 generated the most potent deriv. 56(I), which possessed 120-fold more potent antiproliferative activity than oridonin in the TNBC cell line HCC1806.  Importantly, compd. 56 exhibited more potent anticancer activity than paclitaxel in TNBC xenograft nude mice.  Moreover, 56 could attenuate the expression of MMP-2, MMP-9, p-FAK, and integrin β1 to inhibit TNBC cell metastasis.  All results suggest that compd. 56 may warrant further investigation as a promising candidate agent for the treatment of TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGnnn_26w0F7Vg90H21EOLACvtfcHk0lhXTBxC0AFSog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtlSisLvO&md5=b4e9b8257dbdfe0873608d2258e8f2aa</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00408%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DH.%26aulast%3DXie%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DYao%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DD.%2BH.%26aulast%3DChen%26aufirst%3DZ.%2BS.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520a%2520Potent%2520Oridonin%2520Analogue%2520for%2520Treatment%2520of%2520Triple-Negative%2520Breast%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D8157%26epage%3D8178%26doi%3D10.1021%2Facs.jmedchem.0c00408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Candas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eldridge, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wachsmann-Hogiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chromy, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nantajit, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duru, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finkel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. J.</span></span> <span> </span><span class="NLM_article-title">Cyclin B1/Cdk1 coordinates mitochondrial respiration for cell-cycle G2/M progression</span>. <i>Dev. Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1016/j.devcel.2014.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2Fj.devcel.2014.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=24746669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsVCht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2014&pages=217-232&author=Z.+Wangauthor=M.+Fanauthor=D.+Candasauthor=T.+Q.+Zhangauthor=L.+Qinauthor=A.+Eldridgeauthor=S.+Wachsmann-Hogiuauthor=K.+M.+Ahmedauthor=B.+A.+Chromyauthor=D.+Nantajitauthor=N.+Duruauthor=F.+Heauthor=M.+Chenauthor=T.+Finkelauthor=L.+S.+Weinsteinauthor=J.+J.+Li&title=Cyclin+B1%2FCdk1+coordinates+mitochondrial+respiration+for+cell-cycle+G2%2FM+progression&doi=10.1016%2Fj.devcel.2014.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin B1/Cdk1 Coordinates Mitochondrial Respiration for Cell-Cycle G2/M Progression</span></div><div class="casAuthors">Wang, Zhaoqing; Fan, Ming; Candas, Demet; Zhang, Tie-Qiao; Qin, Lili; Eldridge, Angela; Wachsmann-Hogiu, Sebastian; Ahmed, Kazi M.; Chromy, Brett A.; Nantajit, Danupon; Duru, Nadire; He, Fuchu; Chen, Min; Finkel, Toren; Weinstein, Lee S.; Li, Jian Jian</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">217-232</span>CODEN:
                <span class="NLM_cas:coden">DCEEBE</span>;
        ISSN:<span class="NLM_cas:issn">1534-5807</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A substantial amt. of mitochondrial energy is required for cell-cycle progression.  The mechanisms underlying the coordination of the mitochondrial respiration with cell-cycle progression, esp. the G2/M transition, remain to be elucidated.  Here, we show that a fraction of cyclin B1/Cdk1 proteins localizes to the matrix of mitochondria and phosphorylates a cluster of mitochondrial proteins, including the complex I (CI) subunits in the respiratory chain.  Cyclin B1/Cdk1-mediated CI phosphorylation enhances CI activity, whereas deficiency of such phosphorylation in each of the relevant CI subunits results in impairment of CI function.  Mitochondria-targeted cyclin B1/Cdk1 increases mitochondrial respiration with enhanced oxygen consumption and ATP generation, which provides cells with efficient bioenergy for G2/M transition and shortens overall cell-cycle time.  Thus, cyclin B1/Cdk1-mediated phosphorylation of mitochondrial substrates allows cells to sense and respond to increased energy demand for G2/M transition and, subsequently, to upregulate mitochondrial respiration for successful cell-cycle progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8A5dc209Mm7Vg90H21EOLACvtfcHk0liUq3vc5p73TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsVCht7Y%253D&md5=2f95e9ad8d22502a7ce640f02fc0ecea</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.devcel.2014.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.devcel.2014.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DM.%26aulast%3DCandas%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DT.%2BQ.%26aulast%3DQin%26aufirst%3DL.%26aulast%3DEldridge%26aufirst%3DA.%26aulast%3DWachsmann-Hogiu%26aufirst%3DS.%26aulast%3DAhmed%26aufirst%3DK.%2BM.%26aulast%3DChromy%26aufirst%3DB.%2BA.%26aulast%3DNantajit%26aufirst%3DD.%26aulast%3DDuru%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DFinkel%26aufirst%3DT.%26aulast%3DWeinstein%26aufirst%3DL.%2BS.%26aulast%3DLi%26aufirst%3DJ.%2BJ.%26atitle%3DCyclin%2520B1%252FCdk1%2520coordinates%2520mitochondrial%2520respiration%2520for%2520cell-cycle%2520G2%252FM%2520progression%26jtitle%3DDev.%2520Cell%26date%3D2014%26volume%3D29%26spage%3D217%26epage%3D232%26doi%3D10.1016%2Fj.devcel.2014.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quaas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engeland, K.</span></span> <span> </span><span class="NLM_article-title">The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1093/nar/gkv927</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1093%2Fnar%2Fgkv927" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=26384566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvFCktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=164-174&author=M.+Fischerauthor=M.+Quaasauthor=L.+Steinerauthor=K.+Engeland&title=The+p53-p21-DREAM-CDE%2FCHR+pathway+regulates+G2%2FM+cell+cycle+genes&doi=10.1093%2Fnar%2Fgkv927"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes</span></div><div class="casAuthors">Fischer, Martin; Quaas, Marianne; Steiner, Lydia; Engeland, Kurt</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">164-174</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The tumor suppressor p53 functions predominantly as a transcription factor by activating and downregulating gene expression, leading to cell cycle arrest or apoptosis.  P53 was shown to indirectly repress transcription of the CCNB2, KIF23 and PLK4 cell cycle genes through the recently discovered p53-p21-DREAM-CDE/CHR pathway.  However, it remained unclear whether this pathway is commonly used.  Here, we identify genes regulated by p53 through this pathway in a genome-wide computational approach.  The bioinformatic anal. is based on genome-wide DREAM complex binding data, p53-dependent mRNA expression data and a genome-wide definition of phylogenetically conserved CHR promoter elements.  We find 210 target genes that are expected to be regulated by the p53-p21-DREAM-CDE/CHR pathway.  The target gene list was verified by detailed anal. of p53-dependent repression of the cell cycle genes B-MYB (MYBL2), BUB1, CCNA2, CCNB1, CHEK2, MELK, POLD1, RAD18 and RAD54L.  Most of the 210 target genes are essential regulators of G2 phase and mitosis.  Thus, downregulation of these genes through the p53-p21-DREAM-CDE/CHR pathway appears to be a principal mechanism for G2/M cell cycle arrest by p53.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolH70n7R6cHbVg90H21EOLACvtfcHk0liUq3vc5p73TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvFCktrk%253D&md5=6a5999c8a37fb9fd77832aeb9a3cd60a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkv927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkv927%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DM.%26aulast%3DQuaas%26aufirst%3DM.%26aulast%3DSteiner%26aufirst%3DL.%26aulast%3DEngeland%26aufirst%3DK.%26atitle%3DThe%2520p53-p21-DREAM-CDE%252FCHR%2520pathway%2520regulates%2520G2%252FM%2520cell%2520cycle%2520genes%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2016%26volume%3D44%26spage%3D164%26epage%3D174%26doi%3D10.1093%2Fnar%2Fgkv927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surman, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diggs, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurusamy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLoughlin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drake, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feingold, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wangsa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wangsa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ried, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souza, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrump, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor
Ripley, R.</span></span> <span> </span><span class="NLM_article-title">Bile acid-induced ″Minority MOMP″ promotes esophageal carcinogenesis while maintaining apoptotic resistance via Mcl-1</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">877</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/s41388-019-1029-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1038%2Fs41388-019-1029-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=31570787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVOlur7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2020&pages=877-890&author=Y.+Xuauthor=D.+R.+Surmanauthor=L.+Diggsauthor=S.+Xiauthor=S.+Gaoauthor=D.+Gurusamyauthor=K.+McLoughlinauthor=J.+Drakeauthor=P.+Feingoldauthor=K.+Brownauthor=D.+Wangsaauthor=D.+Wangsaauthor=X.+Zhangauthor=T.+Riedauthor=J.+L.+Davisauthor=J.+Hernandezauthor=C.+D.+Hoangauthor=R.+F.+Souzaauthor=D.+S.+Schrumpauthor=R.+Taylor%0ARipley&title=Bile+acid-induced+%E2%80%B3Minority+MOMP%E2%80%B3+promotes+esophageal+carcinogenesis+while+maintaining+apoptotic+resistance+via+Mcl-1&doi=10.1038%2Fs41388-019-1029-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Bile acid-induced "Minority MOMP" promotes esophageal carcinogenesis while maintaining apoptotic resistance via Mcl-1</span></div><div class="casAuthors">Xu, Yuan; Surman, Deborah R.; Diggs, Laurence; Xi, Sichuan; Gao, Shaojian; Gurusamy, Devikala; McLoughlin, Kaitlin; Drake, Justin; Feingold, Paul; Brown, Kate; Wangsa, Danny; Wangsa, Darawalee; Zhang, Xi; Ried, Thomas; Davis, Jeremy L.; Hernandez, Jonathan; Hoang, Chuong; Souza, Rhonda F.; Schrump, David S.; Taylor Ripley, R.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">877-890</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Barrett's esophagus (BE) is assocd. with reflux and is implicated the development of esophageal adenocarcinoma (EAC).  Apoptosis induces cell death through mitochondrial outer membrane permeabilization (MOMP), which is considered an irreversible step in apoptosis.  Activation of MOMP to levels that fail to reach the apoptotic threshold may paradoxically promote cancer - a phenomenon called "Minority MOMP.".  We asked whether reflux-induced esophageal carcinogenesis occurred via minority MOMP and whether compensatory resistance mechanisms prevented cell death during this process.  We exposed preneoplastic, hTERT-immortalized Barrett's cell, CP-C and CP-A, to the oncogenic bile acid, deoxycholic acid (DCA), for 1 yr.  Induction of minority MOMP was tested via comet assay, CyQuant, annexin V, JC-1, cytochrome C subcellular localization, caspase 3 activation, and immunoblots.  We used bcl-2 homol. domain-3 (BH3) profiling to test the mitochondrial apoptotic threshold.  One-year exposure of Barrett's cells to DCA induced a malignant phenotype noted by clone and tumor formation.  DCA promoted minority MOMP noted by minimal release of cytochrome C and limited caspase 3 activation, which resulted in DNA damage without apoptosis.  Upregulation of the antiapoptotic protein, Mcl-1, ROS generation, and NF-κB activation occurred in conjunction with minority MOMP.  Inhibition of ROS blocked minority MOMP and Mcl-1 upregulation.  Knockdown of Mcl-1 shifted minority MOMP to complete MOMP as noted by dynamic BH3 profiling and increased apoptosis.  Minority MOMP contributes to DCA induced carcinogenesis in preneoplastic BE.  Mcl-1 provided a balance within the mitochondria that induced resistance complete MOMP and cell death.  Targeting Mcl-1 may be a therapeutic strategy in EAC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj1vg15qLl6LVg90H21EOLACvtfcHk0lhUaEI1HEKRxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVOlur7O&md5=25c8ad40b5c92a8e792139ff65057e74</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fs41388-019-1029-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41388-019-1029-6%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26aulast%3DSurman%26aufirst%3DD.%2BR.%26aulast%3DDiggs%26aufirst%3DL.%26aulast%3DXi%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DS.%26aulast%3DGurusamy%26aufirst%3DD.%26aulast%3DMcLoughlin%26aufirst%3DK.%26aulast%3DDrake%26aufirst%3DJ.%26aulast%3DFeingold%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DK.%26aulast%3DWangsa%26aufirst%3DD.%26aulast%3DWangsa%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DRied%26aufirst%3DT.%26aulast%3DDavis%26aufirst%3DJ.%2BL.%26aulast%3DHernandez%26aufirst%3DJ.%26aulast%3DHoang%26aufirst%3DC.%2BD.%26aulast%3DSouza%26aufirst%3DR.%2BF.%26aulast%3DSchrump%26aufirst%3DD.%2BS.%26aulast%3DTaylor%2BRipley%26aufirst%3DR.%26atitle%3DBile%2520acid-induced%2520%25E2%2580%25B3Minority%2520MOMP%25E2%2580%25B3%2520promotes%2520esophageal%2520carcinogenesis%2520while%2520maintaining%2520apoptotic%2520resistance%2520via%2520Mcl-1%26jtitle%3DOncogene%26date%3D2020%26volume%3D39%26spage%3D877%26epage%3D890%26doi%3D10.1038%2Fs41388-019-1029-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span> <span> </span><span class="NLM_article-title">Hypocrellin A-based photodynamic action induces apoptosis in A549 cells through ROS-mediated mitochondrial signaling pathway</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">293</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2018.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2Fj.apsb.2018.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=30972277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A280%3ADC%252BB3M%252FktFKktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=279-293&author=S.+Qiauthor=L.+Guoauthor=S.+Yanauthor=R.+J.+Leeauthor=S.+Yuauthor=S.+Chen&title=Hypocrellin+A-based+photodynamic+action+induces+apoptosis+in+A549+cells+through+ROS-mediated+mitochondrial+signaling+pathway&doi=10.1016%2Fj.apsb.2018.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Hypocrellin A-based photodynamic action induces apoptosis in A549 cells through ROS-mediated mitochondrial signaling pathway</span></div><div class="casAuthors">Qi Shanshan; Guo Lingyuan; Yan Shuzhen; Chen Shuanglin; Qi Shanshan; Lee Robert J; Yu Shuqin</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">279-293</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">Over recent decades, many studies have reported that hypocrellin A (HA) can eliminate cancer cells with proper irradiation in several cancer cell lines.  However, the precise molecular mechanism underlying its anticancer effect has not been fully defined.  HA-mediated cytotoxicity and apoptosis in human lung adenocarcinoma A549 cells were evaluated after photodynamic therapy (PDT).  A temporal quantitative proteomics approach by isobaric tag for relative and absolute quantitation (iTRAQ) 2D liquid chromatography with tandem mass spectrometric (LC-MS/MS) was introduced to help clarify molecular cytotoxic mechanisms and identify candidate targets of HA-induced apoptotic cell death.  Specific caspase inhibitors were used to further elucidate the molecular pathway underlying apoptosis in PDT-treated A549 cells.  Finally, down-stream apoptosis-related protein was evaluated.  Apoptosis induced by HA was associated with cell shrinkage, externalization of cell membrane phosphatidylserine, DNA fragmentation, and mitochondrial disruption, which were preceded by increased intracellular reactive oxygen species (ROS) generations.  Further studies showed that PDT treatment with 0.08 μmol/L HA resulted in mitochondrial disruption, pronounced release of cytochrome c, and activation of caspase-3, -9, and -7.  Together, HA may be a possible therapeutic agent directed toward mitochondria and a promising photodynamic anticancer candidate for further evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSB60VxKgx5l6-9TkgmBqTqfW6udTcc2eaem55XRJWD1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M%252FktFKktg%253D%253D&md5=b7d40109224eb4b6bc534625aec24fd0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2018.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2018.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DS.%26atitle%3DHypocrellin%2520A-based%2520photodynamic%2520action%2520induces%2520apoptosis%2520in%2520A549%2520cells%2520through%2520ROS-mediated%2520mitochondrial%2520signaling%2520pathway%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2019%26volume%3D9%26spage%3D279%26epage%3D293%26doi%3D10.1016%2Fj.apsb.2018.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Denton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span> <span> </span><span class="NLM_article-title">Autophagy-dependent cell death</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">616</span>, <span class="refDoi"> DOI: 10.1038/s41418-018-0252-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1038%2Fs41418-018-0252-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=30568239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFKrt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=605-616&author=D.+Dentonauthor=S.+Kumar&title=Autophagy-dependent+cell+death&doi=10.1038%2Fs41418-018-0252-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy-dependent cell death</span></div><div class="casAuthors">Denton, Donna; Kumar, Sharad</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">605-616</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Autophagy-dependent cell death can be defined as cell demise that has a strict requirement of autophagy.  Although autophagy often accompanies cell death following many toxic insults, the requirement of autophagic machinery for cell death execution, as established through specific genetic or chem. inhibition of the process, is highly contextual.  During animal development, perhaps the best validated model of autophagy-dependent cell death is the degrdn. of the larval midgut during larval-pupal metamorphosis, where a no. of key autophagy genes are required for the removal of the tissues.  Surprisingly though, even in the midgut, not all of the canonical autophagic machinery appears to be required.  In other organisms and cancer cells many variations of autophagy-dependent cell death are apparent, pointing to the lack of a unifying cell death pathway.  It is thus possible that components of the autophagy machinery are selectively utilized or repurposed for this type of cell death.  In this review, we discuss examples of cell death that utilize autophagy machinery (or part thereof), the current knowledge of the complexity of autophagy-dependent cellular demise and the potential mechanisms and regulatory pathways involved in such cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8KGUmkO-q37Vg90H21EOLACvtfcHk0lhi2os2gaLLxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFKrt77K&md5=ebf1b6451cb66f3fb0a9c2b96254458e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fs41418-018-0252-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41418-018-0252-y%26sid%3Dliteratum%253Aachs%26aulast%3DDenton%26aufirst%3DD.%26aulast%3DKumar%26aufirst%3DS.%26atitle%3DAutophagy-dependent%2520cell%2520death%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2019%26volume%3D26%26spage%3D605%26epage%3D616%26doi%3D10.1038%2Fs41418-018-0252-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kocaturk, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkoc, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kig, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayraktar, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gozuacik, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutlu, O.</span></span> <span> </span><span class="NLM_article-title">Autophagy as a molecular target for cancer treatment</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">116</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2019.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2Fj.ejps.2019.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=30981885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC1MXoslWkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2019&pages=116-137&author=N.+M.+Kocaturkauthor=Y.+Akkocauthor=C.+Kigauthor=O.+Bayraktarauthor=D.+Gozuacikauthor=O.+Kutlu&title=Autophagy+as+a+molecular+target+for+cancer+treatment&doi=10.1016%2Fj.ejps.2019.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy as a molecular target for cancer treatment</span></div><div class="casAuthors">Kocaturk, Nur Mehpare; Akkoc, Yunus; Kig, Cenk; Bayraktar, Oznur; Gozuacik, Devrim; Kutlu, Ozlem</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">116-137</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Autophagy is an evolutionarily conserved catabolic mechanism, by which eukaryotic cells recycle or degrades internal constituents through membrane-trafficking pathway.  Thus, autophagy provides the cells with a sustainable source of biomols. and energy for the maintenance of homeostasis under stressful conditions such as tumor microenvironment.  Recent findings revealed a close relationship between autophagy and malignant transformation.  However, due to the complex dual role of autophagy in tumor survival or cell death, efforts to develop efficient treatment strategies targeting the autophagy/cancer relation have largely been unsuccessful.  Here we review the two-faced role of autophagy in cancer as a tumor suppressor or as a pro-oncogenic mechanism.  In this sense, we also review the shared regulatory pathways that play a role in autophagy and malignant transformation.  Finally, anti-cancer therapeutic agents used as either inhibitors or inducers of autophagy have been discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9c81uabGR9LVg90H21EOLACvtfcHk0lgh3d5Ja1Ipzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXoslWkt74%253D&md5=3b1ca71f8bb483d3372d485b54ea1386</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2019.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2019.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKocaturk%26aufirst%3DN.%2BM.%26aulast%3DAkkoc%26aufirst%3DY.%26aulast%3DKig%26aufirst%3DC.%26aulast%3DBayraktar%26aufirst%3DO.%26aulast%3DGozuacik%26aufirst%3DD.%26aulast%3DKutlu%26aufirst%3DO.%26atitle%3DAutophagy%2520as%2520a%2520molecular%2520target%2520for%2520cancer%2520treatment%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2019%26volume%3D134%26spage%3D116%26epage%3D137%26doi%3D10.1016%2Fj.ejps.2019.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guntuku, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gangasani, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thummuri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borkar, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manavathi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragampeta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaidya, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sistla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vegi, N. G. M.</span></span> <span> </span><span class="NLM_article-title">IITZ-01, a novel potent lysosomotropic autophagy inhibitor, has single-agent antitumor efficacy in triple-negative breast cancer in vitro and in vivo</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">595</span>, <span class="refDoi"> DOI: 10.1038/s41388-018-0446-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1038%2Fs41388-018-0446-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=30166591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Wkt7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2019&pages=581-595&author=L.+Guntukuauthor=J.+K.+Gangasaniauthor=D.+Thummuriauthor=R.+M.+Borkarauthor=B.+Manavathiauthor=S.+Ragampetaauthor=J.+R.+Vaidyaauthor=R.+Sistlaauthor=N.+G.+M.+Vegi&title=IITZ-01%2C+a+novel+potent+lysosomotropic+autophagy+inhibitor%2C+has+single-agent+antitumor+efficacy+in+triple-negative+breast+cancer+in+vitro+and+in+vivo&doi=10.1038%2Fs41388-018-0446-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">IITZ-01, a novel potent lysosomotropic autophagy inhibitor, has single-agent antitumor efficacy in triple-negative breast cancer in vitro and in vivo</span></div><div class="casAuthors">Guntuku, Lalita; Gangasani, Jagadeesh Kumar; Thummuri, Dinesh; Borkar, Roshan M.; Manavathi, Bramanandam; Ragampeta, Srinivas; Vaidya, Jayathirtha Rao; Sistla, Ramakrishna; Vegi, Naidu G. M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">581-595</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Autophagy is a homeostatic process that recycles damaged organelles and long-lived proteins by delivering them in double-membrane vesicles to lysosomes for degrdn.  Autophagy has a prominent role in survival, proliferation, and resistance of tumors in metabolic and chemotherapeutic stress conditions.  Clin. trials with chloroquine-a known autophagy inhibitor-were unable to achieve complete autophagy inhibition in vivo, warranting the search for more potent autophagy inhibitors.  In a process of exploring the mechanism of action of previously identified cytotoxic s-triazine analogs, we discovered that both IITZ-01 and IITZ-02 act as potent autophagy inhibitors.  Treatment with these compds. resulted in the vacuolated appearance of cells due to their specific accumulation in lysosomes.  In addn., these basic compds. also deacidify lysosomes as evidenced by the decrease in lysotracker red staining and inhibit maturation of lysosomal enzymes leading to lysosomal dysfunction.  IITZ-01 and IITZ-02 enhance autophagosome accumulation but inhibit autophagosomal degrdn. by impairing lysosomal function, finally resulting in the inhibition of autophagy.  Interestingly, compd. IITZ-01 exhibited more than 10-fold potent autophagy inhibition along with 12- to 20-fold better cytotoxic action than CQ.  IITZ-01 and IITZ-02 also abolished mitochondrial membrane potential and triggered apoptosis through the mitochondria-mediated pathway.  Furthermore, IITZ-01 and IITZ-02 displayed potent antitumor action in vivo through autophagy inhibition and apoptosis induction in MDA-MB-231 breast cancer xenograft model with IITZ-01 exhibiting superior anticancer efficacy.  Overall, these data demonstrate that IITZ-01 is potent autophagy inhibitor with single-agent anticancer activity and awaits further preclin. development as potential anticancer therapeutic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCsXE4ORp_orVg90H21EOLACvtfcHk0lgh3d5Ja1Ipzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Wkt7fL&md5=9c57f666aa58f2719178b4e3ddcd7923</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fs41388-018-0446-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41388-018-0446-2%26sid%3Dliteratum%253Aachs%26aulast%3DGuntuku%26aufirst%3DL.%26aulast%3DGangasani%26aufirst%3DJ.%2BK.%26aulast%3DThummuri%26aufirst%3DD.%26aulast%3DBorkar%26aufirst%3DR.%2BM.%26aulast%3DManavathi%26aufirst%3DB.%26aulast%3DRagampeta%26aufirst%3DS.%26aulast%3DVaidya%26aufirst%3DJ.%2BR.%26aulast%3DSistla%26aufirst%3DR.%26aulast%3DVegi%26aufirst%3DN.%2BG.%2BM.%26atitle%3DIITZ-01%252C%2520a%2520novel%2520potent%2520lysosomotropic%2520autophagy%2520inhibitor%252C%2520has%2520single-agent%2520antitumor%2520efficacy%2520in%2520triple-negative%2520breast%2520cancer%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DOncogene%26date%3D2019%26volume%3D38%26spage%3D581%26epage%3D595%26doi%3D10.1038%2Fs41388-018-0446-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gombart, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. W.</span></span> <span> </span><span class="NLM_article-title">Chloroquine treatment of ARPE-19 cells leads to lysosome dilation and intracellular lipid accumulation: possible implications of lysosomal dysfunction in macular degeneration</span>. <i>Cell Biosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">10</span>, <span class="refDoi"> DOI: 10.1186/2045-3701-1-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1186%2F2045-3701-1-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=21711726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVWgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=10&author=P.+M.+Chenauthor=Z.+J.+Gombartauthor=J.+W.+Chen&title=Chloroquine+treatment+of+ARPE-19+cells+leads+to+lysosome+dilation+and+intracellular+lipid+accumulation%3A+possible+implications+of+lysosomal+dysfunction+in+macular+degeneration&doi=10.1186%2F2045-3701-1-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Chloroquine treatment of ARPE-19 cells leads to lysosome dilation and intracellular lipid accumulation: possible implications of lysosomal dysfunction in macular degeneration</span></div><div class="casAuthors">Chen, Patrick M.; Gombart, Zoe J.; Chen, Jefferson W.</div><div class="citationInfo"><span class="NLM_cas:title">Cell & Bioscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10</span>CODEN:
                <span class="NLM_cas:coden">CBEIB8</span>;
        ISSN:<span class="NLM_cas:issn">2045-3701</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Age-related macular degeneration (AMD) is the leading cause of vision loss in elderly people over 60.  The pathogenesis is still unclear.  It has been suggested that lysosomal stress may lead to drusen formation.  In this study, ARPE-19 cells were treated with chloroquine to inhibit lysosomal function.  Results: Chloroquine treated ARPE-19 cells demonstrate a marked increase in vacuolation and dense intracellular debris.  These are identified as chloroquine dilated lysosomes and lipid bodies with LAMP-2 and LIPIDtox co-localization resp.  Dilation is an indicator of successful lysosomal dysfunction.  Chloroquine disrupts uptake of exogenously applied rhodamine labeled dextran by these cells.  This suggests a disruption in the phagocytic pathway.  The increase in LAMP protein levels as assessed by Western Blots suggests the possible involvement in autophagy.  Oxidative stress with H2O2 does not induce vacuolation or lipid accumulation.  Conclusion: These findings suggest a role for lysosomes in AMD.  Chloroquine treatment of RPE cells may provide an in vitro model of AMD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1FM4g527b0LVg90H21EOLACvtfcHk0lijPmfbWuvtkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVWgs7c%253D&md5=00e3bc51e8a163191be1f412eaefa3e6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1186%2F2045-3701-1-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2045-3701-1-10%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%2BM.%26aulast%3DGombart%26aufirst%3DZ.%2BJ.%26aulast%3DChen%26aufirst%3DJ.%2BW.%26atitle%3DChloroquine%2520treatment%2520of%2520ARPE-19%2520cells%2520leads%2520to%2520lysosome%2520dilation%2520and%2520intracellular%2520lipid%2520accumulation%253A%2520possible%2520implications%2520of%2520lysosomal%2520dysfunction%2520in%2520macular%2520degeneration%26jtitle%3DCell%2520Biosci.%26date%3D2011%26volume%3D1%26spage%3D10%26doi%3D10.1186%2F2045-3701-1-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Florey, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gammoh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overholtzer, M.</span></span> <span> </span><span class="NLM_article-title">V-ATPase and osmotic imbalances activate endolysosomal LC3 lipidation</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.4161/15548627.2014.984277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.4161%2F15548627.2014.984277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=25484071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A280%3ADC%252BC2MzmtVynsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=88-99&author=O.+Floreyauthor=N.+Gammohauthor=S.+E.+Kimauthor=X.+Jiangauthor=M.+Overholtzer&title=V-ATPase+and+osmotic+imbalances+activate+endolysosomal+LC3+lipidation&doi=10.4161%2F15548627.2014.984277"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">V-ATPase and osmotic imbalances activate endolysosomal LC3 lipidation</span></div><div class="casAuthors">Florey Oliver; Gammoh Noor; Kim Sung Eun; Jiang Xuejun; Overholtzer Michael</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">88-99</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Recently a noncanonical activity of autophagy proteins has been discovered that targets lipidation of microtubule-associated protein 1 light chain 3 (LC3) onto macroendocytic vacuoles, including macropinosomes, phagosomes, and entotic vacuoles.  While this pathway is distinct from canonical autophagy, the mechanism of how these nonautophagic membranes are targeted for LC3 lipidation remains unclear.  Here we present evidence that this pathway requires activity of the vacuolar-type H(+)-ATPase (V-ATPase) and is induced by osmotic imbalances within endolysosomal compartments.  LC3 lipidation by this mechanism is induced by treatment of cells with the lysosomotropic agent chloroquine, and through exposure to the Heliobacter pylori pore-forming toxin VacA.  These data add novel mechanistic insights into the regulation of noncanonical LC3 lipidation and its associated processes, including LC3-associated phagocytosis (LAP), and demonstrate that the widely and therapeutically used drug chloroquine, which is conventionally used to inhibit autophagy flux, is an inducer of LC3 lipidation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3XZd4i2M3Sv6xYuD7tu2XfW6udTcc2eYuq8cIxVSUprntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MzmtVynsg%253D%253D&md5=0f3e78cc0dfbde641583c6326a8843db</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.4161%2F15548627.2014.984277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252F15548627.2014.984277%26sid%3Dliteratum%253Aachs%26aulast%3DFlorey%26aufirst%3DO.%26aulast%3DGammoh%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DS.%2BE.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DOverholtzer%26aufirst%3DM.%26atitle%3DV-ATPase%2520and%2520osmotic%2520imbalances%2520activate%2520endolysosomal%2520LC3%2520lipidation%26jtitle%3DAutophagy%26date%3D2015%26volume%3D11%26spage%3D88%26epage%3D99%26doi%3D10.4161%2F15548627.2014.984277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kessenbrock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plaks, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werb, Z.</span></span> <span> </span><span class="NLM_article-title">Matrix metalloproteinases: regulators of the tumor microenvironment</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2010.03.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2Fj.cell.2010.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=20371345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2010&pages=52-67&author=K.+Kessenbrockauthor=V.+Plaksauthor=Z.+Werb&title=Matrix+metalloproteinases%3A+regulators+of+the+tumor+microenvironment&doi=10.1016%2Fj.cell.2010.03.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases: regulators of the tumor microenvironment</span></div><div class="casAuthors">Kessenbrock, Kai; Plaks, Vicki; Werb, Zena</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-67</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Extracellular proteolysis mediates tissue homeostasis.  In cancer, altered proteolysis leads to unregulated tumor growth, tissue remodeling, inflammation, tissue invasion, and metastasis.  The matrix metalloproteinases (MMPs) represent the most prominent family of proteinases assocd. with tumorigenesis.  Recent technol. developments have markedly advanced our understanding of MMPs as modulators of the tumor microenvironment.  In addn. to their role in extracellular matrix turnover and cancer cell migration, MMPs regulate signaling pathways that control cell growth, inflammation, or angiogenesis and may even work in a nonproteolytic manner.  These aspects of MMP function are reorienting our approaches to cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAwNenyy027LVg90H21EOLACvtfcHk0lj_lPybDV3tcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSgtb4%253D&md5=fb7ee4c41ef31db0310b985e87bcdb94</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DKessenbrock%26aufirst%3DK.%26aulast%3DPlaks%26aufirst%3DV.%26aulast%3DWerb%26aufirst%3DZ.%26atitle%3DMatrix%2520metalloproteinases%253A%2520regulators%2520of%2520the%2520tumor%2520microenvironment%26jtitle%3DCell%26date%3D2010%26volume%3D141%26spage%3D52%26epage%3D67%26doi%3D10.1016%2Fj.cell.2010.03.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizwanullah, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, K.</span></span> <span> </span><span class="NLM_article-title">PI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2181</span>– <span class="NLM_lpage">2191</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2019.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2Fj.drudis.2019.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=31520748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVWju7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2019&pages=2181-2191&author=M.+A.+Khanauthor=V.+K.+Jainauthor=M.+Rizwanullahauthor=J.+Ahmadauthor=K.+Jain&title=PI3K%2FAKT%2FmTOR+pathway+inhibitors+in+triple-negative+breast+cancer%3A+a+review+on+drug+discovery+and+future+challenges&doi=10.1016%2Fj.drudis.2019.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">PI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges</span></div><div class="casAuthors">Khan, Mohammad A.; Jain, Vineet K.; Rizwanullah, Md.; Ahmad, Javed; Jain, Keerti</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2181-2191</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Triple-neg. breast cancer (TNBC) is a highly malignant subtype of breast cancer assocd. with poor prognosis.  Although conventional chemotherapy regimens have shown some effectiveness in early TNBC cases, the outcome in advanced stages is poor.  The PI3K/AKT/mTOR pathway is one of the important and active pathways involved in chemoresistance and survival of TNBC.  This pathway is speculated to play an important part in malignant transformation and has been considered as a potential mol. target for the design of therapeutic agents to treat TNBC.  This review discusses the potentials and drug discovery perspectives of PI3K/AKT/mTOR as a therapeutic target for effective management of TNBC with anticipated challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4h1LPJcV0U7Vg90H21EOLACvtfcHk0lj_lPybDV3tcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVWju7rF&md5=dbde097d9af193befbd393d8b62a9136</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2019.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2019.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DM.%2BA.%26aulast%3DJain%26aufirst%3DV.%2BK.%26aulast%3DRizwanullah%26aufirst%3DM.%26aulast%3DAhmad%26aufirst%3DJ.%26aulast%3DJain%26aufirst%3DK.%26atitle%3DPI3K%252FAKT%252FmTOR%2520pathway%2520inhibitors%2520in%2520triple-negative%2520breast%2520cancer%253A%2520a%2520review%2520on%2520drug%2520discovery%2520and%2520future%2520challenges%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2019%26volume%3D24%26spage%3D2181%26epage%3D2191%26doi%3D10.1016%2Fj.drudis.2019.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manning, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toker, A.</span></span> <span> </span><span class="NLM_article-title">AKT/PKB Signaling: Navigating the Network</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">405</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2Fj.cell.2017.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=28431241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsVamuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2017&pages=381-405&author=B.+D.+Manningauthor=A.+Toker&title=AKT%2FPKB+Signaling%3A+Navigating+the+Network&doi=10.1016%2Fj.cell.2017.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">AKT/PKB signaling: Navigating the network</span></div><div class="casAuthors">Manning, Brendan D.; Toker, Alex</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">381-405</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The Ser and Thr kinase AKT, also known as protein kinase B (PKB), was discovered 25 years ago and has been the focus of tens of thousands of studies in diverse fields of biol. and medicine.  There have been many advances in our knowledge of the upstream regulatory inputs into AKT, key multifunctional downstream signaling nodes (GSK3, FoxO, mTORC1), which greatly expand the functional repertoire of AKT, and the complex circuitry of this dynamically branching and looping signaling network that is ubiquitous to nearly every cell in our body.  Mouse and human genetic studies have also revealed physiol. roles for the AKT network in nearly every organ system.  Our comprehension of AKT regulation and functions is particularly important given the consequences of AKT dysfunction in diverse pathol. settings, including developmental and overgrowth syndromes, cancer, cardiovascular disease, insulin resistance and type 2 diabetes, inflammatory and autoimmune disorders, and neurol. disorders.  There has also been much progress in developing AKT-selective small mol. inhibitors.  Improved understanding of the mol. wiring of the AKT signaling network continues to make an impact that cuts across most disciplines of the biomedical sciences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-kLW6vEG_DrVg90H21EOLACvtfcHk0lha0d80-46-_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsVamuro%253D&md5=46302014c33b00c447f187eeaf0162c4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DB.%2BD.%26aulast%3DToker%26aufirst%3DA.%26atitle%3DAKT%252FPKB%2520Signaling%253A%2520Navigating%2520the%2520Network%26jtitle%3DCell%26date%3D2017%26volume%3D169%26spage%3D381%26epage%3D405%26doi%3D10.1016%2Fj.cell.2017.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voegtli, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturgis, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dizon, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigers, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandhuber, B. J.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e12913</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0012913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1371%2Fjournal.pone.0012913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=20886116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A280%3ADC%252BC3cfmvVehsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&author=W.+I.+Wuauthor=W.+C.+Voegtliauthor=H.+L.+Sturgisauthor=F.+P.+Dizonauthor=G.+P.+Vigersauthor=B.+J.+Brandhuber&title=Crystal+structure+of+human+AKT1+with+an+allosteric+inhibitor+reveals+a+new+mode+of+kinase+inhibition&doi=10.1371%2Fjournal.pone.0012913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition</span></div><div class="casAuthors">Wu Wen-I; Voegtli Walter C; Sturgis Hillary L; Dizon Faith P; Vigers Guy P A; Brandhuber Barbara J</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e12913</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AKT1 (NP_005154.2) is a member of the serine/threonine AGC protein kinase family involved in cellular metabolism, growth, proliferation and survival.  The three human AKT isozymes are highly homologous multi-domain proteins with both overlapping and distinct cellular functions.  Dysregulation of the AKT pathway has been identified in multiple human cancers.  Several clinical trials are in progress to test the efficacy of AKT pathway inhibitors in treating cancer.  Recently, a series of AKT isozyme-selective allosteric inhibitors have been reported.  They require the presence of both the pleckstrin-homology (PH) and kinase domains of AKT, but their binding mode has not yet been elucidated.  We present here a 2.7 Å resolution co-crystal structure of human AKT1 containing both the PH and kinase domains with a selective allosteric inhibitor bound in the interface.  The structure reveals the interactions between the PH and kinase domains, as well as the critical amino residues that mediate binding of the inhibitor to AKT1.  Our work also reveals an intricate balance in the enzymatic regulation of AKT, where the PH domain appears to lock the kinase in an inactive conformation and the kinase domain disrupts the phospholipid binding site of the PH domain.  This information advances our knowledge in AKT1 structure and regulation, thereby providing a structural foundation for interpreting the effects of different classes of AKT inhibitors and designing selective ones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSn0Rujn_TlTKcY7HFp97qMfW6udTcc2ea9R8OPXlGhubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfmvVehsw%253D%253D&md5=133c82c3c9f5c3cf6f5a34cf2b4881a3</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0012913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0012913%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.%2BI.%26aulast%3DVoegtli%26aufirst%3DW.%2BC.%26aulast%3DSturgis%26aufirst%3DH.%2BL.%26aulast%3DDizon%26aufirst%3DF.%2BP.%26aulast%3DVigers%26aufirst%3DG.%2BP.%26aulast%3DBrandhuber%26aufirst%3DB.%2BJ.%26atitle%3DCrystal%2520structure%2520of%2520human%2520AKT1%2520with%2520an%2520allosteric%2520inhibitor%2520reveals%2520a%2520new%2520mode%2520of%2520kinase%2520inhibition%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26doi%3D10.1371%2Fjournal.pone.0012913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcomer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kevala, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnaeva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patnaik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southall, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marugan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. Y.</span></span> <span> </span><span class="NLM_article-title">Identification of 4-phenylquinolin-2(1H)-one as a specific allosteric inhibitor of Akt</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">11673</span> <span class="refDoi"> DOI: 10.1038/s41598-017-11870-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1038%2Fs41598-017-11870-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=28916818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A280%3ADC%252BC1cbptF2rsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&author=B.+X.+Huangauthor=K.+Newcomerauthor=K.+Kevalaauthor=E.+Barnaevaauthor=W.+Zhengauthor=X.+Huauthor=S.+Patnaikauthor=N.+Southallauthor=J.+Maruganauthor=M.+Ferrerauthor=H.+Y.+Kim&title=Identification+of+4-phenylquinolin-2%281H%29-one+as+a+specific+allosteric+inhibitor+of+Akt&doi=10.1038%2Fs41598-017-11870-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of 4-phenylquinolin-2(1H)-one as a specific allosteric inhibitor of Akt</span></div><div class="casAuthors">Huang Bill X; Newcomer Kenny; Kevala Karl; Kim Hee-Yong; Barnaeva Elena; Zheng Wei; Hu Xin; Patnaik Samarjit; Southall Noel; Marugan Juan; Ferrer Marc</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11673</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Akt plays a major role in tumorigenesis and the development of specific Akt inhibitors as effective cancer therapeutics has been challenging.  Here, we report the identification of a highly specific allosteric inhibitor of Akt through a FRET-based high-throughput screening, and characterization of its inhibitory mechanism.  Out of 373,868 compounds screened, 4-phenylquinolin-2(1H)-one specifically decreased Akt phosphorylation at both T308 and S473, and inhibited Akt kinase activity (IC50 = 6 μM) and downstream signaling. 4-Phenylquinolin-2(1H)-one did not alter the activity of upstream kinases including PI3K, PDK1, and mTORC2 as well as closely related kinases that affect cell proliferation and survival such as SGK1, PKA, PKC, or ERK1/2.  This compound inhibited the proliferation of cancer cells but displayed less toxicity compared to inhibitors of PI3K or mTOR.  Kinase profiling efforts revealed that 4-phenylquinolin-2(1H)-one does not bind to the kinase active site of over 380 human kinases including Akt.  However, 4-phenylquinolin-2(1H)-one interacted with the PH domain of Akt, apparently inducing a conformation that hinders S473 and T308 phosphorylation by mTORC2 and PDK1.  In conclusion, we demonstrate that 4-phenylquinolin-2(1H)-one is an exquisitely selective Akt inhibitor with a distinctive molecular mechanism, and a promising lead compound for further optimization toward the development of novel cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQbbUFiOf_cY4qdXsLcGTEUfW6udTcc2ea9R8OPXlGhubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cbptF2rsA%253D%253D&md5=6c4dfc2d1a5aa44b506a6470c34caadc</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-11870-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-11870-1%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DB.%2BX.%26aulast%3DNewcomer%26aufirst%3DK.%26aulast%3DKevala%26aufirst%3DK.%26aulast%3DBarnaeva%26aufirst%3DE.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DPatnaik%26aufirst%3DS.%26aulast%3DSouthall%26aufirst%3DN.%26aulast%3DMarugan%26aufirst%3DJ.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DH.%2BY.%26atitle%3DIdentification%2520of%25204-phenylquinolin-2%25281H%2529-one%2520as%2520a%2520specific%2520allosteric%2520inhibitor%2520of%2520Akt%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26doi%3D10.1038%2Fs41598-017-11870-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jucker, M.</span></span> <span> </span><span class="NLM_article-title">Distinct functions of AKT isoforms in breast cancer: a comprehensive review</span>. <i>Cell Commun. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span>, <span class="NLM_elocation-id">154</span> <span class="refDoi"> DOI: 10.1186/s12964-019-0450-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1186%2Fs12964-019-0450-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=31752925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlKiu7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&author=N.+Hinzauthor=M.+Jucker&title=Distinct+functions+of+AKT+isoforms+in+breast+cancer%3A+a+comprehensive+review&doi=10.1186%2Fs12964-019-0450-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct functions of AKT isoforms in breast cancer: a comprehensive review</span></div><div class="casAuthors">Hinz, Nico; Juecker, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Cell Communication and Signaling</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">154</span>CODEN:
                <span class="NLM_cas:coden">CCSEC6</span>;
        ISSN:<span class="NLM_cas:issn">1478-811X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Background: AKT, also known as protein kinase B, is a key element of the PI3K/AKT signaling pathway.  Moreover, AKT regulates the hallmarks of cancer, e.g. tumor growth, survival and invasiveness of tumor cells.  After AKT was discovered in the early 1990s, further studies revealed that there are three different AKT isoforms, namely AKT1, AKT2 and AKT3.  Despite their high similarity of 80%, the distinct AKT isoforms exert non-redundant, partly even opposing effects under physiol. and pathol. conditions.  Breast cancer as the most common cancer entity in women, frequently shows alterations of the PI3K/AKT signaling.  Main content: A plethora of studies addressed the impact of AKT isoforms on tumor growth, metastasis and angiogenesis of breast cancer as well as on therapy response and overall survival in patients.  Therefore, this review aimed to give a comprehensive overview about the isoform-specific effects of AKT in breast cancer and to summarize known downstream and upstream mechanisms.  Taking account of conflicting findings among the studies, the majority of the studies reported a tumor initiating role of AKT1, whereas AKT2 is mainly responsible for tumor progression and metastasis.  In detail, AKT1 increases cell proliferation through cell cycle proteins like p21, p27 and cyclin D1 and impairs apoptosis e.g. via p53.  On the downside AKT1 decreases migration of breast cancer cells, for instance by regulating TSC2, palladin and EMT-proteins.  However, AKT2 promotes migration and invasion most notably through regulation of β-integrins, EMT-proteins and F-actin.  While AKT3 is assocd. with a neg. ER-status, findings about the role of AKT3 in regulation of the key properties of breast cancer are sparse.  Accordingly, AKT1 is mutated and AKT2 is amplified in some cases of breast cancer and AKT isoforms are assocd. with overall survival and therapy response in an isoform-specific manner.  Conclusions: Although there are several discussed hypotheses how isoform specificity is achieved, the mechanisms behind the isoform-specific effects remain mostly unrevealed.  As a consequence, further effort is necessary to achieve deeper insights into an isoform-specific AKT signaling in breast cancer and the mechanism behind it.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6J0u0yDk2N7Vg90H21EOLACvtfcHk0li1CmBv9xomJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlKiu7rK&md5=778c10b62fbf43b381479463a29a6ee4</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1186%2Fs12964-019-0450-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12964-019-0450-3%26sid%3Dliteratum%253Aachs%26aulast%3DHinz%26aufirst%3DN.%26aulast%3DJucker%26aufirst%3DM.%26atitle%3DDistinct%2520functions%2520of%2520AKT%2520isoforms%2520in%2520breast%2520cancer%253A%2520a%2520comprehensive%2520review%26jtitle%3DCell%2520Commun.%2520Signaling%26date%3D2019%26volume%3D17%26doi%3D10.1186%2Fs12964-019-0450-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Molina, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jafari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignatushchenko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sreekumar, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordlund, P.</span></span> <span> </span><span class="NLM_article-title">Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>341</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1126/science.1233606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1126%2Fscience.1233606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=23828940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVCgs7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2013&pages=84-87&author=D.+M.+Molinaauthor=R.+Jafariauthor=M.+Ignatushchenkoauthor=T.+Sekiauthor=E.+A.+Larssonauthor=C.+Danauthor=L.+Sreekumarauthor=Y.+Caoauthor=P.+Nordlund&title=Monitoring+drug+target+engagement+in+cells+and+tissues+using+the+cellular+thermal+shift+assay&doi=10.1126%2Fscience.1233606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay</span></div><div class="casAuthors">Molina, Daniel Martinez; Jafari, Rozbeh; Ignatushchenko, Marina; Seki, Takahiro; Larsson, E. Andreas; Dan, Chen; Sreekumar, Lekshmy; Cao, Yihai; Nordlund, Paer</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">6141</span>),
    <span class="NLM_cas:pages">84-87</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The efficacy of therapeutics is dependent on a drug binding to its cognate target.  Optimization of target engagement by drugs in cells is often challenging, because drug binding cannot be monitored inside cells.  We have developed a method for evaluating drug binding to target proteins in cells and tissue samples.  This cellular thermal shift assay (CETSA) is based on the biophys. principle of ligand-induced thermal stabilization of target proteins.  Using this assay, we validated drug binding for a set of important clin. targets and monitored processes of drug transport and activation, off-target effects and drug resistance in cancer cell lines, as well as drug distribution in tissues.  CETSA is likely to become a valuable tool for the validation and optimization of drug target engagement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaaWSoozY7ObVg90H21EOLACvtfcHk0li1CmBv9xomJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVCgs7rP&md5=f8ba686ba38b67dbdf366c49eb7375b4</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1126%2Fscience.1233606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1233606%26sid%3Dliteratum%253Aachs%26aulast%3DMolina%26aufirst%3DD.%2BM.%26aulast%3DJafari%26aufirst%3DR.%26aulast%3DIgnatushchenko%26aufirst%3DM.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DLarsson%26aufirst%3DE.%2BA.%26aulast%3DDan%26aufirst%3DC.%26aulast%3DSreekumar%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DNordlund%26aufirst%3DP.%26atitle%3DMonitoring%2520drug%2520target%2520engagement%2520in%2520cells%2520and%2520tissues%2520using%2520the%2520cellular%2520thermal%2520shift%2520assay%26jtitle%3DScience%26date%3D2013%26volume%3D341%26spage%3D84%26epage%3D87%26doi%3D10.1126%2Fscience.1233606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, D.</span></span> <span> </span><span class="NLM_article-title">AKT and ERK dual inhibitors: The way forward?</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>459</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2019.05.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2Fj.canlet.2019.05.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=31128213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFensLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=459&publication_year=2019&pages=30-40&author=Z.+Caoauthor=Q.+Liaoauthor=M.+Suauthor=K.+Huangauthor=J.+Jinauthor=D.+Cao&title=AKT+and+ERK+dual+inhibitors%3A+The+way+forward%3F&doi=10.1016%2Fj.canlet.2019.05.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">AKT and ERK dual inhibitors: The way forward?</span></div><div class="casAuthors">Cao, Zhe; Liao, Qianjin; Su, Min; Huang, Kai; Jin, Junfei; Cao, Deliang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">459</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">30-40</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Phosphatidylinositol 3-kinase (PI3K)/AKT pathway regulates cell growth, proliferation, survival, mobility and invasion.  Mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) pathway is also an important mitogenic signaling pathway involved in various cellular progresses.  AKT, also named protein kinase B (PKB), is a primary mediator of the PI3K signaling pathway; and ERK at the end of MAPK signaling is the unique substrate and downstream effector of mitogen-activated protein/extracellular signal-regulated kinase (MEK).  The AKT and ERK signaling are both aberrantly activated in a wide range of human cancers and have long been targeted for cancer therapy, but the clin. benefits of these targeted therapies have been limited due to complex cross-talk.  Novel strategies, such as AKT/ERK dual inhibitors, may be needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2mQop_AQFH7Vg90H21EOLACvtfcHk0li1CmBv9xomJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFensLnE&md5=bdb7fd9232b6f75f46b0800a2627a4e1</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2019.05.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2019.05.025%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DLiao%26aufirst%3DQ.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DK.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DD.%26atitle%3DAKT%2520and%2520ERK%2520dual%2520inhibitors%253A%2520The%2520way%2520forward%253F%26jtitle%3DCancer%2520Lett.%26date%3D2019%26volume%3D459%26spage%3D30%26epage%3D40%26doi%3D10.1016%2Fj.canlet.2019.05.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, G.</span></span> <span> </span><span class="NLM_article-title">Dual inhibition of Akt and ERK signaling induces cell senescence in triple-negative breast cancer</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>448</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2019.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2Fj.canlet.2019.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=30742942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjt1Clsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=448&publication_year=2019&pages=94-104&author=Q.+Heauthor=S.+Xueauthor=Y.+Tanauthor=L.+Zhangauthor=Q.+Shaoauthor=L.+Xingauthor=Y.+Liauthor=T.+Xiangauthor=X.+Luoauthor=G.+Ren&title=Dual+inhibition+of+Akt+and+ERK+signaling+induces+cell+senescence+in+triple-negative+breast+cancer&doi=10.1016%2Fj.canlet.2019.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Dual inhibition of Akt and ERK signaling induces cell senescence in triple-negative breast cancer</span></div><div class="casAuthors">He, Qiang; Xue, Shuyin; Tan, Yiqing; Zhang, Ling; Shao, Qing; Xing, Lei; Li, Yunhai; Xiang, Tingxiu; Luo, Xinrong; Ren, Guosheng</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">448</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">94-104</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Activated Akt and ERK signaling pathways are closely related to breast cancer progression, and Akt or ERK inhibition induces cell senescence.  However, the crosstalk between the Akt and ERK signaling pathways in cell senescence and how to simultaneously suppress Akt and ERK signaling in triple-neg. breast cancer (TNBC) are undefined.  In this study, we found that norcantharidin (NCTD) effectively induced cell senescence and cell cycle arrest in TNBC in vitro, which was accompanied by a decline in phosphorylated Akt and ERK1/2 and a rise in p21 and p16.  The inhibitors LY294002 and U0126 imitated the effect of NCTD when these two inhibitors were combined regardless of crosstalk between these two signaling pathways.  In addn., NCTD inhibited the growth of xenografts via downregulation of phosphorylated Akt and ERK1/2 and upregulation of p21 in vivo.  However, NCTD upregulated the level of sol. signaling factors of the senescence-assocd. secretory phenotype (SASP) in a NF-κB-independent manner.  Collectively, these findings demonstrate that NCTD induced cell senescence and cell cycle arrest mainly by simultaneously blocking Akt and ERK signaling in TNBC, suggesting that NCTD may be used as a potential adjuvant therapy in TNBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCyKsXlTOVZLVg90H21EOLACvtfcHk0lgRhwgOk7RzPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjt1Clsbo%253D&md5=22793342d13431bd800588b9ec09545c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2019.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2019.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DQ.%26aulast%3DXue%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DShao%26aufirst%3DQ.%26aulast%3DXing%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXiang%26aufirst%3DT.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DRen%26aufirst%3DG.%26atitle%3DDual%2520inhibition%2520of%2520Akt%2520and%2520ERK%2520signaling%2520induces%2520cell%2520senescence%2520in%2520triple-negative%2520breast%2520cancer%26jtitle%3DCancer%2520Lett.%26date%3D2019%26volume%3D448%26spage%3D94%26epage%3D104%26doi%3D10.1016%2Fj.canlet.2019.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yerushalmi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravdin, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelmon, K. A.</span></span> <span> </span><span class="NLM_article-title">Ki67 in breast cancer: prognostic and predictive potential</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">174</span>– <span class="NLM_lpage">183</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(09)70262-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1016%2FS1470-2045%2809%2970262-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=20152769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGgtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=174-183&author=R.+Yerushalmiauthor=R.+Woodsauthor=P.+M.+Ravdinauthor=M.+M.+Hayesauthor=K.+A.+Gelmon&title=Ki67+in+breast+cancer%3A+prognostic+and+predictive+potential&doi=10.1016%2FS1470-2045%2809%2970262-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Ki67 in breast cancer: prognostic and predictive potential</span></div><div class="casAuthors">Yerushalmi, Rinat; Woods, Ryan; Ravdin, Peter M.; Hayes, Malcolm M.; Gelmon, Karen A.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">174-183</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The leading parameters that define treatment recommendations in early breast cancer are estrogen-receptor, progesterone-receptor, and human epidermal growth-factor status.  Although some pathologists report Ki67 in addn. to other biol. markers, the existing guidelines of the American Society of Clin. Oncol. do not include Ki67 in the list of required routine biol. markers.  The advent of new genetic tests has emphasized the role of proliferative genes, including Ki67, as prognostic and predictive markers.  Addnl., randomized studies have retrospectively reviewed data and reported on the role of Ki67 in breast cancer.  In light of new data, we have re-assessed evidence that could change guidelines to include Ki67 in the std. pathol. assessment of early breast cancers.  This review provides an update on the current knowledge on Ki67 and of the evidence in the published work about the prognostic and predictive role of this marker, and provides information on the lab. techniques used to det. Ki67.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR3zXY3j2qZLVg90H21EOLACvtfcHk0lgRhwgOk7RzPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGgtbc%253D&md5=ddda49417249c3505a39b116155ac751</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2809%2970262-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252809%252970262-1%26sid%3Dliteratum%253Aachs%26aulast%3DYerushalmi%26aufirst%3DR.%26aulast%3DWoods%26aufirst%3DR.%26aulast%3DRavdin%26aufirst%3DP.%2BM.%26aulast%3DHayes%26aufirst%3DM.%2BM.%26aulast%3DGelmon%26aufirst%3DK.%2BA.%26atitle%3DKi67%2520in%2520breast%2520cancer%253A%2520prognostic%2520and%2520predictive%2520potential%26jtitle%3DLancet%2520Oncol.%26date%3D2010%26volume%3D11%26spage%3D174%26epage%3D183%26doi%3D10.1016%2FS1470-2045%2809%2970262-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindley, D. N.</span></span> <span> </span><span class="NLM_article-title">Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-kappaB activation</span>. <i>Mol. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>, <span class="NLM_elocation-id">36</span> <span class="refDoi"> DOI: 10.1186/s12943-017-0607-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1186%2Fs12943-017-0607-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=28178994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjt1CrsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&author=X.+Tangauthor=X.+Wangauthor=Y.+Y.+Zhaoauthor=J.+M.+Curtisauthor=D.+N.+Brindley&title=Doxycycline+attenuates+breast+cancer+related+inflammation+by+decreasing+plasma+lysophosphatidate+concentrations+and+inhibiting+NF-kappaB+activation&doi=10.1186%2Fs12943-017-0607-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Doxycycline attenuates breast cancer related inflammation by decreasing plasmalysophosphatidate concentrations andinhibiting NF-κB activation</span></div><div class="casAuthors">Tang, Xiaoyun; Wang, Xianyan; Zhao, Yuan Y.; Curtis, Jonathan M.; Brindley, David N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36/1-36/13</span>CODEN:
                <span class="NLM_cas:coden">MCOACG</span>;
        ISSN:<span class="NLM_cas:issn">1476-4598</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">We previously discovered that tetracyclines increase the expression of lipid phosphate phosphatases at the surface of cells.  These enzymes degrade circulating lysophosphatidate and therefore doxycycline increases the turnover of plasma lysophosphatidate and decreases its concn.  Extracellular lysophosphatidate signals through six G protein-coupled receptors and it is a potent promoter of tumor growth, metastasis and chemo-resistance.  These effects depend partly on the stimulation of inflammation that lysophosphatidate produces.  In this work, we used a syngeneic orthotopic mouse model of breast cancer to det. the impact of doxycycline on circulating lysophosphatidate concns. and tumor growth.  Cytokine/chemokine concns. in tumor tissue and plasma were measured by multiplexing laser bead technol.  Leukocyte infiltration in tumors was analyzed by immunohistochem.  The expression of IL-6 in breast cancer cell lines was detd. by RT-PCR.  Cell growth was measured in MatrigelTM 3D culture.  The effects of doxycycline on NF-κB-dependent signaling were analyzed by Western blotting.  Doxycycline decreased plasma lysophosphatidate concns., delayed tumor growth and decreased the concns. of several cytokines/chemokines (IL-1β, IL-6, IL-9, CCL2, CCL11, CXCL1, CXCL2, CXCL9, G-CSF, LIF, VEGF) in the tumor.  These results were compatible with the effects of doxycycline in decreasing the nos. of F4/80 + macrophages and CD31 + blood vessel endothelial cells in the tumor.  Doxycycline also decreased the lysophosphatidate-induced growth of breast cancer cells in three-dimensional culture.  Lysophosphatidate- induced Ki-67 expression was inhibited by doxycycline.  NF-κB activity in HEK293 cells transiently expressing a NF- κB-luciferase reporter vectors was also inhibited by doxycycline.  Treatment of breast cancer cells with doxycycline also decreased the translocation of NF-κB to the nucleus and the mRNA levels for IL-6 in the presence or absence of lysophosphatidate.  These results contribute a new dimension for understanding the anti-inflammatory effects of tetracyclines, which make them potential candidates for adjuvant therapy of cancers and other inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoB_4y4uJ3yubVg90H21EOLACvtfcHk0lhuxSn02KnMAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjt1CrsLY%253D&md5=f98326254031c757329f74d7a70851da</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1186%2Fs12943-017-0607-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12943-017-0607-x%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DY.%2BY.%26aulast%3DCurtis%26aufirst%3DJ.%2BM.%26aulast%3DBrindley%26aufirst%3DD.%2BN.%26atitle%3DDoxycycline%2520attenuates%2520breast%2520cancer%2520related%2520inflammation%2520by%2520decreasing%2520plasma%2520lysophosphatidate%2520concentrations%2520and%2520inhibiting%2520NF-kappaB%2520activation%26jtitle%3DMol.%2520Cancer%26date%3D2017%26volume%3D16%26doi%3D10.1186%2Fs12943-017-0607-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Si, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, J.</span></span> <span> </span><span class="NLM_article-title">Potent effects of dioscin against pancreatic cancer via miR-149-3P-mediated inhibition of the Akt1 signalling pathway</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">553</span>– <span class="NLM_lpage">568</span>, <span class="refDoi"> DOI: 10.1111/bph.13718</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=10.1111%2Fbph.13718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=28095588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;key=1%3ACAS%3A528%3ADC%252BC2sXis1Wqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2017&pages=553-568&author=L.+Siauthor=L.+Xuauthor=L.+Yinauthor=Y.+Qiauthor=X.+Hanauthor=Y.+Xuauthor=Y.+Zhaoauthor=K.+Liuauthor=J.+Peng&title=Potent+effects+of+dioscin+against+pancreatic+cancer+via+miR-149-3P-mediated+inhibition+of+the+Akt1+signalling+pathway&doi=10.1111%2Fbph.13718"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Potent effects of dioscin against pancreatic cancer via miR-149-3P-mediated inhibition of the Akt1 signalling pathway</span></div><div class="casAuthors">Si, Lingling; Xu, Lina; Yin, Lianhong; Qi, Yan; Han, Xu; Xu, Youwei; Zhao, Yanyan; Liu, Kexin; Peng, Jinyong</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">553-568</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : The aim of the present study was to investigate the effects and possible underlying mechanisms of dioscin against pancreatic cancer in vitro and in vivo.  Exptl. Approach : In vitro actions of dioscin on viability of ASPC-1 and PANC-1 cells, and in vivo effects to suppress the tumor growth of cell xenografts in nude mice were assessed.  In addn., microRNA microarray anal. detd. which microRNAs were affected by dioscin.  The mechanisms underlying the actions of dioscin against pancreatic cancer were elucidated in terms of Akt1 and other proteins related to apoptosis.  Key Results : Dioscin markedly induced apoptosis and significantly suppressed the tumor growth of ASPC-1 and PANC-1 cell xenografts, in nude mice.  Total of 107 microRNAs with differential changes were found, in which miR-149-3P targeted with Akt1 was markedly up-regulated by dioscin.  Further studies showed that dioscin significantly down-regulated Akt1 levels, and thus induced cell apoptosis by increasing the levels of Bax, Apaf-1, cleaved caspase-3/9, cleaved PARP, suppressing Bcl-2 levels, and causing cytochrome c release.  The effects of an inhibitor of miR-149-3P and of siRNA of testicular Akt1 suggested that dioscin showed excellent activity against pancreatic cancer via miR- 149-3P-mediated inhibition of Akt1 signalling pathway.  Conclusions and Implications : Collectively, these findings confirmed the potent effects of dioscin against pancreatic cancer and also provided novel insights into the mechanisms of the compd. as a potential candidate for the treatment of pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwPhYBUV2sSLVg90H21EOLACvtfcHk0lhuxSn02KnMAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXis1Wqsbg%253D&md5=cce37dbc551bd956bfa888bab926991f</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1111%2Fbph.13718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13718%26sid%3Dliteratum%253Aachs%26aulast%3DSi%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DYin%26aufirst%3DL.%26aulast%3DQi%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DPeng%26aufirst%3DJ.%26atitle%3DPotent%2520effects%2520of%2520dioscin%2520against%2520pancreatic%2520cancer%2520via%2520miR-149-3P-mediated%2520inhibition%2520of%2520the%2520Akt1%2520signalling%2520pathway%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D174%26spage%3D553%26epage%3D568%26doi%3D10.1111%2Fbph.13718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i67"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00166">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_28077"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00166?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00166</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H–<sup>1</sup>H COSY and key HMBC correlations of <b>1</b> and <b>2</b> (Figure S1); key NOE correlations of compound <b>1</b> (Figure S2); proliferation inhibition of <b>6</b> on TNBC cells incubated under different conditions (Figure S3); PI3Kα kinase assay performed by ADP-Glo assay (Figure S4); survival curve of mice during the treatments1D and 2D NMR spectra and the purity analyses by HPLC or TLC of <b>1</b>–<b>25</b> (Figure S5); IR and HRESIMS spectra of new compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00166/suppl_file/jm1c00166_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings for compounds <b>1</b>–<b>25</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00166/suppl_file/jm1c00166_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00166/suppl_file/jm1c00166_si_001.pdf">jm1c00166_si_001.pdf (15.92 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00166/suppl_file/jm1c00166_si_002.csv">jm1c00166_si_002.csv (3.23 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.1c00166&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.1c00166%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-14" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.1c00166" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679960568e471243","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
